Administration (pdf) - Antimicrobial Agents and Chemotherapy ...
30.10.2012 • Views
Share Embed Flag

Administration (pdf) - Antimicrobial Agents and Chemotherapy ...

Administration (pdf) - Antimicrobial Agents and Chemotherapy ...

Administration (pdf) - Antimicrobial Agents and Chemotherapy ...

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
aac.asm.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

Robert C. Moellering, Jr.,<br />

Editor in Chief (1990)<br />

New Engl<strong>and</strong> Deaconess Hospital<br />

Boston, Mass.<br />

Michael Barza, Editor (1990)<br />

New Engl<strong>and</strong> Medical Center<br />

Hospitals<br />

Boston, Mass.<br />

Lawrence E. Bryan, Editor (1992)<br />

University of Calgary<br />

Calgary, Alberta, Canada<br />

Vincent T. Andriole (1990)<br />

Bascom F. Anthony (1988)<br />

Gordon L. Archer (1989)<br />

George R. Aronoff (1989)<br />

Rashmi H. Barbhaiya (1989)<br />

Arthur L. Barry (1989)<br />

John G. Bartlett (1990)<br />

Arnold S. Bayer (1988)<br />

William M. Bennett (1990)<br />

Michel G. Bergeron (1989)<br />

Richard F. Bergstrom (1988)<br />

Karen K. Biron (1990)<br />

Gerald P. Bodey (1989)<br />

Ward Bullock (1990)<br />

Tsun Chang (1989)<br />

Anthony Chow (1988)<br />

C. Glenn Cobbs (1989)<br />

Paul S. Cohen (1989)<br />

William A. Craig (1990)<br />

Naomi Datta (1990)<br />

Lawrence E. Day (1989)<br />

William E. Dismukes (1990)<br />

Gary V. Doern (1990)<br />

Susan M. Dorrbecker (1989)<br />

R. Gordon Douglas, Jr. (1989)<br />

John C. Drach (1990)<br />

George L. Drusano (1990)<br />

Theodore Eickhoff (1988)<br />

Gertrude B. Elion (1990)<br />

George M. Eliopoulos (1988)<br />

Arthur English (1989)<br />

ANTIMICROBIAL AGENTS AND<br />

CHEMOTHERAPY<br />

VOLUME 32 DECEMBER 1988 NUMBER 12<br />

Jack M. Gwaltney, Jr., Editor (1990)<br />

University of Virginia School of<br />

Medicine<br />

Charlottesville<br />

George A. Jacoby, Jr., Editor (1990)<br />

Massachusetts General Hospital<br />

Boston<br />

EDITORIAL BOARD<br />

Robert J. Fass (1988)<br />

Stuart Feldman (1988)<br />

Sydney Finegold (1988)<br />

Martin Forbes (1989)<br />

John N. Galgiani (1990)<br />

Dale N. Gerding (1988)<br />

Allan Godfrey (1990)<br />

Irving H. Goldberg (1988)<br />

Thomas D. Gootz (1988)<br />

Stephen B. Greenberg (1989)<br />

Scott M. Hammer (1989)<br />

Margaret R. Hammerschlag (1989)<br />

Robert E. W. Hancock (1989)<br />

W. Lee H<strong>and</strong> (1989)<br />

H. Hunter H<strong>and</strong>sfield (1989)<br />

Frederick G. Hayden (1990)<br />

Leonid B. Heifets (1990)<br />

Michael L. Higgins (1989)<br />

David C. Hooper (1990)<br />

Richard Hornick (1989)<br />

George Gee Jackson (1989)<br />

Michael R. Jacobs (1990)<br />

James H. Jorgensen (1990)<br />

William J. Jusko (1989)<br />

A. W. Karchmer (1988)<br />

Donald Kaye (1988)<br />

Mark S. Klempner (1989)<br />

George S. Kobayashi (1988)<br />

Jeffrey R. Koup (1990)<br />

Donald J. Krogstad (1989)<br />

Philip Todd Lavin (1989)<br />

Stephen A. Lerner (1989)<br />

Stuart B. Levy (1989)<br />

David R. Luke (1990)<br />

Joan Lusk (1989)<br />

R. Luthy (1989)<br />

Gerald L. M<strong>and</strong>ell (1989)<br />

Gary R. Matzke (1989)<br />

George H. McCracken (1990)<br />

Antone A. Medeiros (1990)<br />

Michael Miller (1990)<br />

Barbara E. Murray (1990)<br />

Henry W. Murray (1990)<br />

John D. Nelson (1989)<br />

Harold C. Neu (1989)<br />

Lawrence A. Pachla (1990)<br />

Joseph S. Pagano (1990)<br />

James E. Pennington (1989)<br />

T. J. Perun (1989)<br />

Lance R. Peterson (1988)<br />

W. H. G. Richards (1989)<br />

Douglas D. Richman (1990)<br />

Glenn D. Roberts (1989)<br />

Richard Roberts (1988)<br />

Ian M. Rollo (1988)<br />

Allan Ronald (1990)<br />

John P. Rosazza (1989)<br />

Jon E. Rosenblatt (1988)<br />

Robert H. Rubin (1990)<br />

Merle S<strong>and</strong>e (1988)<br />

W. Eugene S<strong>and</strong>ers, Jr. (1990)<br />

W. Michael Scheld (1989)<br />

Christine C. S<strong>and</strong>ers, Editor (1989)<br />

Creighton University School of<br />

Medicine<br />

Omaha, Neb.<br />

John A. Washington II, Editor (1991)<br />

Clevel<strong>and</strong> Clinic Foundation<br />

Clevel<strong>and</strong>, Ohio<br />

Peter G. Welling, Editor (1988)<br />

Warner-Lambert Co.<br />

Ann Arbor, Mich.<br />

Jerome J. Schentag (1988)<br />

Raymond F. Schinazi (1989)<br />

Fritz D. Schoenknecht (1989)<br />

Robert T. Schooley (1990)<br />

F. C. Sciavolino (1988)<br />

William M. Shannon (1989)<br />

Charles Shipman, Jr. (1988)<br />

David M. Shlaes (1988)<br />

Robert W. Sidwell (1990)<br />

Herbert M. Sommers (1989)<br />

P. Frederick Sparling (1990)<br />

Harold St<strong>and</strong>iford (1988)<br />

David A. Stevens (1989)<br />

Stephen E. Straus (1990)<br />

R. Sutherl<strong>and</strong> (1988)<br />

Morton N. Swartz (1988)<br />

Richard B. Sykes (1988)<br />

Francis P. Tally (1990)<br />

Fred C. Tenover (1988)<br />

Alex<strong>and</strong>er Tomasz (1988)<br />

Roger D. Toothaker (1988)<br />

Francis L. S. Tse (1989)<br />

Michael Waring (1990)<br />

Bernard Weisblum (1988)<br />

Peter F. Weller (1989)<br />

Richard Wise (1989)<br />

John S. Wolfson (1990)<br />

David J. Wyler (1989)<br />

Lowell Young (1988)<br />

Pauline K. W. Yu (1988)<br />

Helen R. Whiteley, Chairman, Publications Board Kirk Jensen, Director of Publications<br />

Linda M. Illig, Managing Editor, Journals<br />

Carol J. Neff, Production Editor<br />

<strong>Antimicrobial</strong> <strong>Agents</strong> <strong>and</strong> <strong>Chemotherapy</strong> (ISSN 0066-4804), an interdisciplinary publication of the American Society for Microbiology,<br />

1913 I St., N.W., Washington, DC 20006, is devoted to the dissemination of knowledge relating to all aspects of antimicrobial, antiparasitic,<br />

<strong>and</strong> anticancer agents <strong>and</strong> chemotherapy. Instructions to authors are published in the January issue each year; reprints are available from the<br />

editors <strong>and</strong> the Publications Department. <strong>Antimicrobial</strong> <strong>Agents</strong> <strong>and</strong> <strong>Chemotherapy</strong> is published monthly, one volume per year. The<br />

nonmember subscription price is $220 per year; single copies are $30. The member subscription price is $35 (foreign, $56 [air drop shipping])<br />

per year; single copies are $8. Correspondence relating to subscriptions, reprints, defective copies, availability of back issues, lost or late<br />

proofs, disposition of submitted manuscripts, <strong>and</strong> general editorial matters should be directed to the ASM Publications Department, 1913 I<br />

St., N.W., Washington, DC 20006 (phone: 202 833-9680).<br />

Claims for missing issues from residents of the United States, Canada, <strong>and</strong> Mexico must be submitted within 3 months after publication<br />

of the issues; residents of all other countries must submit claims within 6 months of publication of the issues. Claims for issues missing<br />

because of failure to report an address change or for issues "missing from files" will not be allowed.<br />

Second-class postage paid at Washington, DC 20006, <strong>and</strong> at additional mailing offices.<br />

POSTMASTER: Send address changes to <strong>Antimicrobial</strong> <strong>Agents</strong> <strong>and</strong> <strong>Chemotherapy</strong>, ASM, 1913 I St., N.W., Washington, DC 20006.<br />

Made in the United States of America.<br />

Copyright C) 1988, American Society for Microbiology. 43*:I^ &'iAK,J L Um{f,1; ( I13'f<br />

All Rights Reserved.<br />

The code at the top of the first page of an article in this journal indicates the copyright owner's consent that copies of the article may be<br />

made for personal use or for personal use of specific clients. This consent is given on the condition, however, that the copier pay the stated<br />

per-copy fee through the Copyright Clearance Center, Inc., 21 Congress St., Salem, MA 01970, for copying beyond that permitted by Sections<br />

107 <strong>and</strong> 108 of the U.S. Copyright Law. This consent does not extend to other kinds of copying, such as copying for general distribution, for<br />

advertising or promotional purposes, for creating new collective works, or for resale.

Abele, Gunnar, 1807<br />

Akabane, Taro, 1864<br />

Arnold, Barbara H., 1784<br />

Barg, Neil L., 1834<br />

Beale, Angela S., 1830<br />

Benoni, G., 1875<br />

Bertr<strong>and</strong>, G., 1875<br />

Blumer, Jeffrey L., 1780<br />

Boehme, Richard E., 1887<br />

Brown, David C., 1899<br />

Bubrick, Melvin P., 1845<br />

Budtz-J0rgensen, Ejvind, 1859<br />

Call, N. Branson, 1820<br />

Cannon, Deborah L., 1784<br />

Casas, Ivan A., 1854<br />

Chang, Stephen C., 1763<br />

Chen, Ming S., 1887<br />

Chernow, Marlene, 1887<br />

Chuang, Ronald Y., 1887<br />

Chung, Tung C., 1854<br />

Cocchetto, David M., 1845<br />

Consolo, U., 1875<br />

Cornford, Richard J., 1879<br />

Courvalin, Patrice, 1793<br />

Crenshaw, Deborah, 1780<br />

Cunningham, Eloise, 1788<br />

Curtis, Nigel A. C., 1879<br />

Cuzzolin, L., 1875<br />

Datema, Roelf, 1807<br />

Davis, Joanne, 1801<br />

de Clercq, Erik, 1839<br />

Dirks, Monte S., 1820<br />

Dobrogosz, Walter J., 1854<br />

Doern, Gary V., 1747<br />

East, Simon J., 1879<br />

Edlund, Charlotta, 1869<br />

Eisenstadt, Rosemary L.,<br />

1879<br />

Feldberg, Ross S., 1763<br />

Ferro, Adolph J., 1904<br />

Ferronato, G., 1875<br />

Fitchen, John H., 1904<br />

Flaherty, John F., 1825<br />

Fleishaker, Joseph C., 1825<br />

Fletcher, Courtney V., 1899<br />

Fracasso, M. E., 1875<br />

Franzblau, Scott G., 1758<br />

Gambertoglio, John G., 1825<br />

Gates, Mark L., 1893<br />

Gisby, John, 1830<br />

Goldfarb, Johanna, 1780<br />

Guglielmo, B. Joseph, 1825<br />

Gustavson, Linda E., 1813<br />

Hastings, Robert C., 1758<br />

Hayden, Frederick G., 1813<br />

Heim-Duthoy, Karen L., 1845<br />

Holmstrup, Palle, 1859<br />

Holy, Antonin, 1839<br />

Hori, Ritsuko, 1848<br />

Inoue, Matsuhisa, 1848<br />

Isayama, Yasuro, 1891<br />

Ishikawa, Hitoshi, 1891<br />

Jacobson, Jay A., 1820<br />

Jechorek, Robert P., 1769<br />

Jones, Ronald N., 1747<br />

Joyce, Lyle D., 1899<br />

Karaffa, Camile, 1754<br />

Kasworm, Evelyn M., 1820<br />

Knapp, Cynthia, 1754, 1896<br />

Komiyama, Atsushi, 1864<br />

Kotik, Alan N., 1763<br />

Krogh, Palle, 1859<br />

Lake, Kathleen D., 1899<br />

Lake-Bakaar, Desmond M.,<br />

1807<br />

Author Index<br />

Lemon, Eloise, 1780<br />

Leone, R., 1875<br />

Levy, Stuart B., 1797, 1801<br />

Lindborg, Bjorn, 1807<br />

Lindqvist, Lennart, 1869<br />

Love, Kathryn R., 1899<br />

Maddaus, Michael A., 1769<br />

Marshall, Bonnie, 1801<br />

Martino-Saltzman, David,<br />

1784<br />

Marx, Preston A., 1887<br />

Masuda, Midori, 1864<br />

Matsuoka, Takafumi, 1864<br />

Matthews, Thomas R., 1887<br />

Matzke, Gary R., 1845<br />

McGinnis, E., 1788<br />

McRoberts, Mary Jane, 1887<br />

Mitsuhashi, Susumu, 1848<br />

Mitsuyama, Junichi, 1848<br />

Murata, Kenjiro, 1864<br />

Nadler, Marcus, 1763<br />

Neuwirth, Zeev, 1763<br />

Nord, Carl Erik, 1869<br />

Ohmae, Kenichi, 1891<br />

O'Horo, Jennifer, 1780<br />

Papadopoulou, Barbara, 1793<br />

Parham, Christine, 1788<br />

Park, Britt H., 1797<br />

Prisbe, Ernest J., 1887<br />

Pritzker, Marc R., 1899<br />

Puchetti, V., 1875<br />

Riscoe, Michael K., 1904<br />

Rodondi, Lisa C., 1825<br />

Rosenberg, Ivan, 1839<br />

Rowse, Deborah, 1801<br />

Saikawa, Isamu, 1848<br />

Sakuma, Takashi, 1839<br />

S<strong>and</strong>ers, Christine C., 1893<br />

S<strong>and</strong>ers, W. Eugene, Jr., 1893<br />

Schinazi, Raymond F., 1784<br />

Schluederberg, Susan, 1801<br />

Selitrennikoff, Claude P., 1901<br />

Sierra-Madero, Juan, 1754,<br />

1896<br />

Simmons, Richard L., 1769<br />

Smith, John M., 1776<br />

Snoeck, Robert, 1839<br />

Soike, Kenneth F., 1807<br />

Stark, Tracey, 1901<br />

Steele, Lorraine C., 1776<br />

Sumter, Gwendolyn, 1776<br />

Sundstrom, David C., 1763<br />

Suttmann, Rebecca T., 1887<br />

Taft, Cathy S., 1901<br />

Talarico, Todd L., 1854<br />

Thompson, Nathan H., 1763<br />

Tominack, Rebecca L., 1813<br />

Townsend, Raymond J., 1825<br />

Turner, Ronald B., 1820<br />

Walker, Linda A., 1879<br />

Wallace, Richard J., Jr., 1776<br />

Washington, John A., 1754,<br />

1896<br />

Wells, Carol L., 1769<br />

White, Anthony J., 1879<br />

Wills, Robert J., 1813<br />

Wu, John C., 1887<br />

Yamazaki, Munehiro, 1864<br />

Yasuda, Takashi, 1848<br />

Yasui, Kozo, 1864<br />

Yotsuji, Akira, 1848<br />

Zilhao, Rita, 1793

ACKNOWLEDGMENT<br />

The following persons served as invited special reviewers for the journal during 1988, <strong>and</strong> their help is greatly appreciated.<br />

Charles A. Alford, Jr.<br />

J. Davis Allen<br />

R. Anderson<br />

F. S. Archibald<br />

Devron Averett<br />

Johan S. Bakken<br />

Robert M. Bannatyne<br />

Jules Baum<br />

Robert Beahner<br />

Michael Bennish<br />

J. D. Berman<br />

Robert F. Betts<br />

A. Bock<br />

John M. Boyce<br />

Volkman Braun<br />

Sam Broder<br />

Kenneth Brown<br />

Karen Bush<br />

Peter Canonico<br />

Stephen J. Cavalier<br />

Henry Chambers<br />

John Chapman<br />

Stephen A. Chartr<strong>and</strong><br />

Ming S. Chen<br />

Yung-Chi Cheng<br />

Ian Chopra<br />

Gordon Christensen<br />

Richard B. Clark<br />

Donald Coen<br />

Patrice Courvalin<br />

W. A. Cramer<br />

Lawrence R. Crane<br />

Jorge Crosa<br />

Clyde Crumpacker<br />

George Cuchural, Jr.<br />

Thomas Curran<br />

Richard Davey<br />

Bernard Davis<br />

Eric De Clercq<br />

David Diuguid<br />

Thomas Dougherty<br />

Kathleen M. Downey<br />

Richard Duma<br />

Paul H. Edelstein<br />

Roslyn Eisenberg<br />

Suzanne U. Emerson<br />

Richard H. K. Eng<br />

Lawrence Eron<br />

J. 0. Falkinham<br />

Barry M. Farr<br />

David Feingold<br />

Robert Fekety<br />

A. Ferrante<br />

A. Kirk Field<br />

Cay Fitch<br />

Robert J. Fitzgerald<br />

Cecil W. Forsberg<br />

A. Forsgren<br />

Eben Fox<br />

I. Fridovich<br />

K. P. Fu<br />

Philip Furman<br />

James Fyfe<br />

Denise Galloway<br />

Peter Gemski<br />

Nafsika Georgopapadakou<br />

Donald K. Giger<br />

David Gilbert<br />

Michael Glauser<br />

Joseph Glorioso<br />

Richard V. Goering<br />

Myles Gombert<br />

Robert C. Good<br />

John E. Greenlee<br />

Jerome E. Groopman<br />

Gerri S. Hall<br />

J. Owen Hendley<br />

Martin Hirsch<br />

Jan V. Hirschmann<br />

Glen R. Hodger<br />

B. Houwen<br />

Walter Hughes<br />

Pentti Huovinen<br />

J. Michael J<strong>and</strong>a<br />

Susan Jensen<br />

Dave Johns<br />

Allen Kaiser<br />

Earl R. Kern<br />

A. Kerr<br />

W. M. M. Kirby<br />

Saul Kit<br />

T. R. Klaenhammer<br />

Vernon Knight<br />

M. Kozak<br />

Donald Leblanc<br />

William Ledger<br />

Tim Lee<br />

Rol<strong>and</strong> A. Lev<strong>and</strong>owski<br />

J. J. Lipsky<br />

L. F. Liu<br />

David Livermore<br />

G. Lopez-Berestein<br />

Lionel A. M<strong>and</strong>ell<br />

Joseph Marr<br />

J. R. Martin<br />

Kenneth Mayer<br />

J. K. McClatchy<br />

Mark A. McKinlay<br />

Colin McLaren<br />

Cody Meissner<br />

Miklos H. Muller<br />

William N. Murphy<br />

Kenrad E. Nelson<br />

R. H. Neubauer<br />

Franklin Neva<br />

Ernest Newbrun<br />

Thalia Nicas<br />

H. Nikaido<br />

Carl-Erik Nord<br />

Richard Novick<br />

Paul O'Keefe<br />

Andrew Onderdonk<br />

Michael Otto<br />

W. Paranchych<br />

Roberta Parente<br />

J. T. Parisi<br />

T. Parr<br />

Robert Pass<br />

Gerald Peir<br />

L. Piddock<br />

Philip Pizzo<br />

Laurel C. Preheim<br />

Alice Prince<br />

Peter J. Quesenberry<br />

Jonathan I. Ravdin<br />

D. J. Reed<br />

Jack Remington<br />

K. L. Rinhart, Jr.<br />

Marilyn Roberts<br />

William Robinson<br />

Hans G. Sahl<br />

Irving Salit<br />

K. S<strong>and</strong>erson<br />

Prem Sarin<br />

Priscilla Schaeffer<br />

Charles J. Schleupner<br />

A. Schryvers<br />

Warren Shaw<br />

G. Shockman<br />

Robert Shoemaker<br />

Robert E. Shope<br />

Simon Silver<br />

John Sixbey<br />

Craig A. Smith<br />

Thomas Smith<br />

Jack Sobel<br />

Kenneth F. Soike<br />

Pam Sokol<br />

Tom Specter<br />

David Speert<br />

Magel Spitz<br />

Brian Spratt<br />

Walter Stamm<br />

Victor Stollar<br />

Barbara Styrt<br />

J. W. Suttie<br />

Richard L. Sweet<br />

Francis P. Szoka<br />

H. Taber<br />

Janson M. Tanzer<br />

Martin Tauber<br />

Raymond Testa<br />

Charles Thoen<br />

Clyde Thornsberry<br />

Richard Tidwell<br />

Carmelita Tuazon<br />

E. Tuomanen<br />

Ronald B. Turner<br />

M. Vaara<br />

Leo Vining<br />

Edward E. Walsh<br />

Richard J. Whitley<br />

Kirk Wilhelmis<br />

Murray Wittner<br />

Emanuel Wolinsky<br />

Brian Wong<br />

D. E. Woods<br />

Philip Wyde<br />

Robert Yarchoan<br />

Stephen Zinner<br />

M. Zweerink

Abele, G., 1137, 1807<br />

Abraham, Soman N., 1274<br />

Acar, J. F., 9, 195<br />

Adinolfi, Luigi E., 1012<br />

Adloff, M., 1360<br />

Aguirre, Tania, 1237<br />

Aikawa, M., 1655<br />

Aizawa, Noboru, 1648<br />

Akabane, Taro, 1864<br />

Akerfeldt, Stig, 1720<br />

Akimoto, Yoshiaki, 566<br />

Alarc6n, Balbino, 1257, 1412<br />

Albrecht, Janice K., 47, 224<br />

Alcina, Antonio, 1412<br />

Aidridge, Kenneth, 717<br />

Allais, Jean M., 1327, 1740<br />

Allegra, Carmen J., 324, 430<br />

Allison, Patricia E., 137<br />

Alonso, Marie-Jose, 1204<br />

Alvarez, Emilio, 1061<br />

An, Florence Y., 547<br />

An<strong>and</strong>, Rita, 684<br />

Andrade, J., 780<br />

Andremont, Antoine, 1204<br />

Andrews, J. M., 617, 1251, 1508<br />

Andrews, Kenneth J. M., 814<br />

Andry, G., 1557<br />

Ansehn, Steffan, 1208<br />

Antikainen, Riitta, 1019<br />

Anwar, Hosmin, 364<br />

Aoyagi, Teruo, 110<br />

Aoyama, Hiroshi, 104, 922<br />

Apicella, Michael A., 777<br />

Appelbaum, Frederick R., 271<br />

Arai, Mamoru, 110<br />

Arai, Susumu, 1040, 1396<br />

Arai, Toshihiko, 110<br />

Arakawa, Soichi, 1080<br />

Arathoon, Eduardo G., 369<br />

Araujo, Fausto G., 755<br />

Arca, Pilar, 1552<br />

Armstrong, D., 780, 1676<br />

Arnold, Barbara H., 1784<br />

Arnold, John, 42<br />

Aronoff, Stephen C., 395, 1636<br />

Ashby, J. P., 617, 1251, 1508<br />

Ashdown, Leslie R., 1435<br />

Asmar, Basim I., 1375<br />

Auclair, Pierre, 736<br />

Azuma, Masanobu, 1547<br />

Baba, Masanori, 1025, 1742<br />

Babin-Chevaye, C., 1124<br />

Bachmann, Kenneth, 75, 730<br />

Bacon, Teresa H., 358<br />

Baker, Cynthia B., 374<br />

Baker, Pamela J., 1521<br />

Baker, Richard H., 462<br />

Bakken, Johan S., 1314<br />

Bakker, Leendert J., 473<br />

Bakker-Woudenberg, Irma A.J.M., 1560<br />

Balis, Frank M., 324<br />

Baltch, Aldona L., 1450, 1565<br />

Balzarini, Jan, 1025<br />

Baqar, Shahida, 462<br />

Barber, William E., 814<br />

Barg, Neil L., 202, 1834<br />

Barnett, Bill B., 331<br />

Baron, Patricia A., 1269<br />

Barredo, Jose L., 1061<br />

AUTHOR INDEX<br />

VOLUME 32<br />

Barriere, Steven L., 298<br />

Barry, Arthur L., 150, 346, 443, 752, 1576<br />

Bartlett, J. C., 598<br />

Bartlett, Karen H., 782<br />

Bartlett, Marilyn S., 897<br />

Bartosek, IVan, 1541<br />

Bartucci, F., 1461<br />

Bassford, Philip J., Jr., 164<br />

Baumann, Russell J., 1119<br />

Bayer, Arnold S., 141, 231<br />

Beachey, Edwin H., 1274, 1370, 1603,<br />

1609<br />

Beale, Angela S., 1830<br />

Beauchamp, Denis, 992<br />

Beckman, Howard B., 510<br />

Beggs, William H., 209<br />

Bellin, Eran Y., 1113<br />

Bemis, A. Todd, 63<br />

Bennett, D. B., 758<br />

Bennett, John E., 1619<br />

Bennett, Renee L., 209<br />

Bennett, William M., 844<br />

Benoni, G., 1875<br />

Berger-Bachi, Brigitte, 1494<br />

Bergeron, Michel G., 354, 561, 736, 1227,<br />

1231, 1433, 1515<br />

Bergman, Jan, 1720<br />

Berk, Shirley, 78<br />

Berk, Steven, 78<br />

Berkey, Peter, 1078<br />

Bermudez, Luiz Eduardo M., 1149<br />

Bernard, E. M., 780, 1676<br />

Bernareggi, Alberto, 246, 1223<br />

Bernstein, David I., 761<br />

Berthe, Jackie, 250<br />

Bertino, Joseph S., Jr., 236, 1446<br />

Bertr<strong>and</strong>, G., 1875<br />

Berube, Denise, 354, 1227<br />

Beyer, Jill M., 1710<br />

Bia, Frank J., 1182<br />

Bianchi, A., 1350<br />

Billot-Klein, D., 9, 195<br />

Biron, Karen, 265<br />

Biron, Simon, 1231<br />

Bishop, Monica, 1565<br />

Bittner, Marvin J., 1327<br />

Black, William A., 1441<br />

Blasecki, John W., 1699<br />

Blickens, Donald, 42<br />

Blickle, J. F., 1360<br />

Blum, Robert A., 848<br />

Blumer, Jeffrey L., 1780<br />

Bocquet, V., 1590<br />

Bodey, Gerald P., 1365<br />

Bodhidatta, Ladaporn, 723<br />

Boeckh, Michael, 92<br />

Boehm, Diane M., 137<br />

Boehme, Richard, 1154, 1887<br />

Boelaert, J., 1595<br />

Bohme, Ekkehard H., 1119<br />

Bongaerts, Ger P. A., 740<br />

B3onventre, Peter F., 1012<br />

Boot, J. M., 426<br />

Bornemann, L. D., 592<br />

Borner, Klaus, 92<br />

Borsa, Francoise, 938<br />

Boscia, Jerome A., 262, 877<br />

Boslego, John W., 775<br />

Bottner, Wayne A., 1446<br />

Bower, Robert R., 27<br />

Bowles, Susan K., 510<br />

Boyd, James C., 1644<br />

Boyd, Malcolm R., 358<br />

Bradley, S. G., 962<br />

Brajtburg, Janina, 327, 702<br />

Brafia, Alfredo F., 1552<br />

Br<strong>and</strong>icourt, Olivier, 250<br />

Br<strong>and</strong>t, Roger, 573<br />

Broadhurst, Anne V., 814<br />

Brogard, J. M., 1360<br />

Brown, David C., 1899<br />

Brown, Michael R. W., 364<br />

Brown, Robert, 1269<br />

Brown, S. Anthony, 595<br />

Brown, William J., 385<br />

Brunner, H., 57<br />

Brust, Paula, 1640<br />

Bryan, L. E., 498<br />

Bubrick, Melvin P., 1845<br />

Budtz-J0rgensen, Ejvind, 1859<br />

Bull, Herbert G., 319<br />

Bundy, J. McCall, 882<br />

Bush, Larry M., 877<br />

Byrne, Sean K., 1441<br />

Cabeza Meckert, Patricia, 241<br />

Cacalano, Grace Soong, 838<br />

Cafarell, Robert F., 777<br />

Calame, Wim, 1456<br />

Call, N. Branson, 182Q<br />

Campos, Jos4, 477, 706<br />

Canawati, Hanna N., 81<br />

Cannon, Deborah L., 1784<br />

Cantoral, Jesus M., 1061<br />

Canupp, Kay C., 1500<br />

Carbon, C., 1590<br />

Carlet, J., 9<br />

Carlisle, Ricarda, 997<br />

Carr, Mary E., 844<br />

Carrasco, Luis, 1257<br />

Carret, G., 454<br />

Casadaban, Malcolm, 1379<br />

Casalino, Mariassunta, 1262<br />

Casas, Ivan A., 1854<br />

Casey, Sharon W., 337<br />

Casin, I., 1350<br />

Cassano, Karen, 1031<br />

,Cassell, Gail H., 1500<br />

Castellano, S., 592<br />

Catherall, Elaine J., 1705<br />

Catlin, B. Wesley, 971<br />

Cattier, Bl<strong>and</strong>ine, 147<br />

Cavenaghi, Luigi, 246, 1223<br />

Chabner, Bruce A., 324, 430<br />

Chaffin, Donald O., 706<br />

Chalkley, Lynda J., 24<br />

Chamb6, Jorge G., 241<br />

Chamorro, Roxana M., 1416<br />

Champlin, Franklin R., 1354<br />

Chan, gobert, 1231<br />

Chanal, Catherine M., 626, 1660<br />

Chang, Hernan R., 524<br />

Chang, Stephen C., 1763<br />

Chanock, Robert M., 1269<br />

Chantrain, G., 1557<br />

Chapman, John S., 438<br />

Chastang, Claude, 303<br />

Chen, Man, 678<br />

Chen, Ming S., 1887<br />

Cheng, Nick, 788<br />

Chernow, Marlene, 1887

ii AUTHORINDEX<br />

Chin, Nai Xing, 838<br />

Chin, Nai-Xun, 84, 580, 656, 663, 671,<br />

1666<br />

Chitwarakorn, Anupong, 723<br />

Chongsuphajaisiddhi, T., 250<br />

Chow, AnthonyNW., 782, 788<br />

Chow, Raymond T., 1113<br />

Christenson, James G., 1005<br />

Chu, Chun-Jung, 858<br />

Chu, D. T. W., 27<br />

Chuang, Ronald Y., 1887<br />

Chung, Menger, 42<br />

Chung, Tung C., 1854<br />

Citron, Diane M., 213, 1143<br />

Clark, Richard B., 689, 1314<br />

Clarkson, Allen B., Jr., 1158<br />

Clavier, Francoise, 568<br />

Clayton, Christopher, 1213<br />

Cleary, Timothy, 717<br />

Cleel<strong>and</strong>, Roy, 770<br />

Clewell, Don B., 547<br />

Cluzel, Roger A., 626, 1660<br />

Cocchetto, David M., 1845<br />

Cohen, L. A., 1655<br />

Cohen, Paul S., 770<br />

Cohen, Seth P., 1187<br />

Cohn, Robert C., 395<br />

Cole, Gerald A., 462<br />

Coll, Ram6n, 636<br />

Collaborative <strong>Antimicrobial</strong> Susceptibility<br />

Testing Group, 346<br />

Collatz, E., 195, 1289<br />

Comereski, C. R., 758<br />

Conroy, Joseph V., 1450, 1565<br />

Consolo, U., 1875<br />

Conte, John E., Jr., 1490<br />

Cook, S<strong>and</strong>ra, 1439<br />

Corada, Monica, 1541<br />

Cornaglia, Giuseppe, 552<br />

Corner, Anne-Marie, 350<br />

Cormford, Richard J., 1879<br />

Courtney, Harry S., 1370<br />

Courvalin, Patrice, 15, 945, 1107, 1174,<br />

1793<br />

Couvreur, Patrick, 1204<br />

Craig, William A., 51<br />

Crawford, Carol E., 1441<br />

Crenshaw, Deborah, 1780<br />

Crokaert, F., 1632<br />

Crook, Derrick, 717<br />

Crosa, Jorge H., 1416<br />

Crossley, Kent B., 848<br />

Croteau, Daniel, 561, 1227<br />

Cuchural, George J., Jr., 717<br />

Cuevas, Thomas A., 1327<br />

Cullmann, Wolfgang, 1090<br />

Cunningham, Eloise, 1788<br />

Curran, James W., 684<br />

Curtis, Nigel A. C., 1879<br />

Cushion, Melanie T., 96, 896<br />

Cuzzolin, L., 1875<br />

Daghlian, Charles P., 1627<br />

Daikos, George L., 785<br />

Dajani, Adnan S., 1375<br />

Daly, Jennifer S., 1341<br />

Daneau, D., 1557<br />

Daneels, R., 1595<br />

Danese, Antonio, 246, 1223<br />

Dangor, Y., 1458<br />

Darfeuille-Richaud, Arlette, 1282<br />

Daschner, F. D., 930<br />

Datema, Roelf, 1807<br />

Daum, Robert S., 1034<br />

Davis, Joanne, 1801<br />

Davis, Robin L., 274<br />

Debbia, Eugenio, 279<br />

De Beule, K., 1595<br />

Debs, Robert J., 1404<br />

de Clercq, Erik, 906, 1025, 1742, 1839<br />

Deeg, H. Joachim, 271<br />

Deffrennes, Dominique, 467<br />

de Groot, Ronald, 477<br />

de las Heras, Federico G., 1257<br />

Delgado, Rafael, 1598<br />

Deloron, Philippe, 391<br />

Derouin, Francis, 303<br />

Desmyter, Jan, 1025<br />

Diez, Bruno, 1061<br />

DiGiovanni, Maria A., 982<br />

DiMattia, Arthur, 882<br />

Dirks, Monte S., 1820<br />

Dismukes, William E., I<br />

Divo, Alan A., 1182<br />

Dix, Barbara A., 770<br />

Dobrogosz, Walter J., 1854<br />

Doern, Gary V., 180, 259, 1747<br />

Dohtsu, Yasumasa, 1427<br />

Dolan, Margaret M., 350<br />

Dolan, Stephen A., 928<br />

Dor, P., 1557<br />

Dornbusch, Katherine, 1484<br />

Dorrington, Susan M., 518<br />

Dougherty, Steven H., 337<br />

Dougherty, Thomas J., 1113<br />

Douwes-Idema, Nora, 1456<br />

Draft, Kenneth, 773<br />

Drake, James C., 324, 430<br />

Drucker, William R., 882<br />

Druilhe, Pierre, 250<br />

Drusano, George L., 289, 1537<br />

Dubach, Ulrich C., 573<br />

Dudley, Michael N., 128<br />

Dufresne, Julien, 819<br />

Durica, David, 391<br />

Durkin, Michelle M., 807<br />

Durnell, Monty, 882<br />

Duroux, Michel H., 298<br />

Duzgunes, Nejat, 1404<br />

Dworzack, David L., 1740<br />

East, Simon J., 1879<br />

Ebert, S., 37<br />

Echeverria, Peter, 723<br />

Edelstein, Howard, 1031<br />

Edlund, Charlotta, 1869<br />

Edmondson, Diane G., 68<br />

Edwards, David J., 510<br />

Edwards, F., 780<br />

Ehret, Josephine M., 773, 1295<br />

Eisenstadt, Rosemary L., 1879<br />

Elberg, Svetlana, 327, 702<br />

Eliopoulos, G. M., 434, 1341, 1528<br />

Elvrum, Patricia M., 1170<br />

Elwell, Lynn P., 1086<br />

Elzinga, Lawrence W., 844<br />

Enthoven, D., 592<br />

Eriksson, B., 1137<br />

Escajadillo, A., 1655<br />

Espinoza, Ana Maria, 663<br />

Esteve, Montserrat, 636<br />

Eustice, D. C., 1218<br />

Everett, E. Dale, 928<br />

Evron, Ruth, 1586<br />

ANTIMICROB. AGENTS CHEMOTHER.<br />

Exposto, F. da L., 1458<br />

Fardel, G., 454<br />

Farinotti, R., 1590<br />

Fasco, Michael J., 1446<br />

Fass, Robert J., 1082<br />

Fattal, Elias, 1204<br />

Faurisson, Francois, 568<br />

Feld, Ron, 1231<br />

Feldberg, Ross S., 1763<br />

Feldman, P. A., 1218<br />

Fern<strong>and</strong>es, Prabhavathi B., 27, 1500, 1710<br />

Fern<strong>and</strong>ez-Guerrero, Manuel, 747<br />

Ferraro, Frank M., 1740<br />

Ferrea, Giuseppe, 1223<br />

Ferro, Adolph J., 1904<br />

Ferronato, G., 1875<br />

Fesik, Stephen W., 308<br />

Fetchick, Richard, 1310<br />

Fidalgo, S., 420<br />

Fillastre, Jean-Paul, 919, 938, 942<br />

Finegold, Sydney M., 403, 601, 611, 717<br />

Finnerty, Edmund F., 882<br />

Fischer, James H., 848<br />

Fitchen, John H., 1904<br />

Flaherty, John F., 1825<br />

Fl<strong>and</strong>rois, J. P., 454<br />

Fleishaker, Joseph C., 1825<br />

Fletcher, Courtney V., 1899<br />

Fleurette, J., 873<br />

Foddis, Giovanni, 552<br />

Folan, David W., Jr., 882<br />

Fong, Ignatius W., 834, 1231<br />

Forrest, Alan, 1537<br />

Foster, Timothy J., 1174<br />

Foucault, Paule, 1433<br />

Fourgeaud, M., 1094<br />

Foxall, Carrol, 710<br />

Foy, Jilanna, %, 896<br />

Fracasso, M. E., 1875<br />

Fraimow, Henry S., 1113<br />

Frances, Cathy A., 773<br />

Frank, U., 930<br />

Franzblau, Scott G., 1583, 1758<br />

Franzus, Bettylene, 78<br />

Freimer, E. H., 530<br />

Frelon, Jean-Hughes, 942<br />

French, G. L., 20<br />

Freney, J., 276, 873<br />

Fresno, Manuel, 1412<br />

Fuchs, Peter C., 346<br />

Fujii, Akira, 566, 1080<br />

Fujii, Tadashi, 104, 922<br />

Fujimaki, Kazuo, 104, 827, 922<br />

Fujimoto, Teruo, 1336<br />

Fung-Tomc, Joan, 1443<br />

Fuse, Aisaku, 587<br />

Gadebusch, Hans, 319<br />

Gaffey, Michael J., 1644<br />

Galioto, G. B., 1461<br />

Gambertoglio, John G., 298, 1825<br />

Gangadharam, Pattisapu R. J., 886, 1400,<br />

1404<br />

Garcia-Lopez, M. Teresa, 1257<br />

Gargallo, Domingo, 636<br />

Garry, Franklyn B., 595<br />

Gates, Mark L., 1893<br />

Gaudebout, Claude, 568<br />

Gavignet, Martine, 147

VOL . 32, 1988<br />

Gavini, F., 873<br />

Gaylord, Janet C., 1699<br />

Gaynes, Robert, 1379<br />

Geddes, Glenna L., 1441<br />

Georgopapadakou, Nafsika H., 438<br />

Gerard, M., 1557<br />

Gerbaud, Guy, 15, 626<br />

Gibbs, Ronald S., 853<br />

Gibson, Gene A., 1320<br />

Gilbert, Brian E., 117, 890<br />

Gilbert, Peter, 1693<br />

Ginunas, Virginia J., 81<br />

Girard, Arthur E., 1347<br />

Gisby, John, 1830<br />

Glupczynski, Y., 276, 1632<br />

Godin, Michel, 938, 942<br />

Goering, Richard V., 1164<br />

Golden, Jeffrey A., 1490<br />

Goldfarb, Johanna, 1780<br />

Goldmann, D., 1528<br />

Goldspiel, Barry R., 853<br />

Goldstein, Ellie J. C., 213, 1143<br />

Goldstein, F. W., 9, 195<br />

Goldstein, Jayne A., 1404<br />

Golenbock, D. T., 37<br />

Golper, Thomas A., 844<br />

Gonzalez, M. Eugenia, 1257<br />

Gootz, Thomas D., 159<br />

Goransson, Evelyn, 1484<br />

Gorbach, Sherwood L., 1439<br />

Gordin, Ariel, 1019<br />

Goudeau, Alain, 147<br />

Graham, Theodore, 271<br />

Graybill, John R., 1310<br />

Grayston, J. Thomas, 257<br />

Graziani, Amy L., 1320<br />

Greenberg, Richard, 710<br />

Gresser-Burns, Mary E., 513<br />

Griffith, Brigitte P., 678<br />

Griggs, D., 1508<br />

Groisman, Eduardo, 1379<br />

Gross, M. L., 530<br />

Guay, D. R. P., 485<br />

Guglielmo, B. Joseph, 298, 1511, 1825<br />

Guinea, Jesus, 636<br />

Guizie, Miriam, 1586<br />

Guptill, Douglas R., 755<br />

Gurwith, Dorothy, 802<br />

Gurwith, Marc, 802<br />

Gustavson, Linda E., 1813<br />

Gutmann, L., 9, 195<br />

Gwaltney, Jack M., Jr., 1644<br />

Haase, David A., 1292<br />

Hadley, W. K., 1392<br />

Hall, Gerti S., 1331<br />

Hall, Michael J., 814<br />

Hamati, Fawwaz, 78<br />

Hammer, Mark C., 1450, 1565<br />

Hancock, Robert E. W., 649<br />

H<strong>and</strong>sfield, H. Hunter, 773<br />

Haneishi, Tatsuo, 110<br />

Hanger, D. P., 646<br />

Hanna, Charles B., 882<br />

Hansen, W., 276<br />

Hanson, Charles W., 27<br />

Hanson, Linda H., 369<br />

Hara, Kohei, 1427<br />

Hardin, Thomas C., 1310<br />

Harding, Godfrey K., 1231, 1292<br />

Hardisson, C., 420, 1552<br />

Hardy, Dwight J., 27, 1710<br />

Harkonen, Scott, 710<br />

Harmenberg, J., 1100, 1137, 1533, 1720<br />

Harris, Jeffrey P., 865<br />

Hart, Mark E., 1354<br />

Hartstein, Alan I., 369<br />

Hastings, Robert C., 1758<br />

Haug, Alfred, 308, 649<br />

Hauser, M., 1676<br />

Hayakawa, Tomihiro, 726<br />

Hayasaka, Hiroshi, 1588<br />

Hayashi, Shoryo, 1040, 1396<br />

Hayashi, Toshiaki, 1427<br />

Hayashi, Toshikatsu, 458<br />

Hayashi, Toshio, 912<br />

Hayden, Frederick G., 224, 409, 1644,<br />

1813<br />

Hecht, David, 717<br />

Heeres-Weststrate, P. L., 426<br />

Heifets, Leonid, 1002, 1131<br />

Heim-Duthoy, K. L., 485, 1845<br />

Helsel, Valerie L., 1082<br />

Hemming, Val G., 1269<br />

Hengstler, Bruno, 364<br />

Henry, Nancy, 747<br />

Hensey, Dena M., 1710<br />

Hentges, David J., 337<br />

Herwaldt, Barbara L., 793, 799, 953, 957<br />

Heykants, J., 1595<br />

Hicks, R., 589<br />

Higashi, Katsuyoshi, 726<br />

Higgins, J. T., Jr., 530<br />

Hill, Carter D., 882<br />

Hill, Gale, 717<br />

Hill, James M., 978<br />

Hill, Lori, 1565<br />

Hirai, Keiji, 922<br />

Hirano, Lance, 141, 231<br />

Hirata, Koichi, 1588<br />

Hirota, Masaki, 1427<br />

Hitchcock, Michael J. M., 186<br />

Hoban, Daryl J., 1292<br />

Hobden, Jeffery A., 978<br />

Hoepelman, Andy I. M., 473<br />

Hoffken, Gert, 92<br />

Hoffman, Howard E., 1699<br />

Hoffner, Sven E., 1208<br />

Hohl, P., 1593<br />

Holden, Patricia, 450<br />

Holmstrup, Palle, 1859<br />

Holy, Antonin, 1025, 1839<br />

Hook, Edward W., III, 773<br />

Hooper, David C., 1187<br />

Hooton, Thomas M., 1640<br />

Hopewell, Philip C., 1057<br />

Hori, Michael, 1314<br />

Hori, Ritsuko, 1097, 1848<br />

Horowitz, Edward A., 1740<br />

Hoshino, Makoto, 726<br />

Hosotsubo, Hideo, 1103<br />

Hosotsubo, Kikumi, 1103<br />

Hostetter, Marcia K., 689<br />

Hottendorf, G. H., 314<br />

Howard, R. J., 1655<br />

HPA-23 Cooperative Study Group, 1300<br />

Hsiung, G. D., 678<br />

Huczko, Elizabeth, 1443<br />

Huffman, John H., 331<br />

Huggins, John W., 1304<br />

Hughes, Carolyn E., 209<br />

Hughes, Walter T., 623, 1057<br />

Hull, Richard, 768<br />

Humbert, Guy, 919<br />

Huovinen, Pentti, 134, 175<br />

AUTHOR INDEX iii<br />

Huovinen, Saara, 134, 175, 1730<br />

Hussoh, M. O., 873<br />

Iaconis, Joseph P., 1365<br />

Iannini, Paul, 717<br />

Ihler, Garret M., 391<br />

Ikeda, Fumiaki, 1243<br />

Ikeda, Haruo, 282<br />

Ikeda, Yasushi, 1073<br />

Inoue, Matsuhisa, 104, 587, 827, 922, 1097,<br />

1421, 1848<br />

Isayama, Yasuro, 1891<br />

Iseman, Michael D., 886, 1400<br />

Ishiguro, Edward E., 1247<br />

Ishiguro, Junzo, 1648<br />

Ishii, Junko, 378<br />

Ishikawa, Hitoshi, 1891<br />

Ito, Kazuyuki, 726<br />

Ito, Yasuo, 156<br />

Izard, D., 873<br />

Jackson, George Gee, 785<br />

Jacobs, Michael, 395<br />

Jacobs, Nicholas J., 1627<br />

Jacobs, Richard F., 1481<br />

Jacobson, Jay A., 1820<br />

Jacobson, Kirk D., 882<br />

Jacobus, Nilda V., 584, 717<br />

Jacoby, George A., 134, 175<br />

Janicke, David M., 777<br />

Jauregui, Luis, 75, 730<br />

Jay, Margaret A., 807<br />

Jechorek, Robert P., 1769<br />

Jehl, F., 1360<br />

Jevons, S., 646<br />

Jiang, Baoming M., 986<br />

Johnson, Carolyn R., 1640<br />

Johnson, Curtis A., 51<br />

Johnson, Steven R., 765<br />

Johnston, Michael, 1196<br />

Joly, Bernard H., 1282<br />

Jones, Ronald N., 346, 443, 752, 1576,<br />

1747<br />

Jonsson, Monica, 1278<br />

Jorgensen, James H., 180, 1477<br />

Joshi, Bharati, 285<br />

Joyce, Lyle D., 1899<br />

Judson, Franklyn N., 773, 1295<br />

Junakovic, Nikolaj, 1262<br />

Jusko, William J., 777<br />

Kadurugamuwa, Jagath L., 364<br />

Kaiser, Allen B., 202<br />

Kaiser, Donald L., 224<br />

Kam, K. M., 20<br />

Kamidono, Sadao, 1080<br />

Kamimura, Toshiaki, 1243<br />

Kan, Virginia L., 1619<br />

Kane, James G., 882<br />

Kaneda, Yoshimasa, 966<br />

Kaneko, Kenji, 566<br />

Karaffa, Camile, 1754<br />

Karasawa, Gakuyo, 1588<br />

Karchmer, Adolf W., 434<br />

Karle, Isabella L., 540<br />

Karle, Jean M., 540<br />

Karlsson, A., 1100<br />

Karlsson, Inga, 1484<br />

Kasworm, Evelyn M., 1820<br />

Katagiri, Kenji, 726<br />

Katahira, Junichi, 912<br />

Katayama, Toshiaki, 110

iv AUTHOR INDEX<br />

Kato, Hideo, 190<br />

Kato, Naoki, 1437<br />

Katsu, Kanemasa, 693<br />

Kawahapa, Yukinori, 110<br />

Kaye, Donald, 262, 877<br />

Kayser, Fritz H., 1494<br />

Kearns, Gregory L., 148i<br />

Keeler, Girard H., 1347<br />

Keith, Dennis D., 1005<br />

Kennedy, Donald, 710<br />

Kennedy, James K., 1292<br />

Kernodle, Douglas S., 202<br />

Kernutt, Ian, 1705<br />

Kesavalu, L., 886, 1400, 1404<br />

Kessler, Robert E., 1443<br />

Khan, Waheed N., 775<br />

Kim, C. Kurtis, 96, 8%<br />

Kimura, Hiromichi, 1588<br />

Kirihara, Jean, 1392<br />

Kirk, K. L., 1655<br />

Kirouac, Daniel, 1227<br />

Kitayama, Rieko, 912<br />

Kitoh, Kyosuke, 693<br />

Kitzis, M. D., 9<br />

Klamerus, Karen J., 631<br />

Klastersky, J., 1557<br />

Knapp, Cynthia, 131, 170, 1754, 1896<br />

Knapp, J. S., 426, 488, 765, 1430<br />

K'night, Vernon, 890<br />

Knodel, Leroy C., 853<br />

Kobasa, William D., 262<br />

Kobayashi, George S., 327, 702<br />

Kobayashi, Shinzo, 1046, 13%<br />

Kdeppe, Peter, 92<br />

Koga, Hironobu, 1427<br />

Kohno,'Shigeru, 1427<br />

Kokkonen, Paula, 1019<br />

Kolnig, Anne-Marie, 936<br />

Komiya, Masamichi, 566<br />

Komiyama, Atsushi, 1864<br />

Kondo, Eiko, 110<br />

Kondo, Sinichi, 1421<br />

Konno, Kenji, 906<br />

Koornhof, H. J., 24, 1458<br />

Koseki, Yuichi, 110<br />

Kosuzume, Hiroshi, 1648<br />

Kotaki, Hiromichi, 282<br />

Kotik, Alan N., 1763<br />

Koubaa, Nedra, 147<br />

Koup, Jeffrey R., 274, 573<br />

Kovacs, Joseph A., 430<br />

Kreindler, Thdmas G., 882<br />

Kresken, M.; 1285<br />

Krogh, Palle, 1859<br />

Krogstad, Donald J., 793, 799, 953, 957<br />

Kromann-Andersen, Bjarne, 936<br />

Kronvall, G6ran, 1484<br />

Kuhn, Jbhn G., 1310<br />

Kumada, Teppei, 912<br />

Kumano, Katsuhiko, 912<br />

Kumar, Ashir, 882<br />

Kume, Yothihiro, 190<br />

Kunka, R. L., 1503<br />

Kunz, Samuel, 364<br />

Kuo, Cho-chou, 257<br />

Kurihara, Kozo, 110<br />

Kurth, Reinhard, 1733<br />

Kurzynski, Terrence A., 137<br />

kusmiesz, Helen, 1738<br />

Kusser, Wolfgang C., 1247<br />

Kuvanont, Krit, 723<br />

Labedan, Bernard, 153<br />

Labia, Roger, 626, 1660<br />

Labro, M. T., 1124<br />

Labroo, V. M., 1655<br />

Laforest, H., 1094<br />

Lagrange, P. H., 1094<br />

Laguens, Ruben P., 241<br />

Lake, Kathleen D., 1899<br />

Lake-Bakaar, Desmond M., 1807<br />

Lally, Richard T., 513<br />

Lam, A. W., 20<br />

Lam, Y. W. Francis, 298<br />

Lambert, Thierry, 15<br />

Lane, H. Clifford, 324<br />

Laska, D. A., 314<br />

Laughon, B. E., 598<br />

Laux, David C., 770<br />

Lawson, Lisa A., 1320<br />

Lazardi, Keyla, 1237<br />

LeBel, Marc, 354, 561, 1227, 1515<br />

Leclerc, H., 873<br />

Lee, A. T., 1655<br />

Leggett, James E., 51<br />

Lemel<strong>and</strong>, Jean-Francois, 919<br />

Lemon, Eloise, 1780<br />

Leone, R., 1875<br />

Leoung, Gifford, 1057<br />

Lerner, Stephen A., 1196, 1379<br />

Leroy, Annie, 938<br />

Leslie, James, 1537<br />

Lessard, Celine, 736, 1433<br />

Lettieri, John, 75<br />

Levesque, Roger C., 819<br />

Levine, Bernard E., 369<br />

Levitsky, Sidney, 63i<br />

Levy, Mordekhai, 1586<br />

Levy, Stuart B., 1187, 1797, 1801<br />

Liebowitz, Lynne D., 24<br />

Lin, A. H., 592<br />

Lin, Jung-Chung, 265, 1068<br />

Lindborg, Bjorn, 1807<br />

Lindner, David L., 159<br />

Lindqvist, Lennart, 1869<br />

Ling, Julia, 20<br />

Linke, Michael J., 96, 98%<br />

Lismont, M. J., 1632<br />

Livermore, David M., 1385<br />

Livrelli, Valerie 0., 1282<br />

Lloyd, William J., 814<br />

Lode, Hartmut, 92<br />

Lokerse, A. F., 1560<br />

Lolans, Valentina T., 785<br />

London, William T., 1269<br />

Love, Kathryn R., 1899<br />

Lower, Johannes, 1733<br />

Loy, Anna, 1223<br />

Lucia, Helen L., 678<br />

Lundblad, Leif, 1720<br />

MacGregor, Rob Roy, 1320<br />

Machida, H., 1046, 1068, 1547<br />

Maddaus, Michael A., 1769<br />

Madier, S., 873<br />

Maeda, Hiroshi, 1080<br />

Maher, Louise A., 180, 1477<br />

Mahl<strong>and</strong>t, Bill G., 1304<br />

Maimorie, Francesco, 1262<br />

MalamUld, Daniel, 350<br />

Malouin, F., 498<br />

M<strong>and</strong>ell, Lionel, 1231<br />

Mannisto, Pekka T., 1019<br />

Mant, T. G. K., 1503<br />

ANTIMICROB. AGENTS CHEMOTHER.<br />

Marble, Dwight A., 503<br />

Marciano-Cabral, F., 962<br />

Marini, Patricia M., 1416<br />

Marshall, Bonnie, 1801<br />

Martel, Jean-Louis, 1282<br />

Martin, Juan F., 1061<br />

Martin, Mary E., 730<br />

Martino-Saltzman, David, 1784<br />

Martra, A., 873<br />

Marx, Preston A., 1887<br />

Masecar, Barbara L., 122<br />

Masuda, Midori, 1864<br />

Masur, Henry, 324, 430<br />

Mateos-Mora, Miguel, 170<br />

Matsui, Hidefumi, 33<br />

Matsumoto, Y., 1243, 1655<br />

Matsuoka, Takafumi, 1864<br />

Matthews, R. S., 617<br />

Matthews, Thomas R., 1154, 1887<br />

Matthys, E., 1595<br />

Mattie, Herman, 1456<br />

Matzke, G. R., 485, 1845<br />

McCabe, Robert, 1031<br />

McChesney, Daniel G., 775<br />

McClain, J. Bruce, 285<br />

McCormack, William M., 773<br />

McDonald, Edith'J., 1710<br />

McGinnis, E., 1788<br />

McGroarty, Estelle J., 308, 649<br />

McIntyre, 0. Ross, 1627<br />

McKee, Kelly T., Jr., 1304<br />

McMurry, Laura M., 1187<br />

McRoberts, Mary Jane, 1887<br />

Medina, Ileana, 1057<br />

Medoff, Gerald, 327, 702<br />

Mellencamp, Martha A., 1327<br />

Mendelman, Paul M., 706<br />

Mendelson, Jack, 1231<br />

Mendez, F. J., 420<br />

Mendez-Castrill6n, Paloma P., 1257<br />

Meunier, F., 1557<br />

Mevio, E., 1461<br />

Meyers, Joel D., 271<br />

Michel, M. F., 426<br />

Michelsen, Phyllis, 1565<br />

Mikami, Hidetada, 587<br />

Miller, Michael H., 1113<br />

Miller, S. D., 1458<br />

Mills, John, 1057<br />

Mine, Yasuhiro, 1243<br />

Mintzer, C. L., 391<br />

Mischak, Ronald P., 710<br />

Mitelman, Felix, 936<br />

Mitsuhashi, Susumu, 104, 587, 827, 922,<br />

1097, 1421, 1848<br />

Mitsuyama, Junichi, 1097, 1848<br />

Miyaji, Makoto, 726<br />

Miyauchi, Masayuki, i437<br />

Mizen, Linda, 1705<br />

Mobashery, Shahriar, 1196<br />

Mochida, Ei, 1648<br />

Mochizuki, Hidenori, 1648<br />

Moellering, R. C., Jr., 434, 1341, 1528<br />

Moncla, Bernard J., 1271<br />

Monteil; H., 1360<br />

Montgomerie, John Z., 81<br />

Monto, Arnold S., 47<br />

Moore, pavid, 1078<br />

Moore, Jennifer L., 684<br />

Moosdeen, F., 925<br />

Mor<strong>and</strong>, Annick, 1660<br />

Moriyama, Megumi, 693<br />

Moros, Mariano, 636

VOL. 32, 1988<br />

Morrison, P. J., 1503<br />

Morse, Stephen A., 765<br />

Mosadomi, H. A., 598<br />

Moseley, Steve L., 477<br />

Moskovitz, Bruce L., 1300<br />

Moulin, Bruno, 938, 942<br />

Mounier, J., 195<br />

Mullany, Peter, 1213<br />

Mummaw, Nancy, 1323<br />

Murakami, Kimihiro, 1648<br />

Murata, Kenjiro, 1864<br />

Murphy, James R., 462<br />

Murphy, Robert F., 324<br />

Murray, Barbara E., 547, 768<br />

Murray, Dennis L., 882<br />

Muto, Yoshinori, 1437<br />

Myles, Camille, 1331<br />

Nadler, Marcus, 1763<br />

Nagata, Osamu, 156, 190<br />

Nagayama, Ariaki, 1735<br />

Nakae, Taiji, 378, 966<br />

Nakajima, Mutsuo, 110<br />

Nakamura, Kiyoto, 906<br />

Nakao, Tomokazu, 1735<br />

Nakata, Katsuhisa, 1080<br />

Narukawa, Noriaki, 458<br />

Nassos, Patricia, 1392<br />

Nelson, Eric, 1379<br />

Nelson, John D., 268, 1738<br />

Neu, Harold C., 84, 580, 656, 663, 671,<br />

1666<br />

Neuwirth, Zeev, 1763<br />

Nichols, James S., 1119<br />

Nichols, Wright W., 518<br />

Nickell, Steven P., 462<br />

Nicolau, Claude, 391<br />

Nicoletti, Mauro, 1262<br />

Nightingale, Charles H., 128<br />

Nilsson, Lennart E., 1208<br />

Nishimura, Hitoshi, 566<br />

Nishino, Takeshi, 1073, 1192<br />

Nishiyama, Yukihiro, 1053<br />

Nix, David E., 450<br />

Nord, Carl Erik, 1869<br />

Norman, G. T. 1503<br />

Norrby, Ragnar, 936<br />

Norrby, S. Ragnar, 1278<br />

Norris, Steven J., 68<br />

Norton, James A., 63<br />

Noumi, Toshihiko, 827<br />

Novelli, Andrea, 580, 656, 663, 1666<br />

Oberg, Bo, 1733<br />

O'Callaghan, Richard J., 978<br />

Ochi, James W., 865<br />

O'Connell, Kevin, 492<br />

Ogborne, Kevin T., 186<br />

O'Hara, Denise, 1494<br />

O'Hare, J., 144<br />

Ohmae, Kenichi, 1891<br />

O'Horo, Jennifer, 1780<br />

Oikawa, Yoshihiro, 1648<br />

Okamoto, Ryoichi, 1421<br />

O'Keefe, J. Paul, 717<br />

Okezaki, Eiichi, 156, 190<br />

Okuda, Takao, 33<br />

Olson, L., 589<br />

Omnes, Anne, 1204<br />

Omura, Satoshi, 282<br />

O'Neill, Melanie J., 1725<br />

Opheim, Kent, 274, 1640<br />

Ortisi, G., 1461<br />

Osada, Yasuaki, 1336<br />

Oster, Sharon, 1031<br />

O'Sullivan, John F., 1583<br />

Otero, Joaquin R., 1598<br />

Ouellette, Marc, 397<br />

Pacheco, F., 589<br />

Pagano, Joseph S., 265<br />

Pakiz, Cathy B., 689<br />

Panneton, Anne-Claire, 354, 1515<br />

Panton, L. J., 1655<br />

Papadopoulou, Barbara, 945, 1793<br />

Pares, Juan, 636<br />

Parham, Christine, 1788<br />

Park, Britt H., 1797<br />

Parker, Steven W., 777<br />

Parrillo, Joseph E., 324, 430<br />

Parry, Michael F., 982<br />

Patchett, Arthur A., 319<br />

Patel, I. H., 592<br />

Patterson, Jan Evans, 122<br />

Patterson, Jean L., 492<br />

Patton, Curtis L., 1182<br />

Paul, Gerard C., 397<br />

Pauwels, Rudi, 1025, 1742<br />

Pearce, Maria, 1443<br />

Pechere, Jean-Claude F., 524<br />

Pelletier, Lawrence L., Jr., 374<br />

Peltier, G. L., 485<br />

Perol, Y., 1350<br />

Perumal, Veluchamy K., 886, 1400, 1404<br />

Pesce, Adelaide, 279<br />

Petit, Agnes, 626, 1660<br />

Pettigrew, Martine, 992<br />

Philippon, Alain M., 397<br />

Phillipson, J. David, 1725<br />

Pierson, Carl, 717<br />

Pifat, Dominique Y., 331<br />

Piras, Marta M., 1237<br />

Piras, Romano, 1237<br />

Plaisance, Karen I., 1537<br />

Podapati, N. Rao, 1400<br />

Polacheck, Itzhack, 1586<br />

Pompei, Raffaello, 552<br />

Poplack, David G., 324<br />

Popovski, Zagorka, 510<br />

Portnoy, J., 589<br />

Prainito, Marie, 1375<br />

Pratt, Kathleen J., 1331<br />

Preheim, Laurel C., 1327<br />

Preston, David A., 180<br />

Prince, Alice, 838<br />

Prince, Gregory A., 1269<br />

Prisbe, Ernest J., 1887<br />

Pritzker, Marc R., 1899<br />

Privitera, G., 1461<br />

Proctor, R. A., 37<br />

Pruess, David L., 1005<br />

Puchetti, V., 1875<br />

Pussard, Eric, 568<br />

Queener, Sherry F., 807<br />

Quentin, Rol<strong>and</strong>, 147<br />

Quinn, John P., 1267<br />

Quintiliani, Richard, 128<br />

Quiros, L. M., 420<br />

Rachlis, Anita, 1231<br />

Radstrom, Peter, 1684<br />

Ramer, Nancy R., 27<br />

Rao, Podapati N. R., 886<br />

AUTHOR INDEX v<br />

Raoult, D., 255<br />

Rash, Jay J., 1347<br />

Rashad, Abdel L., 844<br />

Rauramaa, Veikko, 1019<br />

Redding, Judith S., 180, 1477<br />

Rehavi, M., 1624<br />

Reiszner, E., 1528<br />

Reitberg, Donald P., 42, 51, 503, 730<br />

Remington, Jack S., 755<br />

Rescott, Denise L., 450<br />

Reuman, Peter D., 761<br />

Reynolds, Janet, 63<br />

Reynolds, Peter, 1494<br />

Rice, Robert, 285<br />

Rice-Ficht, Allison, 391<br />

Rich, Chantal D., 1282<br />

Richardson, James D., 807<br />

Richet, H., 1094<br />

Richman, Douglas D., 865<br />

Richwald, Gary A., 213<br />

Rico, Manuel, 1552<br />

Riff, Louise J., 848<br />

Rikihisa, Yasuko, 986<br />

Rinaldi, Michael G., 1310<br />

Ringertz, Signe, 1484<br />

Riscoe, Michael K., 1904<br />

Rittenhouse, Brian R., 834<br />

Rivera, Mildred, 649<br />

Roberts, Elizbeth, 462<br />

Roberts, Marilyn C., 488, 765, 1271, 1430<br />

Robillard, Norman J., 535<br />

Robinson, J., 1503<br />

Roblot-Treupel, Liliane, 1204<br />

Roccaforte, Jane S., 1327<br />

Rocque, Warren J., 308<br />

Rodondi, Lisa C., 1511, 1825<br />

Rodvold, Keith A., 631, 848<br />

Roerdink, F. H., 1560<br />

Roessner, Charles A., 391<br />

Rogers, Paul, 324<br />

Rolston, Kenneth, 1078<br />

Ronald Allan R., 1292<br />

Roon, Richard A., 274<br />

Root, Carol J., 773<br />

Root, Jennifer L., 1627<br />

Rootman, David S., 978<br />

Rosenberg, Carl, 1158<br />

Rosenberg, Ivan, 1025, 1839<br />

Rosina, Rita, 1223<br />

Rossan, R. N., 1655<br />

Rotimi, V. O., 598<br />

Rotschafer, John C., 848<br />

Rott-Petri, Jean A., 137<br />

Rouse, Mark, 747<br />

Roussellier, P., 255<br />

Rowse, Deborah, 1801<br />

Roy, Paul H., 397<br />

Roy, Rejean, 1433<br />

Rubinstein, E., 1624<br />

Russo, T., 717, 1439<br />

Rutala, William A., 642<br />

Rybak, Michael J., 510<br />

Saag, Michael S., I<br />

Saez-Nieto, Juan A., 706<br />

Saha, Gita, 580<br />

Saikawa, Isamu, 827, 912, 1097, 1848<br />

Saino, Yushi, 587<br />

Saito, Akira, 156<br />

Saito, Atsushi, 1427<br />

Saito, Hajime, 400<br />

Sakaguchi, Takashi, 1040, 1396

Vi AUTHOR INDEX<br />

Sakuma, Takashi, 1046, 1547, 1839<br />

Salas, J. A., 420<br />

Salfinger, Max, 1002<br />

Salmeron, C. M., 1350<br />

Samonis, George, 1365<br />

S<strong>and</strong>ers, Christine C., 689, 1314, 1365,<br />

1740, 1893<br />

S<strong>and</strong>ers, Cynthia, 1392<br />

S<strong>and</strong>ers, W. Eugene, Jr., 1740, 1893<br />

Sapico, Francisco L., 81<br />

Sartorelli, Alan C., 1182<br />

Sassella, D., 1461, 1541<br />

Sato, Hitoshi, 190<br />

Sato, Kenichi, 104, 922, 1336<br />

Satta, Giuseppe, 552<br />

Saunders, Jean, 24<br />

Sauzieres, Jacques, 1204<br />

Saviteer, Susan M., 642<br />

Savolainen, Seppo, 1019<br />

Sawyer, Janet G., 649<br />

Scannon, Patrick, 710<br />

Scarpa, Alphonse L., 535<br />

Schalla, W. O., 426<br />

Scheifele, David W., 1034<br />

Schell, Ronald F., 137<br />

Schentag, Jerome J., 450, 503<br />

Schiff, Gilbert M., 761<br />

Schifferli, Dieter M., 1603, 1609<br />

Schinazi, Raymond F., 997, 1784<br />

Schindler, M., 930<br />

Schito, Gian Carlo, 279<br />

Schlesinger, Paul H., 793, 799, 953, 957<br />

Schlosser, V., 930<br />

Schluederberg, Susan, 1801<br />

Schmidt-Eisenlohr, E., 930<br />

Schmitt, B., 780<br />

Schmitt, H. J., 780, 1676<br />

Schols, Dominique, 1025<br />

Schuening, Friedrich, 271<br />

Schultz, Robert W., 503<br />

Schurgers, M., 1595<br />

Schwartz, Jules, 75, 730<br />

Schwartz, Stanley A., 47<br />

Schwartzman, Michael S., 236<br />

Scieux, C., 1350<br />

Scott, Virginia R., 1154<br />

Sears, S. D., 144<br />

Segal, Neil B., 1231<br />

Segev, S., 1624<br />

Selitrennikoff, Claude P., 1901<br />

Serfass, Debra A., 706<br />

Shalaby, Lamaat M., 1699<br />

Sh<strong>and</strong>s, Joseph W., 773<br />

Sharp, Patricia A., 865<br />

Shaw, J. T. B., 646<br />

Shearer, Glenmore, Jr., 341<br />

Sheehan, Gerard J., 1292<br />

Shelton, Sharon, 268, 1738<br />

Shepherd, Julia A., 1693<br />

Sherwood, James R., 761<br />

Shigeta, Shiro, 906<br />

Shimada, Nobuyoshi, 1053<br />

Shimizu, Kihachiro, 912<br />

Shinners, Elizabeth N., 971<br />

Shiraishi, Akio, 110<br />

Shiramatsu, Koji, 1588<br />

Shyu, Wen Chyi, 128<br />

Siber, George R., 1034<br />

Sidwell, Robert W., 331<br />

Sieradzan, Raymond R., 1446<br />

Sierra-Madero, Juan, 1754, 1896<br />

Silva, Eric J., 865<br />

Silverman, Norman A., 631<br />

Simbul, Moises, 834<br />

Simmons, Richard L., 1769<br />

Simon, Francois, 568<br />

Sirot, Danielle L., 626, 1660<br />

Sirot, Jacques L., 626, 1660<br />

Six, Howard R., 890<br />

Slack, Mary P. E., 518<br />

Slee, A. M., 1218<br />

Sligh, James E., Jr., 702<br />

Smego, Douglas A., 982<br />

Smeltzer, Brian D., 236<br />

Smith, Arnold L., 477, 706, 1034<br />

Smith, Arnold N., 274<br />

Smith, Gary G., 595<br />

Smith, J. Kelly, 78<br />

Smith, James W., 63, 807<br />

Smith, John M., 1776<br />

Smith, M. Carolyn, 265<br />

Smith, Raymond P., 1450, 1565<br />

Smithwick, Ronald W., 125<br />

Snoeck, Robert, 1742, 1839<br />

Soike, Kenneth F., 1807<br />

Sokol-Anderson, Marcia, 702<br />

Somani, P., 530<br />

Someya, Tetsufumi, 1588<br />

Sommadossi, Jean-Pierre, 997<br />

Sommer, Peter, 936<br />

Sookpranee, Mondej, 1740<br />

Souza, Kathleen S., 1187<br />

Sperber, Steven J., 409<br />

Spillner, G., 930<br />

Spitler, Lynn E., 710<br />

Spitzer, Peter G., 434<br />

Srinivasan, A., 684<br />

Stamm, John M., 27<br />

Stamm, Lola V., 164<br />

Stamm, Walter E., 1640<br />

St<strong>and</strong>iford, Harold C., 1537<br />

Stankewich, Joseph P., 1347<br />

Stapleton, Jack T., 164<br />

Stark, Tracey, 1901<br />

Steele, Lorraine C., 1776<br />

Stein, Gary E., 802<br />

Steinberg, Marvin A., 1320<br />

Stenberg, Kjell, 1533<br />

Stevens, David A., 369<br />

Stieglitz, Michaela, 1090<br />

Stoeckel, Klaus, 573<br />

Stolz, E., 426<br />

Stone, J. W., 1508<br />

Storb, Rainer, 271<br />

Storrs, Michele J., 1174<br />

Strassle, Anni, 1494<br />

Strombeck, Bodil, 936<br />

Struck, Douglas K., 391<br />

Studemeister, Alex E., 1267<br />

Suarez, Juan E., 1552<br />

Subashi, Timothy A., 159<br />

Suenaga, Itaru, 458<br />

Sugarman, Barrett, 1323<br />

Sugimoto, Kyoko, 595<br />

Suh, Byungse, 1571<br />

Sumter, Gwendolyn, 1776<br />

Sun, Daxi, 1274, 1370<br />

Sundstrom, David C., 1763<br />

Suttmann, Rebecca T., 1887<br />

Sutton, David, 358<br />

Suzutani, Tatsuo, 1046, 1547<br />

Swan, Judith C., 430<br />

Swanson, Robert N., 27<br />

Swarz, Herbert, 42<br />

Swedberg, Gote, 1684<br />

Sypherd, Paul S., 341<br />

ANTIMICROB. AGENTS CHEMOTHER.<br />

Syriopoulou, Vassiliki P., 1034<br />

Szoka, Francis C., Jr., 858<br />

Tabaqchali, Soad, 1213<br />

Tachibana, Hiroshi, 966<br />

Taen, Haruko, 1735<br />

Taenaka, Nobuyuki, 1103<br />

Taft, Cathy S., 1901<br />

Takahara, Yoshio, 156<br />

Takahash, Katsutoshi, 1053<br />

Takahata, Masahiro, 1192<br />

Takano, Mitsuo, 1680<br />

Takeuchi, Toshihiko, 726<br />

Takezawa, Jun, 1103<br />

Talarico, Todd L., 1854<br />

Talbot, M. Kelly, 1005<br />

Tally, Francis P., 584, 717<br />

Tamai, Ikumi, 190<br />

Tamalet, J., 255<br />

Tamura, Atsushi, 1421<br />

Tamura, Toyoyuki, 566<br />

Tamura, Yuka, 932<br />

Tanaka, Haruo, 282<br />

Tancrede, Cyrille, 1204<br />

Tartaglione, Teresa A., 1640<br />

Taub, David, 319<br />

Tay, L. K., 314<br />

Taylor, David N., 723<br />

Taylor, Diane E., 1107<br />

Tenover, Fred C., 1170<br />

Terragna, Alberto, 1223<br />

Tesch, Wolfgang, 1494<br />

Thal, Wendy R., 337<br />

Thauvin, Claudie, 919<br />

Thomann, Charlotte A., 642<br />

Thompson, Nathan H., 1763<br />

Thomson, Margaret J., 1292<br />

Thomberry, Nancy A., 319<br />

Thornsberry, Clyde, 180, 752<br />

Tokunaga, Tohru, 110<br />

Tolmasky, Marcelo E., 1416<br />

Toltzis, Philip, 492<br />

Tomich, Paul K., 1465, 1472<br />

Tominack, Rebecca L., 1813<br />

Tomioka, Haruaki, 400<br />

Torikata, Akio, 110<br />

Townsend, Raymond J., 1825<br />

Trahan, Creighton J., 1304<br />

Tran Ba Huy, Patrice, 467<br />

Tran Van Nhieu, G., 9, 1289<br />

Treger, Thomas, 63<br />

Trouvin, J. H., 1590<br />

Tsuchido, Tetsuaki, 1680<br />

Tsuji, Akira, 190<br />

Tsukada, Katsuhiko, 726<br />

Tubert, Tracey, 180, 259<br />

Tucker, Richard M., 369<br />

Tuna, Ishik C., 209<br />

Turley, C. Patrick, 1481<br />

Turner, Ronald B., 1820<br />

Ueno, Kazue, 1437<br />

Une, Tsutomu, 1336<br />

Urbina, Julio A., 1237<br />

Urias, Barbara, 1292<br />

Usuki, Toshihiro, 1588<br />

Vaal, Mark, 1119<br />

Valiant, Mary E., 319<br />

Vall6e, Francois, 354<br />

V<strong>and</strong>enbroucke, Arthur C., 834<br />

Van der Auwera, P., 1557

VOL. 32, 1988<br />

van der Linden, M. P., 1632<br />

van der Waals, Ron, 1456<br />

van der Willigen, A. H., 426<br />

van Furth, Ralph, 1456<br />

van Klingeren, B., 426<br />

Van Peer, A., 1595<br />

Vavra, James J., 216<br />

Verdier, Francoise, 568<br />

Verdon, Michael S., 773<br />

Verghese, Abraham, 78<br />

Verhoef, Jan, 473<br />

Vermerie, N., 1590<br />

Vezina, Guy, 819<br />

Villa, Pia, 1541<br />

Villar, Claudio J., 1552<br />

Vliegenthart, John S., 740<br />

Vojtko, Charlene, 1710<br />

von Graevenitz, A., 1593<br />

Vrang, Lotta, 1733<br />

Wadstein, Jan, 936<br />

Wadsworth, S<strong>and</strong>ra J., 1571<br />

Wagenvoort, J. H. T., 426<br />

Wagner, Jutta, 92<br />

Wahren, B., 1137, 1720<br />

Waigh, Roger D., 1693<br />

Waites, Ken B., 1500<br />

Walker, Linda A., 1879<br />

Wallace, Richard J., Jr., 1776<br />

Walmsley, Harold L., 518<br />

Walton, Leslie, 1086<br />

Walzer, Peter D., 96, 8%<br />

Warhurst, David C., 1725<br />

Washington, John A., 131, 170, 1331, 1754,<br />

1896<br />

Watanabe, Kunitomo, 1437<br />

Watanabe, Nao-Aki, 693<br />

Watanabe, Yasuo, 912<br />

Waxman, Kenneth, 882<br />

Weber, David A., 1164<br />

Weber, David J., 642<br />

Weir, Matthew, 1537<br />

Weissberger, Barbara, 319<br />

Wells, Carol L., 1769<br />

Wennersten, C., 1528<br />

Wentworth, Berttina B., 216<br />

Wexler, Hannah M., 403, 601, 611<br />

Whall, Thomas J., 42, 51, 503<br />

Wheat, Lawrence J., 63<br />

White, Anthony J., 1879<br />

Whitney, Charles C., Jr., 1699<br />

Wiedemann, B., 1285<br />

Will, J. A., 37<br />

Willey, S<strong>and</strong>ra, 1341<br />

Williams, Deborah E., 1158<br />

Williams, J. D., 925<br />

Williams, P. D., 314, 758<br />

Williams, Paul L., 369<br />

Williamson, R., 9, 195<br />

Wills, Robert J., 1813<br />

Wilson, Mark E., 1521<br />

Wilson, Samuel Z., 890<br />

Wilson, Walter, 747<br />

Winton, Mark D., 928<br />

Wise, R., 617, 1251, 1508<br />

Wiseman, Jeffrey S., 1119<br />

Woestenborghs, R., 1310, 1595<br />

Wofsy, Constance, 1057<br />

Wolfson, John S., 1187<br />

Wong, Justina, 782<br />

Wong-Kai-In, Philippe, 814<br />

Wood, Mark S., 838<br />

Woodley, Charles L., 125<br />

Woodnutt, Gary, 1705<br />

Woods, Gail L., 1614<br />

Woolf, Nigel K., 865<br />

Woolfrey, Bert F., 513<br />

Wren, Brendan W., 1213<br />

Wright, Colin W., 1725<br />

Wu, John C., 1887<br />

Wyde, Philip R., 117, 890<br />

Wyss, Ronald, 573<br />

Xicota, M. Angels, 636<br />

Yagi, Betty Hannon, 216<br />

Yajko, David M., 1392<br />

Yam, Paul, 1614<br />

Yamabe, S., 925<br />

AUTHOR INDEX vii<br />

Yamada, Hidehiko, 1648<br />

Yamada, Takehisa, 156<br />

Yamada, Takeshi, 1588<br />

Yamaguchi, Keizo, 1427<br />

Yamamoto, Haruo, 1421<br />

Yamamoto, Naohiko, 1053<br />

Yamamoto, Tatsuo, 932<br />

Yamamoto, Toshiyuki, 726<br />

Yamazaki, Munehiro, 1864<br />

Yamazaki, Toshiyuki, 458<br />

Yang, Youjun, 1385<br />

Yankell, Samuel L., 350<br />

Yasuda, Takashi, 912, 1097, 1848<br />

Yasui, Kozo, 1864<br />

Yih, Jennifer, 141, 231<br />

Ylikoski, Jukka, 1019<br />

Yokota, Takeshi, 932<br />

Yokota, Tomoyuki, 906<br />

Yokota, Yoshiko, 1243<br />

Yoshida, Takashi, 1421<br />

Yoshihara, Eisaku, 966<br />

Yoshiya, Ikuto, 1103<br />

Yotsuji, Akira, 1097, 1848<br />

Young, Elizabeth C., 761<br />

Young, Lowell S., 1149<br />

Yourassowsky, E., 276, 1632<br />

Youssef, Mohammad, 1204<br />

Zajac, I., 1218<br />

Zak, Oto, 364<br />

Zehavi, Uri, 1586<br />

Zeiler, H.-J., 57<br />

Zenilman, Jonathan M., 765<br />

Zervos, Marcus J., 122<br />

Zhang, Lei, 962<br />

Zhang, Zhen-Xi, 265<br />

Zhou, Zhu, 997<br />

Zighelboim-Daum, S., 1528<br />

Zilhao, Rita, 1793<br />

Zimmerman, Stephen W., 51<br />

Zokufa, Humphrey Z., 848<br />

Zollinger-Iten, J., 1593<br />

Zscheck, Karen K., 768<br />

Zurenko, Gary E., 216

A723U<br />

herpes simplex virus type 1, 1100<br />

A40926<br />

pharmacokinetics, 246<br />

A-56268<br />

H. ducreyi, 1458<br />

T. gondii, 524<br />

A-56620<br />

M. tuberculosis, 1441<br />

Nocardia spp., 1078<br />

P. maltophilia, 782<br />

A-61827<br />

B. fragilis, 27<br />

C. jejuni, 27<br />

E. coli, 27<br />

Enterobacteriaceae, 27<br />

H. influenzae, 27<br />

L. pneumophila, 27<br />

N. gonorrhoeae, 27<br />

P. aeruginosa, 27<br />

S. aureus, 27<br />

S. pyogenes, 27<br />

S. typhimurium, 27<br />

Staphylococcus spp., 27<br />

Streptococcus spp., 27<br />

A-62254<br />

Nocardia spp., 1078<br />

A-62671<br />

comparative activity, 1710<br />

A-63075<br />

comparative activity<br />

erythromycin, 1500<br />

M. hominis, 1500<br />

M. pneumoniae, 1500<br />

U. urealyticum, 1500<br />

Acetyltransferase<br />

chloramphenicol<br />

C. difficile, 1213<br />

3-V-acetyltransferase<br />

gene probe, 1834<br />

6'-N-Acetyltransferase type 4<br />

Enterobacteriaceae, 1289<br />

S. marcescens, 1289<br />

Acinetobacter spp.<br />

3'-aminoglycoside phosphotransferase,<br />

15<br />

E1040, 693<br />

PD 117,596, 1450<br />

R plasmid, 15<br />

tigemonam, 84<br />

U-76,253A, 443<br />

Acquired immunodeficiency syndrome<br />

HPA-23, 1300<br />

M. avium complex, 1392<br />

P. carinii, 1057<br />

Acriflavin<br />

S. aureus resistance, 932<br />

Acrinol<br />

S. aureus resistance, 932<br />

Acrolein<br />

amoebic meningoencephalitis, 962<br />

N. fowleri, 962<br />

Actinobacillus actinomycetemcomitans<br />

clindamycin, 1521<br />

neutrophil killing, 1521<br />

Actinobacillus lignieresii<br />

actinomycin D, 1354<br />

daptomycin, 1354<br />

novobiocin, 1354<br />

phospholipid composition, 1354<br />

polymyxin, 1354<br />

SUBJECT INDEX<br />

VOLUME 32<br />

rifamycin, 1354<br />

Actinomyces spp.<br />

daptomycin, 788<br />

paldimycin, 788<br />

Actinomycin D<br />

A. lignieresii, 1354<br />

P. multocida, 1354<br />

Acyclovir<br />

combinations<br />

3'-azido-3'-deoxythymidine, 265<br />

AZT, 265<br />

Epstein-Barr virus, 265<br />

comparative activity<br />

I-3-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil<br />

<strong>and</strong><br />

E-5(2-bromovinyl)-2'-deoxyuridine,<br />

1068<br />

Epstein-Barr virus, 1068<br />

guinea pig embryonic fibroblasts, 1533<br />

herpes simplex virus type 1, 1100, 1533<br />

monophosphate<br />

guinea pig embryonic fibroblasts, 1533<br />

herpes simplex virus type 1, 1533<br />

triphosphate<br />

DNA polymerases, 1137<br />

varicella-zoster virus, 1137<br />

(RS)-3-Adenin-9-yl-2-hydroxypropanoic<br />

acid<br />

influenza viruses, 906<br />

Adenovirus<br />

sulfated polysaccharides, 1742<br />

type 5<br />

P-536, 1257<br />

Adhesion, bacterial<br />

antibiotic modulation, 1603, 1609<br />

folate pathway, 1609<br />

membrane structures, 1609<br />

nucleic acid synthesis, 1609<br />

peptidoglycan synthesis, 1609<br />

protein synthesis, 1603<br />

minireviews, 1603, 1609<br />

Aerobic bacteria<br />

pristinamycin, 1094<br />

Aerobic-anaerobic infections<br />

minireview, 611<br />

Aeromonas hydrophila<br />

CS-807, 1082<br />

tigemonam, 84<br />

U-76,252, 1082<br />

Aeromonas spp.<br />

,B-lactam resistance, 1314<br />

13-lactamases, 1314<br />

Agar dilution plate count method<br />

effect of temperature on inoculum, 513<br />

errors, 513<br />

(RS)-AHPA<br />

influenza viruses, 906<br />

Alanine racemase<br />

halovinylglycine compounds, 319<br />

L-norvalyl peptide derivatives, 319<br />

Alcaligenes denitrificans subsp. xylosoxidans<br />

amdinocillin, 276<br />

amikacin, 276<br />

amoxicillin-clavulanic acid, 276<br />

ampicillin, 276<br />

cefam<strong>and</strong>ole, 276<br />

cefazolin, 276<br />

ceforanide, 276<br />

cefotaxime, 276<br />

cefotetan, 276<br />

viii<br />

ceftazidime, 276<br />

ceftriaxone, 276<br />

cefuroxime, 276<br />

ciprofloxacin, 276<br />

gentamicin, 276<br />

imipenem, 276<br />

netilmicin, 276<br />

norfloxacin, 276<br />

ofloxacin, 276<br />

pefloxacin, 276<br />

piperacillin, 276<br />

temocillin, 276<br />

ticarcillin-clavulanic acid, 276<br />

tobramycin, 276<br />

trimethoprim-sulfamethoxazole, 276<br />

Alcaligenes faecalis<br />

diffusion pore, 378<br />

Alginate<br />

P. aeruginosa<br />

tobramycin binding, 518<br />

Allicin<br />

mechanism of action, 1763<br />

S. typhimurium, 1763<br />

Alpha-2b interferon<br />

influenza A virus, 47<br />

influenza B virus, 47<br />

rhinovirus, 47<br />

AM-833<br />

C. trachomatis, 1080, 1735<br />

comparative activity<br />

doxycycline <strong>and</strong> minocycline, 1735<br />

Amdinocillin<br />

A. denitrificans subsp. xylosoxidans, 276<br />

combinations<br />

ceftazidime, 1632<br />

E. cloacae, 1632<br />

E. cloacae, 1632<br />

Amdinocillin pivoxil<br />

pharmacokinetics<br />

influence of food, 592<br />

Amicarbalide<br />

P. carinii, 896<br />

Amifloxacin<br />

comparative activity<br />

ciprofloxacin, enoxacin, norfloxacin,<br />

<strong>and</strong> ofloxacin, 928<br />

Nocardia spp., 1078<br />

P. falciparum, 1182<br />

P. pseudomallei, 928<br />

Amikacin<br />

A. denitrificans subsp. xylosoxidans, 276<br />

B. catarrhalis, 259<br />

combinations<br />

ceftazidime, 231<br />

ciprofloxacin, 782<br />

clindamycin, 1557<br />

clofazimine, 1400<br />

endocarditis, 231<br />

head <strong>and</strong> neck surgery in cancer patients,<br />

1557<br />

M. avium complex, 1149, 1400<br />

P. aeruginosa, 231<br />

P. maltophilia, 782<br />

resistance, development of, 231<br />

rifabutin, 1400<br />

tumor necrosis factor, 1149<br />

wound infections, 1557<br />

dysgonic fermenter 2, 78<br />

E. coli<br />

lipopolysaccharide, 1247<br />

Enterobacteriaceae, 873

VOL. 32, 1988<br />

resistance, 1289<br />

K. pneumoniae resistance, 1379, 1416<br />

liposome encapsulated<br />

M. avium-M. intracellulare, 1404<br />

M. avium, 1131<br />

M. avium complex, 886, 1149, 1400<br />

M. avium-M. intracellulare, 1404<br />

N. asteroides, 1776<br />

P. maltophilia, 782<br />

pharmacokinetics, 236<br />

S. aureus resistance, 932<br />

S. marcescens resistance, 1289, 1379<br />

Shigella spp., 20<br />

Amikacin-ceftazidime<br />

comparative activity<br />

pefloxacin, 23i<br />

endocarditis, 231<br />

P. aeruginosa, 231<br />

resistance, development of, 231<br />

Amiloride<br />

combinations<br />

Pseudomonas spp., 395<br />

tobramycin, 395<br />

Pseudomonas spp., 395<br />

y-Aminobutyric acid binding<br />

BMY-262252 758<br />

cefazolin, 758<br />

imipenem-cilastatin, 758<br />

inhibition of<br />

quiholones, 190<br />

rat model, 758,<br />

Aminoglycoside 3-V-acetyltransferase<br />

gene probe, 1834<br />

3'-Aminoglycoside phosphotransferase<br />

Acinetobacter spp., 15<br />

Aminoglycoside-modifying enzymes<br />

reaction rates, 740<br />

Aminoglycosides<br />

cochlear binding sites, 467<br />

P. aeruginosa resistance, 689<br />

S. faecalis resistance, 1528<br />

T. vaginalis, 144<br />

Amodiaquine<br />

polymorphonuclear neutrophils, 1124<br />

Ainoebic meningoencephalitis<br />

acrolein, 962<br />

cyclophosphamide, 962<br />

Amopyroquin<br />

comparative activity<br />

chloroquine <strong>and</strong> monodesethylamodiaquine,<br />

568<br />

P. falciparum, 568<br />

pharmacokinetics, 568<br />

Amooxicillin<br />

Bordetella spp., 137<br />

H. ducreyi, 1458<br />

P. pseudomallei, 1435<br />

Amoxicillin-clavulanic acid<br />

A. denitrificans subsp. xylosoxidans, 276<br />

B. catarrhalis, 259<br />

B. fragilis-E. coli, 1830<br />

bite wound bacteria, 1143<br />

comparative activity<br />

ampicillin-sulbactam, 1830<br />

Enterobacteriaceae, 873<br />

H. ducreyi, 1458<br />

P. multocida, 213<br />

P. pseudomallei, 1435<br />

Amphotericin B<br />

Aspergillus spp'., 1676<br />

C. albicans<br />

2-chloroethyl-1-nitrosoureas, 327<br />

resistance, 702<br />

comparative activity<br />

miconazole, 1864<br />

high-performance liquid chromatography,<br />

1103<br />

polymorphonuclear leukocytes, 1864<br />

pulmonary aspergillosis, 1676<br />

S. schenckii, 1619<br />

sporotrichosis, 1619<br />

T. vaginalis, 1323<br />

Ampicillin<br />

A. denitrificans subsp. xylosoxidans, 276<br />

B. bronchiseptica, 1891<br />

B. catarrhalis, 259<br />

bite wound bacteria, 1143<br />

Chlamydia sp. strain TWAR, 257<br />

combinations<br />

B. fragilis-E. coli, 1830<br />

biliary tract infections, 1231<br />

sulbactam, 1830<br />

tobramycin, 1231<br />

dental granuloma, 566<br />

E. coli, 450, 552<br />

Enterobacteriaceae, 873<br />

fecal flora resistance, 1801<br />

H. influenzae, 180<br />

in vitro simulation of serious infections,<br />

552<br />

L. monocytogenes, 1204, 1560<br />

liposome entrapped<br />

L. monocytogenes, 1560<br />

lipid composition, 1560<br />

M. morganii, 1385<br />

N. asteroides, 1776<br />

nanoparticle polyisohexylcyanoacrylate<br />

bound<br />

L. monocytogenes, 1204<br />

P. aeruginosa, 552<br />

P. carinii, 896<br />

P. multocida, 213<br />

P. vulgaris, 1385<br />

postantibiotic effect, 450<br />

S. paratyphi A, resistant, 195<br />

S. pneumoniae, 552<br />

Shigella spp., 20<br />

Ampicillin-gulbactam<br />

B. catarrhalis, 259<br />

B. fragilis-E. coli, 1830<br />

comparative activity<br />

amoxicillin-clavulanic acid, 1830<br />

Shigella spp., 20<br />

Ampicillin-tobramycin<br />

biliary tract infections, 1231<br />

comparative activity<br />

cefoperazone, 1231<br />

Anesthetics<br />

E. coli permeability, 153<br />

Anisomycin<br />

T. vaginalis, 144<br />

Anogeissus leiocurpus<br />

B. gingivalis, 598<br />

B. melaninogenicus, 598<br />

Antacids<br />

ciprofloxacin, 949<br />

letter to the editor, 949<br />

Antibiotic biosynthetic genes<br />

minireview, 1472<br />

Streptomyces spp., 1472<br />

Antibodies<br />

monoclonal<br />

C. trachomatis, 1295<br />

minireview, 1295<br />

P. aeruginosa, 649<br />

monoclonal anti-lipid A<br />

SUBJECT INDEX<br />

bacteremia, 710<br />

immunogenicity, 710<br />

pharmacokinetics, 710<br />

toxicity, 710<br />

Antifungal agents<br />

jasplakinolide, 1154<br />

minireview, I<br />

T. vaginalis, 144<br />

Antimalarial drugs<br />

polymorphonuclear neutrophils, 1124<br />

Apalcillin<br />

nephrotoxicity, 942<br />

pharmacokinetics, 942<br />

9-p-D-Arabinofuranosyladenine<br />

herpes simplex virus type 1, 1046<br />

1- ,-D-Arabinofuranosyl-E-5-(2-bromovinyl)<br />

uracil<br />

comparative activity<br />

acyclovir <strong>and</strong> E-5-(2-bromovinyl)-2'deoxyuridine,<br />

1068<br />

Epstein-Barr virus, 1068<br />

herpes simplex virus type 1, 1547<br />

herpes simplex virus type 2, 1547<br />

nucleosides, effect of, 1547<br />

1-4-D-Arabinofuranosyl-E-(2-bromovinyl)<br />

uracil<br />

herpes simplex virus type 1, 1046<br />

1-P-D-Arabinofuranosylthymine<br />

herpes simplex virus type 1, 1046<br />

Argentine hemorrhagic fever<br />

ribavirin, 1304<br />

Arthrobacter spp,<br />

carbomycin, 420<br />

celesticetin, 420<br />

clindamycin, 420<br />

erythromycin, 420<br />

josamycin, 420<br />

lincomycin, 420<br />

lincosamide resistance, 420<br />

ole<strong>and</strong>omycin, 420<br />

rosaramicin, 420<br />

spiramycin, 420<br />

tylosin, 420<br />

vernamycin B, 420<br />

Aspergillus spp.<br />

amphotericin B, 1676<br />

terbinafine, 780<br />

Astiban<br />

P. carinii, 896<br />

ATP<br />

M. tuberculosis bioluminescence assay,<br />

1208<br />

Avermectins<br />

glucose metabolism, 282<br />

3'-Azido-3'-deoxythymidine<br />

combinations<br />

acyclovir, 265<br />

Epstein-Barr virus, 265<br />

human immunodeficiency virus type 1,<br />

1784<br />

isoprinosine, 1784<br />

cytomegalovirus, 265<br />

Epstein-Barr virus, 265<br />

herpes simplex virus type 1, 265<br />

herpes simplex virus type 2, 265<br />

human immunodeficiency virus type 1,<br />

1784<br />

toxicity<br />

uridine, 997<br />

varicella-zoster virus, 265<br />

3'-Azido-3'-deoxythymidine triphosphate<br />

human immunodeficiency virus type 1,<br />

1733<br />

ix

x SUBJECT INDEX<br />

human immunodeficiency virus type 2,<br />

1733<br />

simian immunodeficiency virus, 1733<br />

Azithromycin<br />

B. catarrhalis, 752<br />

combinations<br />

M. avium complex, 1149<br />

tumor necrosis factor, 1149<br />

comparative activity, 1710<br />

clarithromycin, clindamycin, erythromycin,<br />

<strong>and</strong> roxithromycin, 752<br />

H. influenzae, 752<br />

L. monocytogenes, 752<br />

L. pneumophila, 752<br />

M. avium complex, 1149<br />

N. gonorrhoeae, 752<br />

N. meningitidis, 752<br />

T. gondii, 524, 755<br />

Azlocillin<br />

B. catarrhalis, 259<br />

Azoles<br />

minireview, 1<br />

AZT<br />

combinations<br />

acyclovir, 265<br />

Epstein-Barr virus, 265<br />

human immunodeficiency virus type 1,<br />

1784<br />

isoprinosine, 1784<br />

cytomegalovirus, 265<br />

Epstein-Barr virus, 265<br />

herpes simplex virus type 1, 265<br />

herpes simplex virus type 2, 265<br />

human immunodeficiency virus type 1,<br />

1784<br />

toxicity<br />

uridine, 997<br />

triphosphate<br />

human immunodeficiency virus type 1,<br />

1733<br />

human immunodeficiency virus type 2,<br />

1733<br />

simian immunodeficiency virus, 1733<br />

varicella-zoster virus, 265<br />

Aztreonam<br />

B. catarrhalis, 259<br />

combinations<br />

ciprofloxacin, 782<br />

P. maltophilia, 782<br />

dysgonic fermenter 2, 78<br />

E. coli, 552<br />

hyperbilirubinemia<br />

centrifugal ultrafiltration, 1571<br />

in vitro simulation of serious infections,.<br />

552<br />

P. aeruginosa, 552<br />

P. maltophilia, 782<br />

S. pneumoniae, 552<br />

B-220<br />

cytomegalovirus, 1720<br />

herpes simplex virus type 1, 1720<br />

mechanism of action, 1720<br />

varicella-zoster virus, 1720<br />

Babesia microti<br />

inositol hexaphosphate, 391<br />

Bacillus spp.<br />

cefazolin, 642<br />

cefotaxime, 642<br />

cefoxitin, 642<br />

cefuroxime, 642<br />

chloramphenicol, 642<br />

ciprofloxacin, 642<br />

clindamycin, 642<br />

daptomycin, 642<br />

erythromycin, 642<br />

gentamicin, 642<br />

imipenem, 642<br />

mezlocillin, 642<br />

oxacillin, 642<br />

penicillin, 642<br />

tetracycline, 642<br />

ticarcillin-clavulanate, 642<br />

trimethoprim-sulfamethoxazole, 642<br />

vancomycin, 642<br />

Bacillus stearothermophilus<br />

etoposide, 1456<br />

Bacillus subtilis<br />

etoposide, 1456<br />

letter to the editor, 949<br />

streptomycin adenylyltransferase, 949<br />

Bacteremia<br />

monoclonal anti-lipid A antibody, 710<br />

Bacterial adhesion<br />

antibiotic modulation, 1603, 1609<br />

folate pathway, 1609<br />

membrane structures, 1609<br />

nucleic acid synthesis, 1609<br />

peptidoglycan synthesis, 1609<br />

protein synthesis, 1603<br />

minireviews, 1603, 1609<br />

Bactericidal testing<br />

oxacillin, 1614<br />

S. aureus, 1614<br />

Bacteroides fragilis<br />

A-61827, 27<br />

P-lactam resistance, 1437<br />

P-lactamase, 1848<br />

cefam<strong>and</strong>ole, 1097, 1848<br />

cefazolin, 1097, 1848<br />

cefoperazone, 1097, 1848<br />

cefoperazone-sulbactam, 403<br />

cefotetan, 601<br />

cefoxitin, 1511<br />

ceftezole, 1097, 1848<br />

ceftizoxime, 1511<br />

cephalosporins<br />

outer membrane permeation, 1097<br />

resistance, 1848<br />

cephalothin, 1097, 1848<br />

ciprofloxacin, 1437<br />

clindamycin, 1825<br />

DR-3355, 1336<br />

DuP 105, 580<br />

DuP 721, 580<br />

enoxacin, 1437<br />

fluoroquinolone resistance, 1437<br />

lomefloxacin, 617<br />

mixed infection with E. coli<br />

amoxicillin-clavulanic acid, 1830<br />

ampicillin-sulbactam, 1830<br />

norfloxacin, 1437, 1869<br />

NY-198, 1437<br />

ofloxacin, 1437<br />

PD 127,391, 1251<br />

penicillin-binding proteins, 1848<br />

susceptibility patterns<br />

analysis by site of isolation, 717<br />

T-3262, 663, 1437<br />

tetracycline<br />

resistance, 1271<br />

trospectomycin, 584<br />

Bacteroides gingivalis<br />

A. leiocarpus, 598<br />

B. paradoxum, 598<br />

ANTIMICROB. AGENTS CHEMOTHER.<br />

chewing sticks, 598<br />

D. benthamianus, 598<br />

F. zanthoxyloides, 598<br />

M. accuminata, 598<br />

N. latifolia, 598<br />

Nigerian chewing sticks, 598<br />

S. werneckei, 598<br />

T. glaucescens, 598<br />

V. amygdalina, 598<br />

Bacteroides melaninogenicus<br />

A. leiocarpus, 598<br />

B. paradoxum, 598<br />

chewing sticks, 598<br />

D. benthamianus, 598<br />

F. zanthoxyloides, 598<br />

M. accuminata, 598<br />

N. latifolia, 598<br />

Nigerian chewing sticks, 598<br />

S. werneckei, 598<br />

T. glaucescens, 598<br />

V. amygdalina, 598<br />

Bacteroides spp.<br />

E-1040, 1666<br />

R-3746, 671<br />

tigemonam, 84<br />

trospectomycin, 216, 584<br />

Benzalkonium chloride<br />

S. aureus resistance, 932<br />

Berberine sulfate<br />

E. coli Pap fimbrial adhesion, 1274<br />

S. pyogenes<br />

fibronectin, 1370<br />

hexadecane, 1370<br />

host cell adherence, 1370<br />

P-Lactamases<br />

Aeromonas spp., 1314<br />

B. fragilis, 1848<br />

13C nuclear magnetic resonance spectroscopy,<br />

1196<br />

CTX-1, 9<br />

DNA probes, 175<br />

E-1040, 1666<br />

E. coli, 1243<br />

Enterobacteriaceae, 1365<br />

H. influenzae, 180<br />

isoelectric focusing, 397, 1730<br />

K. pneumoniae, 626, 1660<br />

letter to the editor, 158<br />

M. morganii, 1385<br />

ME1207, 1421<br />

N. asteroides, 1776<br />

N. gonorrhoeae, 158, 1430<br />

oligonucleotide probes, 397<br />

oxacillin susceptibility, 1754<br />

oxyimino-cephalosporins, 1243<br />

P. aeruginosa, 1443<br />

heterogeneity, 1893<br />

P. cepacia, 838<br />

P. maltophilia<br />

cloning of operon in E. coli, 819<br />

P. vulgaris, 1073, 1385<br />

PADAC assay, 1040<br />

Pasteurella spp., 1282<br />

PhastSystem, 1730<br />

plasmid mediated, 175<br />

PSE-2 sequence, 134<br />

pyridinium-2-azo-p-dimethylaniline chromophore<br />

assay, 1040<br />

S. aureus, 1614, 1754<br />

transposon, 1164<br />

S.faecalis, 122, 547<br />

hybridization studies, 768<br />

restriction mapping, 768

VOL. 32, 1988<br />

staphylococci, coagulase negative, 1754<br />

YTR 830, 925<br />

P-Lactams<br />

Aeromonas resistance, 1314<br />

-y-aminobutyric acid binding, 758<br />

B. fragilis, 1437<br />

K. pneumoniae resistance, 1660<br />

M. morganii, 1385<br />

P. cepacia resistance, 1636<br />

P. vulgaris, 1385<br />

paradoxical effect, 1073<br />

pentylenetetrazole convulsive threshold,<br />

758<br />

T. vaginalis, 144<br />

Bifidobacterium spp.<br />

daptomycin, 788<br />

paldimycin, 788<br />

Biliary drainage<br />

cefotiam, 726<br />

sulbenicillin, 726<br />

ursodeoxycholate, 726<br />

Biliary tract infections<br />

ampicillin-tobramycin, 1231<br />

cefoperazone, 1231<br />

ceftazidime, 1588<br />

tobramycin-ampicillin, 1231<br />

Bioassay<br />

sulbactam, 1347<br />

Biofilms<br />

E. coli, 770<br />

radiochemical method, 770<br />

Bioluminescence assay<br />

M. tuberculosis ATP, 1208<br />

Biosynthetic genes<br />

minireview, 1472<br />

Streptomyces spp., 1472<br />

Bite wound bacteria<br />

amoxicillin-clavulanic acid, 1143<br />

ampicillin, 1143<br />

cefadroxil, 1143<br />

cefuroxime, 1143<br />

cephalexin, 1143<br />

ciprofloxacin, 1143<br />

enoxacin, 1143<br />

ofloxacin, 1143<br />

penicillin G, 1143<br />

tetracycline, 1143<br />

BMY-26225<br />

y-aminobutyric acid binding, 758<br />

pentylenetetrazole convulsive threshold,<br />

758<br />

Bordetella bronchiseptica<br />

ampicillin, 1891<br />

antigenic modulation, 1891<br />

carbenicillin, 1891<br />

cephalothin, 1891<br />

chloramphenicol, 1891<br />

chlortetracycline, 1891<br />

colistin, 1891<br />

doxycycline, 1891<br />

erythromycin, 1891<br />

gentamicin, 1891<br />

kanamycin, 1891<br />

nalidixic acid, 1891<br />

neomycin, 1891<br />

novobiocin, 1891<br />

oxolinic acid, 1891<br />

oxytetracycline, 1891<br />

phase variation, 1891<br />

polymyxin B, 1891<br />

rifampin, 1891<br />

sulfadimethoxine, 1891<br />

sulfamonomethoxine, 1891<br />

tetracycline, 1891<br />

Bordetella spp.<br />

amoxicillin, 137<br />

ciprofloxacin, 137<br />

enoxacin, 137<br />

erythromycin, 137<br />

norfloxacin, 137<br />

ofloxacin, 137<br />

rifampin, 137<br />

roxithromycin, 137<br />

sulfamethoxazole-trimethoprim, 137<br />

tetracycline, 137<br />

Branhamella catarrhalis<br />

amikacin, 259<br />

amoxicillin-clavulanic acid, 259<br />

ampicillin, 259<br />

ampicillin-sulbactam, 259<br />

azithromycin, 752<br />

azlocillin, 259<br />

aztreonam, 259<br />

carbenicillin, 259<br />

cefaclor, 259<br />

cefam<strong>and</strong>ole, 259<br />

cefixime, 259, 1896<br />

cefonicid, 259<br />

cefoperazone, 259<br />

cefotaxime, 259<br />

cefoxitin, 259<br />

cefpodoxime, 1896<br />

ceftazidime, 259<br />

ceftibuten, 1576<br />

ceftizoxime, 259<br />

ceftriaxone, 259, 1896<br />

cefuroxime, 259<br />

cephalexin, 259<br />

cephalothin, 259<br />

chloramphenicol, 259<br />

ciprofloxacin, 259<br />

CS-807, 1082<br />

erythromycin, 259<br />

erythromycin estolate, 1227<br />

erythromycin ethylsuccinate, 1227<br />

erythromycin-sulfisoxazole, 259<br />

gentamicin, 259<br />

imipenem, 259<br />

LY163892, 268<br />

mezlocillin, 259<br />

minireview, 1747<br />

moxalactam, 259<br />

netilmicin, 259<br />

PD 117,596, 1450<br />

pefloxacin, 259<br />

penicillin, 259<br />

piperacillin, 259<br />

rifampin, 259<br />

sulfisoxazole, 259<br />

susceptibility testing, 1747<br />

T-3262, 663<br />

tetracycline, 259<br />

ticarcillin, 259<br />

ticarcillin-clavulanic acid, 259<br />

tigemonam, 84<br />

tobramycin, 259<br />

trimethoprim-sulfamethoxazole, 259<br />

trospectomycin, 216<br />

U-76,252, 1082<br />

U-76,253A, 443<br />

Branhamella spp.<br />

lomefloxacin, 656<br />

R-3746, 671<br />

BRL 39123<br />

comparative activity<br />

acyclovir, 358<br />

SUBJECT INDEX xi<br />

herpes simplex virus type 1, 358<br />

herpes simplex virus type 2, 358<br />

2-Bromo-2-nitropropane-1,3-diol<br />

E. coli, 1693<br />

mechanism of action, 1693<br />

2-Bromo-L-histidine<br />

P. falciparum, 1655<br />

E-5-(2-Bromovinyl)-2'-deoxyuridine<br />

comparative activity<br />

acyclovir <strong>and</strong> l-P-D-arabinofuranosyl-<br />

E-5-(2-bromovinyl)uracil, 1068<br />

Epstein-Barr virus, 1068<br />

Bromovinyl nucleoside analogs<br />

comparative activity<br />

acyclovir, 1068<br />

Epstein-Barr virus, 1068<br />

Bromovinyldeoxyuridine<br />

guinea pig embryonic fibroblasts, 1533<br />

herpes simplex virus type 1, 1533<br />

Bronopol<br />

E. coli, 1693<br />

mechanism of action, 1693<br />

Brucea javanica<br />

B. javanica, 1725<br />

E. histolytica, 1725<br />

quassinoids, 1725<br />

Buciclovir<br />

DNA polymerases, 1137<br />

guinea pig embryonic fibroblasts, 1533<br />

herpes simplex virus type 1, 1533<br />

monophosphate<br />

guinea pig embryonic fibroblasts, 1533<br />

herpes simplex virus type 1, 1533<br />

varicella-zoster virus, 1137<br />

4-(tert-Butyl)2-(tert-butylaminomethyl)-6-<br />

(4-chlorophenyl)phenol dihydrogen<br />

phosphate<br />

crystal <strong>and</strong> molecular structure, 540<br />

BW A855U<br />

cleavable-complex assay, 1086<br />

Bytyrospermum paradoxum<br />

B. gingivalis, 598<br />

B. melaninogenicus, 598<br />

C31G<br />

C. albicans, 350<br />

comparative activities<br />

chlorhexidine, Fluorigard, Listerine,<br />

<strong>and</strong> Viadent, 350<br />

S. sobrinus, 350<br />

Streptococcus spp., 350<br />

13C nuclear magnetic resonance spectroscopy<br />

P-lactamases, 1196<br />

Calcium fosfomycin<br />

pharmacokinetics, 938<br />

young <strong>and</strong> elderly adults, 938<br />

Campylobacter coli<br />

kanamycin resistance, 1170<br />

R plasmid, 1170<br />

Campylobacter jejuni<br />

A-61827, 27<br />

kanamycin resistance, 1170<br />

PD 117,596, 1450<br />

R plasmid, 1170<br />

Campylobacter spp.<br />

DNA annealing, 945<br />

kanamycin resistance, 945<br />

minireview, 1107<br />

resistance mechanisms, 1107<br />

tetracycline resistance gene, 1793

xii SUBJECT INDEX<br />

Cancer patients<br />

clindamycin-amikacin, 1557<br />

head <strong>and</strong> neck surgery, 1557<br />

ticarcillin-clavulanic acid, 1557<br />

wound infections, 1557<br />

C<strong>and</strong>ida albicans<br />

amphotericin B, 327<br />

resistance, 702<br />

C31G, 350<br />

2-chloroethyl-1-nitrosoureas, 327<br />

cilofungin, 1331, 1901<br />

denture stomatitis, 1859<br />

ergosterol, 702<br />

fluconazole, 209, 1859<br />

(1-3)-3-D-glucan synthase<br />

cilofungin, 1901<br />

jasplakinolide, 1154<br />

ketoconazole, 209<br />

stomatitis, denture, 1859<br />

C<strong>and</strong>ida parapsilosis<br />

cilofungin, 1331<br />

C<strong>and</strong>ida spp.<br />

jasplakinolide, 1154<br />

C<strong>and</strong>ida tropicalis<br />

cilofungin, 1331<br />

Capnocytophaga ochracea<br />

clindamycin, 1521<br />

neutrophil killing, 1521<br />

Capreomycin<br />

M. avium, 1131<br />

Carbapenems<br />

[14C]dimethyl sulfate labeling, 186<br />

high-performance liquid chromatography,<br />

186<br />

Carbenicillin<br />

B. bronchiseptica, 1891<br />

B. catarrhalis, 259<br />

hyperbilirubinemia<br />

centrifugal ultrafiltration, 1571<br />

M. morganii, 1385<br />

N. asteroides, 1776<br />

P. maltophilia, 782<br />

P. vulgaris, 1385<br />

Carbocyclin 3-deazaadenosine<br />

influenza viruses, 906<br />

Carbodine<br />

influenza viruses, 906<br />

Carbomycin<br />

Arthrobacter spp., 420<br />

Staphylococcus spp., 420<br />

Cardiac surgery<br />

Staphylococcus infection, 202<br />

Cardiopulmonary bypass<br />

netilmicin, 631<br />

vancomycin, 631<br />

Caromonam<br />

comparative activity<br />

ceftazidime, 1031<br />

urinary tract infections, 1031<br />

Carrageenans<br />

cytomegalovirus, 1742<br />

herpes simplex virus, 1742<br />

human immunodeficiency virus, 1742<br />

vesicular stomatitis virus, 1742<br />

Carumonam<br />

comparative activity<br />

gentamicin, 473<br />

Enterobacteriaceae, 1593<br />

high-pressure liquid chromatography,<br />

354<br />

L. pneumophila, 1593<br />

P. aeruginosa, 1593<br />

P. pseudomallei, 1435<br />

pharmacokinetics, 354<br />

urinary tract infections, 473<br />

Catechol-cephalosporins<br />

mechanisms of action, 1879<br />

Catheters<br />

disodium EDTA, 1627<br />

S. epidermidis, 1627<br />

vancomycin, 1627<br />

Cefaclor<br />

B. catarrhalis, 259<br />

H. influenzae, 180<br />

P. multocida, 213<br />

Cefadroxil<br />

bite wound bacteria, 1143<br />

P. maltocida, 213<br />

Cefam<strong>and</strong>ole<br />

A. denitrificans subsp. xylosoxidans, 276<br />

B. catarrhalis, 259<br />

B. fragilis, 1848<br />

outer membrane permeation, 1097<br />

comparative activity<br />

cefazolin, daptomycin, <strong>and</strong> vancomycin,<br />

63<br />

dysgonic fermenter 2, 78<br />

endocarditis, 63<br />

H. influenzae, 180<br />

S. epidermidis, 63<br />

Shigella spp., 20<br />

Cefazolin<br />

A. denitrificans subsp. xylosoxidans, 276<br />

y-aminobutyric acid binding, 758<br />

B. fragilis, 1848<br />

outer membrane permeation, 1097<br />

Bacillus spp., 642<br />

comparative activity<br />

cefam<strong>and</strong>ole, daptomycin, <strong>and</strong> vancomycin,<br />

63<br />

difloxacin <strong>and</strong> enoxacin, 262<br />

dysgonic fermenter 2, 78<br />

endocarditis, 63, 262<br />

nephrotoxicity, 314<br />

pentylenetetrazole convulsive threshold,<br />

758<br />

pharmacokinetics, 33<br />

S. aureus, 262<br />

S. epidermidis, 63<br />

Cefbuperazone<br />

P. vulgaris, 1073<br />

Cefepime<br />

Nocardia spp., 1078<br />

P. aeruginosa resistance, 1443<br />

Cefetamet<br />

pharmacokinetics, 573<br />

Cefetamet pivoxil<br />

pharmacokinetics, 573<br />

Cefixime<br />

B. catarrhalis, 259, 18%<br />

comparative activity<br />

cefpodoxime <strong>and</strong> ceftriaxone, 18%<br />

Enterobacteriaceae, 18%<br />

Enterococcus spp., 18%<br />

H. influenzae, 18%<br />

N. meningitidis, 18%<br />

P. aeruginosa, 18%<br />

Staphylococcus spp., 18%<br />

Cefmenoxime<br />

P. vulgaris, 1073<br />

Cefmetazole<br />

P. vulgaris, 1073<br />

Cefodizime<br />

comparative activity<br />

cefotaxime, 426<br />

gonorrhea, 426<br />

ANTIMICROB. AGENTS CHEMOTHER.<br />

N. gonorrhoeae, 426<br />

Cefonicid<br />

B. catarrhalis, 259<br />

high-performance liquid chromatography,<br />

485<br />

M. tuberculosis, 1441<br />

pharmacokinetics, 485<br />

protein binding, 128<br />

skin infections, 485<br />

skin structure infections, 485<br />

Cefoperazone<br />

B. catarrhalis, 259<br />

B. fragilis, 403, 1848<br />

outer membrane permeation, 1097<br />

biliary tract infections, 1231<br />

combinations<br />

B. fragilis, 403<br />

ceftazidime, 298<br />

ciprofloxacin, 782<br />

intra-abdominal infections, 730<br />

P. aeruginosa, 298<br />

P. maltophilia, 782<br />

pharmacokinetics, 730<br />

sulbactam, 403, 730<br />

comparative activity<br />

ampicillin-tobramycin, 1231<br />

dysgonic fermenter 2, 78<br />

high-pressure liquid chromatography,<br />

298<br />

hyperbilirubinemia<br />

centrifugal ultrafiltration, 1571<br />

nephrotoxicity, 314<br />

P. maltophilia, 782<br />

P. vulgaris, 1073<br />

pharmacokinetics, 42<br />

protein binding, 298<br />

Shigella spp., 20<br />

Cefoperazone-sulbactam<br />

B. fragilis, 403<br />

comparative activity<br />

cefoperazone, cefoxitin, chloramphenicol,<br />

clindamycin, imipenem, metronidazole,<br />

<strong>and</strong> penicillin G, 403<br />

pharmacokinetics, 42, 503<br />

continuous ambulatory peritoneal dialysis,<br />

51<br />

renal failure, 503<br />

Ceforanide<br />

A. denitrificans subsp. xylosoxidans, 276<br />

M. tuberculosis, 1441<br />

Cefotaxime<br />

A. denitrificans subsp. xylosoxidans, 276<br />

B. catarrhalis, 259<br />

Bacillus spp., 642<br />

combinations<br />

chloramphenicol, 1375<br />

E. coli, 1375<br />

gram-negative bacteria, 1375<br />

S. aureus, 1375<br />

streptococci, group B, 1375<br />

comparative activity<br />

cefodizime, 426<br />

dysgonic fermenter 2, 78<br />

Enterobacteriaceae, 873<br />

gonorrhea, 426<br />

H. ducreyi, 1458<br />

M. morganii, 1385<br />

M. tubetculosis, 1441<br />

N. asteroides, 1776<br />

N. gonorrhoeae, 426<br />

P. aerugindsa resistance, 1443<br />

P. pseudomallei, 1435<br />

P. vulgaris, 1073, 1385

VOL. 32, 1988<br />

pharmacokinetics<br />

protein binding, 128<br />

Shigella spp., 20<br />

Cefotetan<br />

A. denitrificans subsp. xylosoxidans, 276<br />

B. fragilis, 601<br />

C. difficile, 601<br />

comparative activity<br />

cefoxitin, ceftizoxime, chloramphenicol,<br />

clindamycin, <strong>and</strong> metronidazole,<br />

601<br />

prothrombin, 1446<br />

vitamin K metabolism, 1446<br />

Cefotiam<br />

biliary excretion<br />

ursodeoxycholate, 726<br />

P. vulgaris, 1073<br />

percutaneous transhepatic biliary drainage,<br />

726<br />

Cefoxitin<br />

B. catarrhalis, 259<br />

B. fragilis, 1511<br />

Bacillus spp., 642<br />

comparative activity<br />

ceftizoxime, 1511<br />

E. coli, 1511<br />

Enterobacteriaceae, 873<br />

H. ducreyi, 1458<br />

M. morganii, 1385<br />

P. vulgaris, 1385<br />

prothrombin, 1446<br />

serum bactericidal activity, 1511<br />

vitamin K metabolism, 1446<br />

Cefpiramide<br />

hepatic excretion, 1360<br />

high-performance liquid chromatography,<br />

1360<br />

pharmacokinetics, 33, 1360<br />

Cefpirome<br />

comparative activity<br />

cefoperazone, cefotaxime,<br />

ceftazidime, <strong>and</strong> moxalactam,<br />

1396<br />

croton oil-induced rat granuloma pouch,<br />

1396<br />

E. coli, 1396<br />

high-performance liquid chromatography,<br />

1481<br />

M. tuberculosis, 1441<br />

Nocardia spp., 1078<br />

P. aeruginosa, 1396<br />

pharmacokinetics, 1396<br />

S. aureus, 1396<br />

Cefpodoxime<br />

B. catarrhalis, 1896<br />

comparative activity<br />

cefixime <strong>and</strong> ceftriaxone, 1896<br />

Enterobacteriaceae, 1896<br />

Enterococcus spp., 1896<br />

H. influenzae, 1896<br />

N. meningitidis, 1896<br />

P. aeruginosa, 1891<br />

Staphylococcus spp., 1896<br />

Cefsulodin<br />

combinations<br />

ciprofloxacin, 782<br />

P. maltophilia, 782<br />

P. maltophilia, 782<br />

Ceftazidime<br />

A. denitrificans subsp. xylosoxidans, 276<br />

B. catarrhalis, 259<br />

biliary tract infections, 1588<br />

cholelithiasis, 1588<br />

combinations<br />

amdinocillin, 1632<br />

amikacin, 231<br />

cefoperazone, 298<br />

ciprofloxacin, 782<br />

E. cloacae, 1632<br />

endocarditis, 231<br />

P. aeruginosa, 231, 298<br />

P. maltophilia, 782<br />

resistance, development of, 231<br />

comparative activity<br />

carumonam, 1031<br />

concentrations in bile <strong>and</strong> gallbladder<br />

wall, 1588<br />

dysgonic fermenter 2, 78<br />

E. cloacae, 1632<br />

resistance, 1632<br />

high-performance liquid chromatography,<br />

1845<br />

high-pressure liquid chromatography,<br />

298<br />

nephrotoxicity, 314<br />

P. aeruginosa resistance, 1443<br />

P. maltophilia, 782<br />

P. pseudomallei, 1435<br />

P. vulgaris, 1073<br />

pharmacokinetics, 1845<br />

protein binding, 298<br />

Shigella spp., 20<br />

urinary tract infections, 1031<br />

Ceftazidime-amikacin<br />

comparative activity<br />

pefloxacin, 231<br />

endocarditis, 231<br />

P. aeruginosa, 231<br />

resistance, development of, 231<br />

Ceftazidime-vancomycin<br />

pharmacokinetics, 92<br />

Ceftetrame<br />

H. ducreyi, 1458<br />

Ceftezole<br />

B. fragilis, 1848<br />

outer membrane permeation, 1097<br />

Ceftibuten<br />

B. catarrhalis, 1576<br />

comparative activity<br />

amoxicillin, amoxicillin-clavulanic<br />

acid, cefaclor, cefixime, <strong>and</strong> cefuroxime,<br />

1576<br />

Enterobacteriaceae, 1576<br />

H. influenzae, 1576<br />

Neisseria spp., 1576<br />

Streptococcus spp., 1576<br />

susceptibility testing, 1576<br />

Ceftizoxime<br />

B. catarrhalis, 259<br />

B. fragilis, 1511<br />

comparative activity<br />

cefoxitin, 1511<br />

E. coli, 1511<br />

M. tuberculosis, 1441<br />

P. vulgaris, 1073<br />

pharmacokinetics<br />

protein binding, 128<br />

serum bactericidal activity, 1511<br />

Ceftriaxone<br />

A. denitrificans subsp. xylosoxidans, 276<br />

B. catarrhalis, 259, 1896<br />

combinations<br />

chloramphenicol, 1375<br />

E. coli, 1375<br />

gram-negative bacteria, 1375<br />

S. aureus, 1375<br />

SUBJECT INDEX xiii<br />

streptococci, group B, 1375<br />

comparative activity<br />

cefixime <strong>and</strong> cefpodoxime, 1896<br />

E. coli, 552<br />

Enterobacteriaceae, 1896<br />

Enterococcus spp., 1896<br />

H. ducreyi, 1458<br />

H. influenzae, 1896<br />

home parenteral therapy, 1439<br />

hyperbilirubinemia<br />

centrifugal ultrafiltration, 1571<br />

in vitro simulation of serious infections,<br />

552<br />

lidocaine reconstitution, 1439<br />

M. morganii, 1385<br />

N. asteroides, 1776<br />

N. meningitidis, 1896<br />

P. aeruginosa, 552, 1896<br />

P. pseudomallei, 1435<br />

P. vulgaris, 1073, 1385<br />

S. pneumoniae, 552<br />

Shigella spp., 20<br />

Staphylococcus spp., 1896<br />

Cefuroxime<br />

A. denitrificans subsp. xylosoxidans, 276<br />

B. catarrhalis, 259<br />

Bacillus spp., 642<br />

bite wound bacteria, 1143<br />

hyperbilirubinemia<br />

centrifugal ultrafiltration, 1571<br />

P. multocida, 213<br />

P. vulgaris, 1073<br />

Shigella spp., 20<br />

Cefuzonam<br />

P. vulgaris, 1073<br />

Celesticetin<br />

Arthrobacter spp., 420<br />

Staphylococcus spp., 420<br />

Cell cultures<br />

human immunodeficiency virus type 1,<br />

684<br />

Cephalexin<br />

B. catarrhalis, 259<br />

bite wound bacteria, 1143<br />

H. influenzae, 180<br />

P. multocida, 213<br />

Cephalexin hydrochloride<br />

comparative activity<br />

cephalexin monohydrate, 882<br />

gram-negative bacteria, 882<br />

S. aureus, 882<br />

S. pyogenes, 882<br />

skin infections, 882<br />

soft tissue infections, 882<br />

Staphylococcus spp., 882<br />

Cephalexin monohydrate<br />

comparative activity<br />

cephalexin hydrochloride, 882<br />

gram-negative bacteria, 882<br />

S. aureus, 882<br />

S. pyogenes, 882<br />

skin infections, 882<br />

soft tissue infections, 882<br />

Siaphylococcus spp., 882<br />

Cephaloglycin<br />

nephrotoxicity, 314<br />

Cephaloridine<br />

K. pneumoniae, 364<br />

M. morganii, 1385<br />

nephrotoxicity, 314<br />

piperacillin protective effect, 912<br />

P. vulgaris, 1073, 1385

xiv SUBJECT INDEX<br />

Cephalosporins<br />

B. fragilis, 1848<br />

outer membrane permeation, 1097<br />

catechol substituted<br />

mechanism of action, 1879<br />

K. pneumoniae resistance, 1660<br />

oxyimino<br />

3-lactamase, 1243<br />

E. coli, 1243<br />

S. aureus, 170<br />

Cephalothin<br />

B. bronchiseptica, 1891<br />

B. catarrhalis, 259<br />

B. fragilis, 1848<br />

outer membrane permeation, 1097<br />

Enterobacteriaceae, 873<br />

H. influenzae, 180<br />

nephrotoxicity, 314<br />

P. vulgaris, 1073<br />

S. aureus MBCs, 374<br />

Shigella spp., 20<br />

Cephapirin<br />

M. tuberculosis, 1441<br />

CGP 17520<br />

K. pneumoniae, 364<br />

Chagas' disease<br />

ketoconazole, 1237<br />

SF 86-327, 1237<br />

Charcoal<br />

tobramycin clearance, effect on, 274<br />

Chemotaxis<br />

T. vaginalis, 1323<br />

Chewing sticks<br />

B. gingivalis, 598<br />

B. melaninogenicus, 598<br />

Chlamydia trachomatis<br />

AM-833, 1080, 1735<br />

antibodies<br />

monoclonal, 1295<br />

Chlamydiazyme, 1350<br />

chloramphenicol, 1350<br />

ciprofloxacin, 1080, 1350, 1735<br />

doxycycline, 1350, 1735<br />

enoxacin, 1080<br />

erythromycin, 1350<br />

fleroxacin, 1080<br />

imipenem-cilastatin, 773<br />

josamycin, 1350<br />

minireview, 1295<br />

minocycline, 1080, 1350, 1735<br />

norfloxacin, 1080, 1350, 1735<br />

NY-198, 1080, 1735<br />

ofloxacin, 1080, 1350, 1735<br />

PD 127,391, 1251<br />

pefloxacin, 1350<br />

pipemidic acid, 1080<br />

rifampin, 1350<br />

rikamycin, 1350<br />

RO 23-6240, 1080<br />

rosoxacin, 1350<br />

roxithromycin, 1350<br />

sulfamethoxazole, 1350<br />

susceptibility testing, 1295, 1350<br />

T-3262, 1080<br />

tetracycline, 1350<br />

trospectomycin, 216<br />

Chlamydia sp. strain TWAR<br />

ampicillin, 257<br />

erythromycin, 257<br />

penicillin, 257<br />

sulfisoxazole, 257<br />

tetracycline, 257<br />

trospectomycin, 257<br />

Chlamydiazyme<br />

evaluation, 1350<br />

Chloramphenicol<br />

acetyltransferase<br />

C. difficile, 1213<br />

H. influenzae, 180<br />

B. bronchiseptica, 1891<br />

B. catarrhalis, 259<br />

Bacillus spp., 642<br />

C. trachomatis, 1350<br />

combinations<br />

cefotaxime, 1375<br />

ceftriaxone, 1375<br />

E. coli, 1375<br />

gram-negative bacteria, 1375<br />

S. aureus, 1375<br />

streptococci, group B, 1375<br />

comparative activity<br />

ciprofloxacin <strong>and</strong> gentamicin, 285<br />

dysgonic fermenter 2, 78<br />

E. coli<br />

heat treatment, 1680<br />

Enterobacteriaceae, 873<br />

fecal flora resistance, 1801<br />

H. ducreyi, 1458<br />

H. influenzae, 180<br />

susceptibility testing, 1484<br />

P. carinii, 8%<br />

P. multocida, 213<br />

scrub typhus, 285<br />

Shigella spp., 20<br />

Chlorhexidine<br />

S. aureus resistance, 932<br />

Chlorhexidine digluconate<br />

Enterobacteriaceae, 873<br />

3-Chlorodiaminopimelic acid<br />

diaminopimelic acid epimerase, 1119<br />

E. coli, 1119<br />

2-Chloroethyl- I -nitrosoureas<br />

amphotericin B<br />

C. albicans, 327<br />

2-Chloro-L-histidine<br />

P. falciparum, 1655<br />

Chloroquine<br />

malaria, 799<br />

minireview, 799<br />

P. falciparum, 799<br />

polymorphonuclear neutrophils, 1124<br />

resistance, 799<br />

5-Chlorotubercidin<br />

influenza viruses, 906<br />

Chlorovinylglycine<br />

comparative activity, 319<br />

gram-positive bacteria, 319<br />

Staphylococcus spp., 319<br />

Chlorpromazine<br />

E. coli permeability, 153<br />

P. carinii, 8%<br />

Chlortetracycline<br />

B. bronchiseptica, 1891<br />

Cholelithiasis<br />

ceftazidime, 1588<br />

CI-934<br />

cleavable-complex assay, 1086<br />

Cilofungin<br />

C. albicans, 1331<br />

(1-3)-p-D-glucan synthase, 1901<br />

C. parapsilosis, 1331<br />

C. tropicalis, 1331<br />

comparative activity<br />

amphotericin B, flucytosine, <strong>and</strong> ketoconazole,<br />

1331<br />

Cryptococcus spp., 1331<br />

ANTIMICROB. AGENTS CHEMOTHER.<br />

S. cerevisiae, 1331<br />

T. glabrata, 1331<br />

Cinchonidine<br />

P. falciparum, 250<br />

Cinchonine<br />

P. falciparum, 250<br />

Cinoxacin<br />

S. aureus, 1192<br />

Ciprofloxacin<br />

A. denitrificans subsp. xylosoxidans, 276<br />

antacids, 949<br />

B. catarrhalis, 259<br />

B. fragilis, 1437<br />

Bacillus spp., 642<br />

biliary excretion <strong>and</strong> metabolism, 982<br />

bite wound bacteria, 1143<br />

Bordetella spp., 137<br />

C. trachomatis, 1080, 1350, 1735<br />

chancroid, 723, 723<br />

cleavable-complex assay, 1086<br />

combinations<br />

amikacin, aztreonam, cefoperazone,<br />

cefsulodin, ceftazidime, gentamicin,<br />

imipenem, mezlocillin, piperacillin,<br />

<strong>and</strong> tobramycin, 782<br />

clofazimine, 1392<br />

erythromycin, 1392<br />

ethambutol, 1392<br />

M. avium complex, 1392<br />

P. maltophilia, 782<br />

rifabutin, 1392<br />

rifampin, 1392<br />

comparative activity<br />

A-56620, amikacin, aztreonam, carbenicillin,<br />

cefoperazone, cefsulodin,<br />

ceftazidime, difloxacin, gentamicin,<br />

imipenem, mezlocillin,<br />

norfloxacin, piperacillin, Sch<br />

34343, ticarcillin, <strong>and</strong> tobramycin,<br />

782<br />

amifloxacin, enoxacin, norfloxacin,<br />

<strong>and</strong> ofloxacin, 928<br />

ampicillin <strong>and</strong> chloramphenicol, 57<br />

chloramphenicol <strong>and</strong> gentamicin, 285<br />

doxycycline <strong>and</strong> minocycline, 1735<br />

gentamicin, imipenem, nafcillin, <strong>and</strong><br />

vancomycin, 747<br />

trimethoprim-sulfamethoxazole, 1327<br />

cytogenetic effects, 936<br />

dysgonic fermenter 2, 78<br />

E. coli, 450<br />

endocarditis, 747<br />

Enterobacteriaceae, 1327<br />

GABA receptor, 1624<br />

H. ducreyi, 723, 723, 1458<br />

Haemophilus spp., 147<br />

high-pressure liquid chromatography,<br />

1537<br />

letter to the editor, 949<br />

N. asteroides, 1776<br />

N. meningitidis, 1740<br />

Nocardia spp., 1078<br />

P. aeruginosa resistance, 535<br />

P. falciparum, 1182<br />

P. maltophilia, 782<br />

P. pseudomallei, 928, 1435<br />

pharmacokinetics, 949, 982, 1537<br />

polycystic kidney disease, 844<br />

postantibiotic effect, 450<br />

renal cyst infection, 844<br />

S. aureus, 747, 1192<br />

S. typhimurium, 57<br />

scrub typhus, 285

VOL. 32, 1988<br />

Shigella spp., 20<br />

theophylline pharmacokinetics, effect<br />

on, 75<br />

urinary tract infections, 1327<br />

Citrobacter diversus<br />

CS-807, 1082<br />

R-3746, 671<br />

tigemonam, 84<br />

U-76,252, 1082<br />

Citrobacter freundii<br />

DNA gyrase, 922<br />

E1040, 693<br />

norfloxacin resistance, 922<br />

ofloxacin resistance, 922<br />

quinolone resistance, 922<br />

R-3746, 671<br />

R plasmid, 9<br />

YTR 830, 925<br />

Citrobacter spp.<br />

E-1040, 1666<br />

Clarithromycin<br />

comparative activity, 1710<br />

erythromycin, 1500<br />

erythromycin <strong>and</strong> roxithromycin,<br />

1758<br />

M. hominis, 1500<br />

M. leprae, 1758<br />

M. pneumoniae, 1500<br />

U. urealyticum, 1500<br />

Cleavable-complex assay<br />

BW A855U, 1086<br />

CI-934, 1086<br />

ciprofloxacin, 1086<br />

nalidixic acid, 1086<br />

norfloxacin, 1086<br />

ofloxacin, 1086<br />

oxolinic acid, 1086<br />

quinolones, 1086<br />

Clindamycin<br />

A. actinomycetemcomitans, 1521<br />

Arthrobacter spp., 420<br />

B. fragilis, 1825<br />

Bacillus spp., 642<br />

C. ochracea, 1521<br />

combinations<br />

amikacin, 1557<br />

cost analysis, 853<br />

endomyometritis, 853<br />

enterococci, 1769<br />

gentamicin, 853<br />

head <strong>and</strong> neck surgery in cancer patients,<br />

1557<br />

P. carinii, 807<br />

primaquine, 807<br />

streptomycin, 1769<br />

wound infections, 1557<br />

dysgonic fermenter 2, 78<br />

E. corrodens, 1521<br />

enterococci, 1769<br />

high-performance liquid chromatography,<br />

1825<br />

neutrophil killing, 1521<br />

P. carinii, 807<br />

P. multocida, 213<br />

periodontal bacteria, 1521<br />

pharmacokinetics, 1825<br />

serum inhibitory activity, 1825<br />

Staphylococcus spp., 420<br />

Clindamycin-amikacin<br />

comparative activity<br />

ticarcillin-clavulanic acid, 1557<br />

head <strong>and</strong> neck surgery in cancer<br />

patients, 1557<br />

wound infections, 1557<br />

Clindamycin-gentamicin<br />

comparative activity<br />

cost analysis, 853<br />

moxalactam, 853<br />

endomyometritis, 853<br />

Clofazimine<br />

combinations<br />

amikacin, 1400<br />

ciprofloxacin, 1392<br />

ethambutol, 1392<br />

M. avium complex, 1392, 1400<br />

rifabutin, 1392<br />

M. leprae, 1583<br />

structure-activity relationship, 1583<br />

Cloning<br />

antibiotic biosynthetic genes, 1472<br />

biosynthetic genes, 1472<br />

minireviews, 1465, 1472<br />

Streptomyces spp., 1465, 1472<br />

Clostridium difficile<br />

cefotetan, 601<br />

chloramphenicol acetyltransferase determinant<br />

genetic analysis, 1213<br />

molecular cloning, 1213<br />

R plasmid, 1213<br />

trospectomycin, 216<br />

Clostridium spp.<br />

daptomycin, 788<br />

DuP 105, 580<br />

DuP 721, 580<br />

paldimycin, 788<br />

R-3746, 671<br />

trospectomycin, 216<br />

13C nuclear magnetic resonance spectroscopy<br />

P-lactamases, 1196<br />

Coccidioidal meningitis<br />

fluconazole, 369<br />

Colistin<br />

B. bronchiseptica, 1891<br />

Enterobacteriaceae, 873<br />

Common colds<br />

letters to the editor, 605, 606, 608<br />

zinc, 605, 606, 608<br />

Conjunctivitis<br />

H. influenzae, 1820<br />

norfloxacin, 1820<br />

S. aureus, 1820<br />

S. pneumoniae, 1820<br />

Staphylococcus spp., 1820<br />

streptococci, alpha-hemolytic, 1820<br />

tobramycin, 1820<br />

Coronary angioplasty<br />

Staphylococcus infection, 202<br />

Corynebacterium group JK<br />

DuP 105, 580<br />

DuP 721, 580<br />

gentamicin-teicoplanin, 434<br />

gentamicin-vancomycin, 434<br />

teicoplanin, 434<br />

teicoplanin-gentamicin, 434<br />

teicoplanin-tobramycin, 434<br />

tobramycin-teicoplanin, 434<br />

tobramycin-vancomycin, 434<br />

vancomycin, 434<br />

vancomycin-gentamicin, 434<br />

vancomycin-tobramycin, 434<br />

Corynebacterium spp.<br />

PD 117,596, 1450<br />

Co-trimoxazole<br />

H. ducreyi, 1458<br />

SUBJECT INDEX xv<br />

Coumermycin A<br />

P. falciparum, 1182<br />

Coxsackievirus<br />

sulfated polysaccharides, 1742<br />

Cryptococcus spp.<br />

cilofungin, 1331<br />

Cryptosporidium sp.<br />

letter to the editor, 1907<br />

sulfadimethoxine, 1907<br />

Crystal violet<br />

E. coli<br />

heat treatment, 1680<br />

CS-807<br />

A. hydrophila, 1082<br />

B. catarrhalis, 1082<br />

C. diversus, 1082<br />

comparative activity<br />

amoxicillin, amoxicillin-clavulanic<br />

acid, cefaclor, cefuroxime, cephalexin,<br />

<strong>and</strong> erythromycin, 1082<br />

E. coli, 1082<br />

E. faecalis, 1082<br />

Enterobacteriaceae, 1082<br />

H. influenzae, 1082<br />

Klebsiella spp., 1082<br />

P. aeruginosa, 1082<br />

P. mirabilis, 1082<br />

Staphylococcus spp., 1082<br />

Streptococcus spp., 1082<br />

5-Cyano- I -P-D-ribofuranosyl-imidazole-4carboxamide<br />

influenza viruses, 906<br />

5-Cyanoimidazole-4-carboxamide<br />

influenza viruses, 906<br />

Cyclohexane triones<br />

comparative activity<br />

cetrimide, chlorohexidine, FCCP, hexachlorophene,<br />

<strong>and</strong> tribromosalan,<br />

814<br />

gram-positive bacteria, 814<br />

H. influenzae, 814<br />

M. smegmatis, 814<br />

mechanisms of action, 814<br />

Cycloheximide<br />

M. racemosus, 341<br />

Cyclopentenyl cytosine<br />

influenza viruses, 906<br />

Cyclophosphamide<br />

amoebic meningoencephalitis, 962<br />

N. fowleri, 962<br />

Cyclosporine<br />

P. berghei, 462<br />

Cystic fibrosis<br />

P. cepacia, 1636<br />

Cystitis<br />

E-3846, 636<br />

E. coli, 1640<br />

ofloxacin, 1640<br />

trimethoprim-sulfamethoxazole, 1640<br />

Cytogenetic effects<br />

ciprofloxacin, 936<br />

ofloxacin, 936<br />

Cytomegalovirus<br />

3'-azido-3'-deoxythymidine, 265<br />

AZT, 265<br />

B-220, 1720<br />

carrageenans, 1742<br />

cochlear pathophysiology, 865<br />

dextran sulfate, 1742<br />

fucoidan, 1742<br />

ganciclovir, 865<br />

(S)-HPMPC, 1839<br />

(S)- 1-(3-hydroxy-2-phosphonylmethoxy-

xvi SUBJECT INDEX<br />

propyl)cytosine, 1839<br />

interferon, 678<br />

labyrinthitis, 865<br />

oxetanocin G, 1053<br />

pentosan polysulfate, 1742<br />

S26308, 678<br />

sulfated polysaccharides, 1742<br />

Dapsone<br />

combinations<br />

P. carinii, 623<br />

pneumonia, 623<br />

trimethoprim, 623<br />

comparative activity<br />

pentamidine, trimethoprim-dapsone,<br />

<strong>and</strong> trimethoprim-sulfamethoxazole,<br />

623<br />

P. carinii, 96, 623, 1057, 1158<br />

pneumonia, 623, 1057<br />

Daptomycin<br />

A. lignieresii, 1354<br />

Actinomyces spp., 788<br />

Bacillus spp., 642<br />

Bifidobacterium spp., 788<br />

Clostridium spp., 788<br />

combinations<br />

amikacin, fosfomycin, imipenem, netilmicin,<br />

rifampin, teicoplanin, <strong>and</strong><br />

vancomycin, 279<br />

endocarditis, 877<br />

Enterococcus spp., 279<br />

gentamicin, 81, 877<br />

pyelonephritis, 81<br />

S. aureus, 279<br />

S. epidermidis, 279<br />

S. faecalis, 81, 877<br />

Staphylococcus spp., 279<br />

comparative activity<br />

cefam<strong>and</strong>ole, cefazolin, <strong>and</strong> vancomycin,<br />

63<br />

daptomycin-gentamicin, penicillin G<br />

procaine, penicillin G procainegentamicin,<br />

vancomycin, vancomycin-gentamicin,<br />

877<br />

paldimycin, penicillin, <strong>and</strong> vancomycin,<br />

788<br />

penicillin G, 141<br />

vancomycin, 454<br />

E. faecalis, 24<br />

E. faecium, 24<br />

endocarditis, 63, 141, 877<br />

Enterococcus spp., 279<br />

Eubacterium spp., 788<br />

Lactobacillus spp., 788<br />

P. multocida, 1354<br />

Peptostreptococcus spp., 788<br />

Propionibacterium spp., 788<br />

pyelonephritis, 81<br />

S. aureus, 279, 454<br />

S. epidermidis, 63, 279<br />

S. faecalis, 81, 877<br />

translocation, 337<br />

S. pneumoniae, 24<br />

Staphylococcus spp., 24, 279<br />

Streptococcus spp., 141<br />

3-Deazaguanine<br />

influenza viruses, 906<br />

3-Deazauridine<br />

influenza viruses, 906<br />

Dehydroemetine<br />

P. carinii, 896<br />

Dehydropeptidase I<br />

purification <strong>and</strong> characterization, 587<br />

Demeclocycline<br />

comparative activity<br />

doxycycline, erythromycin, minocycline,<br />

nalidixic acid, oxytetracycline,<br />

rifampin, <strong>and</strong> tetracycline,<br />

986<br />

E. risticii, 986<br />

Dental granuloma<br />

ampicillin, 566<br />

talampicillin, 566<br />

Denture stomatitis<br />

C. albicans, 1859<br />

fluconazole, 1859<br />

5'-Deoxy-5-fluorouridine<br />

influenza viruses, 906<br />

Dermatophytes<br />

G2, 1586<br />

Dextran sulfate<br />

cytomegalovirus, 1742<br />

herpes simplex virus, 1742<br />

human immunodeficiency virus,<br />

1742<br />

vesicular stomatitis virus, 1742<br />

(S)-DHPA<br />

influenza viruses, 906<br />

Diallyl thiosulfinate<br />

mechanism of action, 1763<br />

S. typhimurium, 1763<br />

Diaminopimelic acid epimerase<br />

3-chlorodiaminopimelic acid, 1119<br />

E. coli, 1119<br />

Diaveridine<br />

P. carinii, 96<br />

Dibucaine<br />

E. coli permeability, 153<br />

Diclofenac<br />

GABA receptor, 1624<br />

y-aminobutyric acid receptor, 1624<br />

Dicloxacillin<br />

hyperbilirubinemia<br />

centrifugal ultrafiltration, 1571<br />

Difloxacin<br />

comparative activity<br />

cefazolin <strong>and</strong> enoxacin, 262<br />

erythromycin, 1500<br />

endocarditis, 262<br />

H. ducreyi, 1458<br />

M. hominis, 1500<br />

M. pneumoniae, 1500<br />

M. tuberculosis, 1441<br />

Nocardia spp., 1078<br />

P. maltophilia, 782<br />

S. aureus, 262<br />

U. urealyticum, 1500<br />

Difluoromethylornithine<br />

P. carinii, 896<br />

DL-a-Difluoromethylornithine<br />

combinations<br />

P. carinii, 1158<br />

suramin, 1158<br />

comparative activity<br />

dapsone, diminazene aceturate, suramin,<br />

<strong>and</strong> trimethoprim-sulfamethoxazole,<br />

1158<br />

P. carinii, 1158<br />

Dihydromycoplanecin A<br />

comparative activity<br />

isoniazid, ofloxacin, rifampin, <strong>and</strong><br />

streptomycin, 110<br />

Mycobacterium spp., 110<br />

pharmacokinetics, 110<br />

ANTIMICROB. AGENTS CHEMOTHER.<br />

Dihydropteroate synthase gene<br />

nucleotide sequence, 1684<br />

9-(3,4-Dihydroxybutyl)guanine<br />

triphosphate<br />

DNA polymerases, 1137<br />

varicella-zoster virus, 1137<br />

(S)-9-(2,3-Dihydroxypropyl)adenine<br />

influenza viruses, 906<br />

2,3,Dimethyl(dimethylaminoethyl)5H-indolo-(2,3-b)quinoxaline<br />

cytomegalovirus, 1720<br />

herpes simplex virus type 1, 1720<br />

mechanism of action, 1720<br />

varicella-zoster virus, 1720<br />

['4C]dimethyl sulfate<br />

carbapenem labeling, 186<br />

Diminazene<br />

P. carindi, 8%<br />

Diminazene aceturate<br />

P. carinii, 1158<br />

Dirithromycin<br />

comparative activity, 1710<br />

Disodium EDTA<br />

catheters, 1627<br />

S. epidermidis, 1627<br />

Distemonanthus benthamianus<br />

B. gingivalis, 598<br />

B. melaninogenicus, 598<br />

DNA gyrase<br />

C. freundii, 922<br />

cleavable-complex assay, 1086<br />

inhibitors<br />

N. gonorrhoeae, 1788<br />

quinolones, 1086<br />

resistance, 104<br />

S. aureus, 1192<br />

DNA polymerases<br />

varicella-zoster virus, 1137<br />

DNA probes<br />

,B-lactamases, 175<br />

DNA synthesis<br />

E. coli, 1113<br />

quinolones, 1113<br />

Doxycycline<br />

B. bronchiseptica, 1891<br />

C. trachomatis, 1350<br />

comparative activity<br />

demeclocycline, erythromycin, minocycine,<br />

nalidixic acid,<br />

oxytetracycline, rifampin, <strong>and</strong><br />

tetracycline, 986<br />

E. risticii, 986<br />

Enterobacteriaceae, 873<br />

H. ducreyi, 1458<br />

DR-3355<br />

B. fragilis, 1336<br />

comparative activity<br />

ciprofloxacin, fleroxacin, methicillin,<br />

NY-198, <strong>and</strong> ofloxacin, 1336<br />

Peptococcus spp., 1336<br />

Staphylococcus spp., 1336<br />

DuP 105<br />

B. fragilis, 580<br />

Clostridium spp., 580<br />

comparative activity<br />

amoxicillin-clavulanic acid,<br />

cephalexin, teicoplanin, <strong>and</strong> vancomycin,<br />

580<br />

ampicillin, cefaclor, ciprofloxacin,<br />

erythromycin, <strong>and</strong> vancomycin,<br />

150<br />

Corynebacterium group JK, 580<br />

E. faecalis, 580

VOL. 32, 1988<br />

Enterobacteriaceae, 580<br />

Enterococcus spp., 150<br />

L. monocytogenes, 150, 580<br />

P. aeruginosa, 580<br />

S. aureus, 580<br />

S. epidermidis, 580<br />

Staphylococcus sop., 150<br />

Streptococcus spp., 150, 580<br />

DuP 721<br />

B. fragilis, 580<br />

Clostridium spp., 580<br />

comparative activity<br />

amoxicillin-clavulanic acid,<br />

cephalexin, teicoplanin, <strong>and</strong> vancomycin,<br />

580<br />

ampicillin, cefaclor, ciprofloxacin,<br />

erythromycin, <strong>and</strong> vancomycin,<br />

150<br />

Corynebacterium group JK, 580<br />

E. faecalis, 580<br />

Enterobacteriaceae, 580<br />

Enterococcus spp., 150<br />

gram-positive bacteria, 1218<br />

L. monocytogenes, 150, 580<br />

mechanism of action, 1218<br />

P. aeruginosa, 580<br />

protein synthesis, 1218<br />

S. aureus, 580<br />

S. epidermidis, 580<br />

Staphylococcus spp., 150<br />

Streptococcus spp., 150, 580<br />

Dysgonic fermenter 2<br />

amikacin, 78<br />

aztreonam, 78<br />

cefam<strong>and</strong>ole, 78<br />

cefazolin, 78<br />

cefoperazone, 78<br />

cefotaxime, 78<br />

ceftazidime, 78<br />

chloramphenicol, 78<br />

ciprofloxacin, 78<br />

clindamycin, 78<br />

erythromycin, 78<br />

gentamicin, 78<br />

imipenem, 78<br />

methicillin, 78<br />

penicillin G, 78<br />

piperacillin, 78<br />

rifampin, 78<br />

ticarcillin, 78<br />

trimethoprim-sulfamethoxazole, 78<br />

vancomycin, 78<br />

E1040<br />

Acinetobacter spp., 693<br />

Bacteroides spp., 1666<br />

P-lactamases, 1666<br />

C. freundii, 693<br />

Citrobacter spp., 1666<br />

comparative activity<br />

cefazolin, cefmenoxime, cefotiam,<br />

ceftazidime, <strong>and</strong> methicillin,<br />

693<br />

cefepime, cefpirome, ceftazidime,<br />

gentamicin, <strong>and</strong> imipenem,<br />

1666<br />

E. aerogenes, 693<br />

E. cloacae, 693<br />

E. coli, 693<br />

Enterobacter spp., 1666<br />

Enterobacteriaceae, 693, 1666<br />

Haemophilus spp., 1666<br />

Morganella spp., 1666<br />

Neisseria spp., 1666<br />

P. aeruginosa, 693, 1666<br />

P. cepacia, 1666<br />

Pseudomonas spp., 1666<br />

Serratia spp., 1666<br />

Staphylococcus spp., 1666<br />

Streptococcus spp., 1666<br />

X. maltophilia, 1666<br />

E-3846<br />

comparative activity<br />

ciprofloxacin <strong>and</strong> norfloxacin, 636<br />

cystitis, 636<br />

E. coli, 636<br />

Enterobacteriaceae, 636<br />

K. pneumoniae, 636<br />

P. aeruginosa, 636<br />

P. mirabilis, 636<br />

pyelonephritis, 636<br />

S. faecalis, 636<br />

Staphylococcus spp., 636<br />

Ehrlichia risticii<br />

demeclocycline, 986<br />

doxycycline, 986<br />

erythromycin, 986<br />

minocycline, 986<br />

nalidixic acid, 986<br />

oxytetracycline, 986<br />

rifampin, 986<br />

tetracycline, 986<br />

Eikenella corrodens<br />

clindamycin, 1521<br />

neutrophil killing, 1521<br />

R plasmid, 765<br />

tetracycline resistance, 765<br />

Encephalomyocarditis virus<br />

P-536, 1257<br />

Endocarditis<br />

amikacin-ceftazidime, 231<br />

cefam<strong>and</strong>ole, 63<br />

cefazolin, 63, 262<br />

ceftazidime-amikacin, 231<br />

ciprofloxacin, 747<br />

daptomycin, 63, 141, 877<br />

daptomycin-gentamicin, 877<br />

difloxacin, 262<br />

enoxacin, 262<br />

fosfomycin, 919<br />

fosfomycin-pefloxacin, 919<br />

gentamicin-daptomycin, 877<br />

gentamicin-penicillin G procaine, 877<br />

gentamicin-vancomycin, 877<br />

P. aeruginosa, 231<br />

pefloxacin, 231, 919<br />

pefloxacin-fosfomycin, 919<br />

penicillin G, 141<br />

penicillin G procaine, 877<br />

penicillin G procaine-gentamicin, 877<br />

S. aureus, 262, 747, 919<br />

S. epidermidis, 63<br />

S. faecalis, 877<br />

Streptococcus spp., 141<br />

vancomycin, 63, 877<br />

vancomycin-gentamicin, 877<br />

Endomyometritis<br />

cesarean section, 853<br />

clindamycin-gentamicin, 853<br />

gentamicin-clindamycin, 853<br />

moxalactam, 853<br />

treatment cost analysis, 853<br />

Enoxacin<br />

B. fragilis, 1437<br />

bite wound bacteria, 1143<br />

SUBJECT INDEX xvii<br />

Bordetella spp., 137<br />

C. trachomatis, 1080<br />

comparative activity<br />

amifloxacin, ciprofloxacin, norfloxacin,<br />

<strong>and</strong> ofloxacin, 928<br />

cefazolin <strong>and</strong> difloxacin, 262<br />

endocarditis, 262<br />

Haemophilus spp., 147<br />

high-pressure liquid chromatography,<br />

834<br />

Nocardia spp., 1078<br />

osteomyelitis, 834<br />

P. falciparum, 1182<br />

P. pseudomallei, 928<br />

prostatic tissue concentrations, 1433<br />

S. aureus, 262<br />

Shigella spp., 20<br />

Entamoeba histolytica<br />

B. javanica, 1725<br />

quassinoids, 1725<br />

S. amara, 1725<br />

Enterobacter aerogenes<br />

E1040, 693<br />

R-3746, 671<br />

R plasmid, 9<br />

tigemonam, 84<br />

Enterobacter cloacae<br />

amdinocillin, 1632<br />

ceftazidime, 1632<br />

resistance, 1632<br />

ceftazidime-amdinocillin, 1632<br />

E1040, 693<br />

R-3746, 671<br />

tigemonam, 84<br />

YTR 830, 925<br />

Enterobacter spp.<br />

E-1040, 1666<br />

lomefloxacin, 656<br />

PD 117,596, 1450<br />

tigemonam, 84<br />

Enterobacteriaceae<br />

A-61827, 27<br />

6'-N-acetyltransferase type 4, 1289<br />

amikacin, 873<br />

resistance, 1289<br />

aminoglycoside resistance, 1289<br />

amoxicillin-clavulanic acid, 873<br />

ampicillin, 873<br />

P-lactamases, 1365<br />

carumonam, 1593<br />

cefixime, 1896<br />

cefotaxime, 873<br />

cefoxitin, 873<br />

cefpodoxime, 1896<br />

ceftibuten, 1576<br />

ceftriaxone, 1896<br />

cephalothin, 873<br />

chloramphenicol, 873<br />

chlorhexidine digluconate, 873<br />

ciprofloxacin, 1327<br />

colistin, 873<br />

CS-807, 1082<br />

doxycycline, 873<br />

DuP 105, 580<br />

DuP 721, 580<br />

E1040, 693, 1666<br />

E-3846, 636<br />

fluoroquinolone resistance, 1285<br />

gentamicin, 873<br />

iodine alcohol, 873<br />

lomefloxacin, 617<br />

PD 127,391, 1251<br />

polyvinylpyrrolidone, 873

xviii SUBJECT INDEX<br />

R plasmid, 1289<br />

sodium hypochlorite, 873<br />

susceptibility testing, 1365<br />

T-3262, 663, 827<br />

ticarcillin, 873<br />

ticarcillin-potassium clavulanate resistance,<br />

1365<br />

tigemonam, 84<br />

tobramycin, 873<br />

trimethoprim, 873<br />

trimethoprim-sulfamethoxazole, 1327<br />

trospectomycin, 216<br />

U-76,252, 1082<br />

U-76,253A, 443<br />

urinary tract infections, 1327<br />

Enterococcus faecalis<br />

CS-807, 1082<br />

daptomycin, 24<br />

DuP 105, 580<br />

DuP 721, 580<br />

fluoroquinolone resistance, 1285<br />

T-3262, 663<br />

U-76,252, 1082<br />

Enterococcus faecium<br />

daptomycin, 24<br />

norfloxacin, 1869<br />

Enterococcus spp.<br />

Campylobacter resistance gene, 1793<br />

cefixime, 18%<br />

cefpodoxime, 1896<br />

ceftriaxone, 18%<br />

clindamycin, 1769<br />

clindamycin-streptomycin, 1769<br />

daptomycin, 279<br />

DuP 105, 150<br />

DuP 721, 150<br />

intestinal colonization <strong>and</strong> translocation,<br />

1769<br />

metronidazole, 1769<br />

metronidazole-streptomycin, 1769<br />

PD 117,5%, 1450<br />

R-3746, 671<br />

R plasmids, 1793<br />

S-6123, 1341<br />

T-3262, 827<br />

tigemonam, 84<br />

translocation, 1769<br />

U-76,253A, 443<br />

Enviroxime<br />

aerosol, 890<br />

liposomes, 890<br />

rhinoviruses, 890<br />

toxicity, 890<br />

Enzyme immunoassays<br />

Chlamydiazyme, 1350<br />

Enzyme-linked immunosorbent assays<br />

T. gondii, 303<br />

Epidermophyton floccosum<br />

G2, 1586<br />

Epstein-Barr virus<br />

acyclovir, 1068<br />

acyclovir-AZT, 265<br />

1-P-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil,<br />

1068<br />

3'-azido-3'-deoxythymidine, 265<br />

3'-azido-3'-deoxythymidine-acyclovir,<br />

265<br />

AZT, 265<br />

AZT-acyclovir, 265<br />

E-5-(2-bromovinyl)-2'-deoxyuridine, 1068<br />

bromovinyl nucleoside analogs, 1068<br />

Ergosterol<br />

C. albicans, 702<br />

Erythromycin<br />

acistrate<br />

tonsillar <strong>and</strong> plasma concentrations,<br />

1019<br />

Arthrobacter spp., 420<br />

B. bronchiseptica, 1891<br />

B. catarrhalis, 259<br />

Bacillus spp., 642<br />

base<br />

toxicity, 1541<br />

uptake <strong>and</strong> distribution, 1541<br />

Bordetella spp., 137<br />

C. trachomatis, 1350<br />

Chlamydia sp. strain TWAR, 257<br />

combinations<br />

ciprofloxacin, 1392<br />

ethambutol, 1392<br />

M. avium complex, 1392<br />

rifampin, 1392<br />

comparative activity, 1710<br />

clarithromycin <strong>and</strong> roxithromycin,<br />

1758<br />

demeclocycline, doxycycline, minocycline,<br />

nalidixic acid, oxytetracycline,<br />

rifampin, <strong>and</strong> tetracycline,<br />

986<br />

mupirocin, 1780<br />

dysgonic fermenter 2, 78<br />

E. risticii, 986<br />

H. ducreyi, 1458<br />

H. influenzae, 180<br />

impetigo, 1780<br />

M. leprae, 1758<br />

N. asteroides, 1776<br />

P. multocida, 213<br />

R. conorii, 255<br />

R. rickettsii, 255<br />

S. faecalis resistance, 547<br />

Staphylococcus spp., 420<br />

stearate<br />

tonsillar <strong>and</strong> plasma concentrations,<br />

1019<br />

T. pallidum, resistant, 164<br />

Erythromycin estolate<br />

B. catarrhalis, 1227<br />

comparative activity<br />

erythromycin ethylsuccinate, 1227<br />

high-pressure liquid chromatography,<br />

561<br />

pharmacokinetics, 561<br />

plasma bactericidal activity, 1227<br />

Streptococcus spp., 1227<br />

toxicity, 1541<br />

uptake <strong>and</strong> distribution, 1541<br />

Erythromycin ethylsuccinate<br />

B. catarrhalis, 1227<br />

comparative activity<br />

erythromycin estolate, 1227<br />

high-pressure liquid chromatography,<br />

561<br />

pharmacokinetics, 561<br />

plasma bactericidal activity, 1227<br />

Streptococcus spp., 1227<br />

Erythromycin-sulfisoxazole<br />

B. catarrhalis, 259<br />

Erythromycylamine<br />

comparative activity, 1710<br />

Escherichia coli<br />

A-61827, 27<br />

ampicillin, 450, 552<br />

aztreonam, 552<br />

berberine sulfate, 1274<br />

,-lactamase, 1243<br />

ANTIMICROB. AGENTS CHEMOTHER.<br />

biofilms<br />

radiochemical method, 770<br />

2-bromo-2-nitropropane-1,3-diol, 1693<br />

bronopol, 1693<br />

cefotaxime-chloramphenicol, 1375<br />

cefoxitin, 1511<br />

cefpirome, 13%<br />

ceftizoxime, 1511<br />

ceftriaxone, 552<br />

ceftriaxone-chloramphenicol, 1375<br />

cephalosporins<br />

catechol substituted, 1879<br />

3-chlorodiaminopimelic acid, 1119<br />

ciprofloxacin, 450<br />

cloning of P. maltophilia ,B-lactamase<br />

operon, 819<br />

CS-807, 1082<br />

cystitis, 636, 1640<br />

diaminopimelic acid epimerase, 1119<br />

DNA synthesis, 1113<br />

E1040, 693<br />

E-3846, 636<br />

etoposide, 1456<br />

gentamicin, 552<br />

hypersusceptible<br />

gentamicin, 308<br />

lipopolysaccharide polycation affinity<br />

<strong>and</strong> binding, 308<br />

polymyxin, 308<br />

spermine, 308<br />

imipenem sub-MICs<br />

killing, 1012<br />

phagocytosis, 1012<br />

serum sensitivity, 1012<br />

in vitro simulation of serious infections,<br />

552<br />

lipopolysaccharide<br />

amikacin, 1247<br />

gentamicin, 1247<br />

kanamycin, 1247<br />

spectinomycin, 1247<br />

tobramycin, 1247<br />

lomefloxacin, 656<br />

LY163892, 268<br />

M14659, 1648<br />

ME1207, 1421<br />

mixed infection with B. fragilis<br />

amoxicillin-clavulanic acid, 1830<br />

ampicillin-sulbactam, 1830<br />

norfloxacin, 1292<br />

endogenous active efflux, 1187<br />

ofloxacin, 1640<br />

outer membrane proteins<br />

iron regulated, 1879<br />

oxyimino-cephalosporins, 1243<br />

Pap fimbrial adhesion, 1274<br />

PD 117,5%, 1450<br />

permeability, increased<br />

anesthetics, 153<br />

chlorpronmazine, 153<br />

dibucaine, 153<br />

procaine, 153<br />

quinine, 153<br />

tetracaine, 153<br />

postantibiotic effect, 450<br />

pyelonephritis, 636<br />

quinolone permeation, 438<br />

quinolones, 1113<br />

R-3746, 671<br />

R plasmids, 9, 1243, 1552<br />

S-6123, 1341<br />

sensitization by heat treatment<br />

chloramphenicol, 1680

VOL. 32, 1988<br />

crystal violet, 1680<br />

fatty acids, 1680<br />

malachite green, 1680<br />

p-hydroxybenzoic acid, 1680<br />

rifampin, 1680<br />

tylosin, 1680<br />

vancomycin, 1680<br />

T-3262, 663, 827<br />

tigemonam, 84, 346<br />

tobramycin, 450<br />

trimethoprim-sulfamethoxazole,<br />

1640<br />

U-76,252, 1082<br />

urinary tract infections, 1274<br />

YTR 830, 925<br />

Ethambutol<br />

combinations<br />

ciprofloxacin, 1392<br />

clofazimine, 1392<br />

erythromycin, 1392<br />

M. avium complex, 1392<br />

rifabutin, 1392<br />

rifampin, 1392<br />

M. tuberculosis, 1208, 1441<br />

Ethidium<br />

P. carinii, 896<br />

Ethidium bromide<br />

S. aureus resistance, 932<br />

Ethionamide<br />

M. avium, 1131<br />

Etoposide<br />

B. stearothermophilus, 1456<br />

B. subtilis, 1456<br />

comparative activity<br />

cloxacillin, 1456<br />

E. coli, 1456<br />

K. pneumoniae, 1456<br />

P. aeruginosa, 1456<br />

S. aureus, 1456<br />

S. lutea, 1456<br />

S. sanguis, 1456<br />

Eubacterium spp.<br />

daptomycin, 788<br />

paldimycin, 788<br />

tetracycline<br />

resistance, 1271<br />

Fagara zanthoxyloides<br />

B. gingivalis, 598<br />

B. melaninogenicus, 598<br />

Fatty acids<br />

E. coli<br />

heat treatment, 1680<br />

M. avium complex, 400<br />

Fecal flora<br />

antimicrobial resistance, 1801<br />

Feces<br />

norfloxacin binding, 1869<br />

quinolone binding, 1869<br />

Fibronectin<br />

S. pyogenes, 1370<br />

Fleroxacin<br />

C. trachomatis, 1080<br />

high-pressure liquid chromatography,<br />

1515<br />

letter to the editor, 791<br />

pharmacokinetics, 1515<br />

S. typhimurium, 791<br />

Flucloxacillin<br />

open-heart surgery, 930<br />

Fluconazole<br />

C. albicans, 209, 1859<br />

coccidioidal meningitis, 369<br />

comparative activity<br />

ketoconazole, 209, 646<br />

denture stomatitis, 1859<br />

meningitis, coccidioidal, 369<br />

pharmacokinetics, 209, 369<br />

stomatitis, denture, 1859<br />

testosterone, 646<br />

2-Fluoro-L-histidine<br />

P. falciparum, 1655<br />

Fluoroquinolones<br />

B. fragilis, 1437<br />

resistance, development of, 1285<br />

Fluorovinylglycine<br />

comparative activity, 319<br />

gram-positive bacteria, 319<br />

Staphylococcus spp., 319<br />

Flurithromycin<br />

comparative activity, 1710<br />

pharmacokinetics, 1875<br />

Folate pathway<br />

bacterial adhesion, 1609<br />

minireview, 1609<br />

Folic acid antagonists<br />

T. vaginalis, 144<br />

Foscarnet<br />

guinea pig embryonic fibroblasts, 1533<br />

herpes simplex virus type 1, 1533<br />

human immunodeficiency virus type 1,<br />

1733<br />

human immunodeficiency virus type 2,<br />

1733<br />

simian immunodeficiency virus, 1733<br />

Fosfomycin<br />

calcium<br />

pharmacokinetics, 938<br />

young <strong>and</strong> elderly adults, 938<br />

combinations<br />

endocarditis, 919<br />

pefloxacin, 919<br />

S. aureus, 919<br />

endocarditis, 919<br />

glutathione adduct, 1552<br />

plasmid-borne resistance, 1552<br />

S. aureus, 919<br />

tromethamine<br />

pharmacokinetics, 938<br />

young <strong>and</strong> elderly adults, 938<br />

Fucoidan<br />

cytomegalovirus, 1742<br />

herpes simplex virus, 1742<br />

human immunodeficiency virus, 1742<br />

vesicular stomatitis virus, 1742<br />

Furazolidone<br />

T. vaginalis, 144<br />

Fusobacterium nucleatum<br />

tetracycline<br />

resistance, 1271<br />

G2 E. floccosum, 1586<br />

Microsporum spp., 1586<br />

structure, 1586<br />

toxicity, 1586<br />

Trichophyton spp., 1586<br />

GABA receptor<br />

diclofenac, 1624<br />

quinolones, 1624<br />

theophylline, 1624<br />

f-Galactosidase<br />

P. chryosogenum<br />

glucokinase-deficient mutant, 1061<br />

SUBJECT INDEX xix<br />

y-Aminobutyric acid receptor<br />

diclofenac, 1624<br />

quinolones, 1624<br />

theophylline, 1624<br />

Ganciclovir<br />

cochlear pathophysiology, 865<br />

cytomegalovirus, 865<br />

high-pressure liquid chromatography,<br />

865<br />

labyrinthitis, 865<br />

marrow transplantation, 271<br />

pharmacokinetics, 1899<br />

Gene probes<br />

3-V-acetyltransferase, 1834<br />

Gentamicin<br />

A. denitrificans subsp. xylosoxidans, 276<br />

B. bronchiseptica, 1891<br />

B. catarrhalis, 259<br />

Bacillus spp., 642<br />

cerebrospinal fluid penetration, 1034<br />

cochlear binding sites, 467<br />

combinations<br />

ciprofloxacin, 782<br />

clindamycin, 853<br />

cost analysis, 853<br />

daptomycin, 81<br />

endomyometritis, 853<br />

P. maltophilia, 782<br />

pyelonephritis, 81<br />

S. faecalis, 81<br />

comparative activity<br />

carumonam, 473<br />

chloramphenicol <strong>and</strong> ciprofloxacin,<br />

285<br />

dysgonic fermenter 2, 78<br />

E. coli, 308, 552<br />

lipopolysaccharide, 1247<br />

Enterobacteriaceae, 873<br />

fecal flora resistance, 1801<br />

H. influenzae, 1034<br />

in vitro simulation of serious infections,<br />

552<br />

K. pneumoniae resistance, 1379<br />

meningitis, 1034<br />

N. asteroides, 1776<br />

nephrotoxicity<br />

hydrocortisone, influence of, 992<br />

piperacillin protective effect, 912<br />

P. aeruginosa, 552<br />

P. carinii, 896<br />

P. maltophilia, 782<br />

pharmacokinetics, 467, 736<br />

pyelonephritis, 81, 736<br />

S. aureus resistance, 932, 1174<br />

S. faecalis, 81, 736<br />

resistance, 547, 1528<br />

S. marcescens resistance, 1379<br />

S. pneumoniae, 552<br />

scrub typhus, 285<br />

Shigella spp., 20<br />

sodium hydroxide digestion method, 595<br />

T. vaginalis, 1323<br />

urinary tract infections, 473<br />

Gentamicin-clindamycin<br />

comparative activity<br />

cost analysis, 853<br />

moxalactam, 853<br />

endomyometritis, 853<br />

Giardia lamblia<br />

5-methylthioribose analogs, 1904<br />

(1-3)-p-D-Glucan synthase<br />

C. albicans, 1901<br />

cilofungin, 1901

xx SUBJECT INDEX<br />

Glucose<br />

avermectin production, 282<br />

Glutathione<br />

adduct formation, 1552<br />

fosfomycin modification, 1552<br />

GMP<br />

guinea pig embryonic fibroblasts, 1533<br />

herpes simplex virus type 1, 1533<br />

Gonorrhea<br />

cefodizime, 426<br />

cefotaxime, 426<br />

imipenem-cilastatin, 773<br />

spectinomycin<br />

disk zone diameter as predictor of outcome,<br />

775<br />

Gram-negative bacteria<br />

cefotaxime-chloramphenicol, 1375<br />

ceftriaxone-chloramphenicol, 1375<br />

cephalexin hydrochloride, 882<br />

cephalexin monohydrate, 882<br />

norfloxacin, 1292<br />

PD 127,391, 1278<br />

S-6123, 1341<br />

susceptibility testing, 385<br />

Gram-positive bacteria<br />

cyclohexane triones, 814<br />

DuP 721, 1218<br />

halovinylglycine compounds, 319<br />

L-norvalyl peptide derivatives, 319<br />

norfloxacin, 1292<br />

PD 127,391, 1278<br />

Guanosine analogs<br />

guinea pig embryonic fibroblasts, 1533<br />

herpes simplex virus type 1, 1533<br />

Haemophilus ducreyi<br />

A-56268, 1458<br />

amoxicillin, 1458<br />

amoxicillin-clavulanic acid, 1458<br />

cefotaxime, 1458<br />

cefoxitin, 1458<br />

ceftetrame, 1458<br />

ceftriaxone, 1458<br />

chloramphenicol, 1458<br />

ciprofloxacin, 723, 1458<br />

co-trimoxazole, 1458<br />

difloxacin, 1458<br />

doxycycline, 1458<br />

erythromycin, 1458<br />

kanamycin, 1458<br />

minocycline, 1458<br />

penicillin, 1458<br />

rifampin, 1458<br />

rosoxacin, 1458<br />

spectinomycin, 1458<br />

sulfamethoxazole, 1458<br />

tetracycline, 1458<br />

thiamphenicol, 1458<br />

trimethoprim, 1458<br />

trimethoprim-sulfamethoxazole, 1458<br />

Haemophilus influenzae<br />

A-61827, 27<br />

ampicillin, 180<br />

azithromycin, 752<br />

P-lactamase, 180<br />

cefaclor, 180<br />

cefam<strong>and</strong>ole, 180<br />

cefixime, 1896<br />

cefpodoxime, 1896<br />

ceftibuten, 1576<br />

ceftriaxone, 1896<br />

cephalexin, 180<br />

cephalothin, 180<br />

chloramphenicol<br />

acetyltransferase, 180<br />

conjunctivitis, 1820<br />

CS-807, 1082<br />

cyclohexane triones, 814<br />

erythromycin, 180<br />

gentamicin, 1034<br />

lomefloxacin, 617, 656<br />

LY163892, 131, 268<br />

ME1207, 1421<br />

meningitis, 1034<br />

minireview, 1747<br />

norfloxacin, 1820<br />

ocular infections, 1820<br />

PD 127,391, 1251<br />

penicillin G, 498<br />

penicillin-binding proteins, 498<br />

R-3746, 671<br />

rifampin, 180<br />

S-6123, 1341<br />

sulfisoxazole, 180<br />

susceptibility testing, 1747<br />

chloramphenicol, 1484<br />

T-3262, 663<br />

tetracycline, 180<br />

tobramycin, 1820<br />

trimethoprim resistance, 477<br />

trimethoprim-sulfamethoxazole, 180<br />

trospectomycin, 216<br />

U-76,252, 1082<br />

U-76,253A, 443<br />

Haemophilus spp.<br />

ciprofloxacin, 147<br />

E-1040, 1666<br />

enoxacin, 147<br />

norfloxacin, 147<br />

ofloxacin, 147<br />

PD 117,596, 1450<br />

pefloxacin, 147<br />

tigemonam, 84<br />

Halovinylglycine compounds<br />

alanine racemase, 319<br />

comparative activities, 319<br />

gram-positive bacteria, 319<br />

L-norvalyl peptide derivatives, 319<br />

Staphylococcus spp., 319<br />

Head <strong>and</strong> neck surgery<br />

cancer patients, 1557<br />

clindamycin-amikacin, 1557<br />

ticarcillin-clavulanic acid, 1557<br />

Herpes simplex virus<br />

carrageenans, 1742<br />

dextran sulfate, 1742<br />

fucoidan, 1742<br />

pentosan polysulfate, 1742<br />

sulfated polysaccharides, 1742<br />

Herpes simplex virus type I<br />

A723U, 1100<br />

acyclovir, 1100, 1533<br />

monophosphate, 1533<br />

9-p-D-arabinofuranosyladenine, 1046<br />

I -,-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil,<br />

1547<br />

1-0-D-arabinofuranosyl-E-(2-bromovinyl)<br />

uracil, 1046<br />

I-P-D-arabinofuranosylthymine, 1046<br />

3-azido-3'-deoxythymidine, 265<br />

AZT, 265<br />

B-220, 1720<br />

BRL 39123, 358<br />

bromovinyldeoxyuridine, 1533<br />

buciclovir, 1533<br />

ANTIMICROB. AGENTS CHEMOTHER.<br />

monophosphate, 1533<br />

2,3,dimethyl(dimethylaminoethyl)SHindolo-(2,3-b)quinoxaline,<br />

1720<br />

foscarnet, 1533<br />

GMP, 1533<br />

guanosine analogs, 1533<br />

9-4-(hydroxy-3-hydroxymethylbut-1 -yl)<br />

guanine, 358<br />

9-(2-hydroxyethoxymethyl)guanine, 1046<br />

indoloquinoxaline derivatives, 1720<br />

5-iodo-2'-deoxyuridine, 1046<br />

iododeoxyuridine, 1533<br />

P-536, 1257<br />

pyrimidine deoxynucleotide metabolism,<br />

1100<br />

ribonucleotide reductase inhibition,<br />

1100<br />

Herpes simplex virus type 2<br />

1-P-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil,<br />

1547<br />

3'-azido-3'-deoxythymidine, 265<br />

AZT, 265<br />

BRL 39123, 358<br />

9-4-(hydroxy-3-hydroxymethylbut-1-yl)<br />

guanine, 358<br />

phosphonoacetate, 858<br />

phosphonoformate, 858<br />

Hexadecane<br />

S. pyogenes, 1370<br />

High-performance liquid chromatography<br />

amphotericin B, 1103<br />

carbapenem labeling, 186<br />

cefonicid, 485<br />

cefpiramide, 1360<br />

cefpirome, 1481<br />

ceftazidime, 1845<br />

clindamycin, 1825<br />

itraconazole, 1310<br />

lomefloxacin, 1503, 1508<br />

reuterin, 1854<br />

High-pressure liquid chromatography<br />

carumonam, 354<br />

cefoperazone-ceftazidime, 298<br />

ceftazidime-cefoperazone, 298<br />

ciprofloxacin, 1537<br />

enoxacin, 834<br />

erythromycin estolate, 561<br />

erythromycin ethylsuccinate, 561<br />

fleroxacin, 1515<br />

ganciclovir, 865<br />

trimetrexate, 324<br />

Histidine analogs<br />

P. falciparum, 1655<br />

±2HM-HBG<br />

pharmacokinetics, 1807<br />

simian varicella-zoster virus, 1807<br />

Home parenteral therapy<br />

ceftriaxone, 1439<br />

HPA-23<br />

acquired immune deficiency syndrome,<br />

1300<br />

(S)-HPMPA<br />

influenza viruses, 906<br />

(S)-HPMPC<br />

cytomegalovirus, 1839<br />

HRE 664<br />

comparative activity<br />

aztreonam, ceftazidime, ceftriaxone,<br />

imipenem, piperacillin, <strong>and</strong> Sch<br />

34343, 1090<br />

Human granulocytes<br />

P. aeruginosa<br />

moxalactam-induced filamentous

VOL. 32, 1988<br />

forms, 1565<br />

Human immunodeficiency virus<br />

carrageenans, 1742<br />

dextran sulfate, 1742<br />

fucoidan, 1742<br />

pentosan polysulfate, 1742<br />

phosphonylmethoxyethyl purines, 1025<br />

reverse transcriptase, 1887<br />

sulfated polysaccharides, 1742<br />

Human immunodeficiency virus type 1<br />

3'-azido-3'-deoxythymidine, 1784<br />

triphosphate, 1733<br />

AZT, 1784<br />

triphosphate, 1733<br />

AZT-isoprinosine, 1784<br />

cell cultures, 684<br />

foscarnet, 1733<br />

isoprinosine, 1784<br />

isoprinosine-AZT, 1784<br />

reverse transcriptase, 684, 1733<br />

rifabutin, 684<br />

virus-antigen assay, 684<br />

Human immunodeficiency virus type 2<br />

3'-azido-3'-deoxythymidine triphosphate,<br />

1733<br />

AZT triphosphate, 1733<br />

foscarnet, 1733<br />

reverse transcriptase, 1733<br />

Human renal dehydropeptidase I<br />

purification <strong>and</strong> characterization, 587<br />

Hydrocortisone<br />

nephrotoxicity, gentamicin induced, 992<br />

9-[4-Hydroxy-2(hydroxymethyl)butyl]<br />

guanine triphosphate<br />

DNA polymerases, 1137<br />

varicella-zoster virus, 1137<br />

(R,S)-9-[4-Hydroxy-2-(hydroxymethyl)<br />

butyl]guanine<br />

pharmacokinetics, 1807<br />

simian varicella-zoster virus, 1807<br />

(S)-9-(3-Hydroxy-2-phosphonylmethoxypropyl)adenine<br />

influenza viruses, 906<br />

(S)- 1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine<br />

comparative activity<br />

9-(1,3-dihydroxy-2-propoxymethyl)<br />

guanine, (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine,<br />

<strong>and</strong> phosphonoformate, 1839<br />

cytomegalovirus, 1839<br />

9-(4-Hydroxy-3-hydroxymethyl-1-yl)guanine<br />

comparative activity<br />

acyclovir, 358<br />

herpes simplex virus type 1, 358<br />

herpes simplex virus type 2, 358<br />

p-Hydroxybenzoic acids<br />

E. coli<br />

heat treatment, 1680<br />

2-Hydroxybenzoylglycine<br />

hyperbilirubinemia<br />

centrifugal ultrafiltration, 1571<br />

9-(2-hydroxyethoxymethyl)guanine<br />

herpes simplex virus type 1, 1046<br />

9-(2-Hydroxyethoxymethyl)guanine triphosphate<br />

DNA polymerases, 1137<br />

varicella-zoster virus, 1137<br />

Hyperbilirubinemia<br />

aztreonam, 1571<br />

carbenicillin, 1571<br />

cefoperazone, 1571<br />

ceftriaxone, 1571<br />

cefuroxime, 1571<br />

dicloxacillin, 1571<br />

2-hydroxybenzoylglycine, 1571<br />

kanamycin, 1571<br />

mezlocillin, 1571<br />

moxalactam, 1571<br />

nafcillin, 1571<br />

sulfamethoxazole, 1571<br />

sulfisoxazole, 1571<br />

Imidazoles<br />

T. vaginalis, 1323<br />

Imidocarb<br />

P. carinii, 896<br />

Imipenem<br />

A. denitrificans subsp. xylosoxidans, 276<br />

B. catarrhalis, 259<br />

Bacillus spp., 642<br />

combinations<br />

ciprofloxacin, 782<br />

P. maltophilia, 782<br />

comparative activity<br />

piperacillin, 1012<br />

dysgonic fermenter 2, 78<br />

M. morganii, 1385<br />

M. tuberculosis, 1441<br />

N. asteroides, 1776<br />

Nocardia spp., 1078<br />

P. aeruginosa resistance, 1267<br />

P. maltophilia, 782<br />

P. pseudomallei, 1435<br />

P. vulgaris, 1385<br />

sub-MICs<br />

E. coli, 1012<br />

killing, 1012<br />

phagocytosis, 1012<br />

S. aureus, 1012<br />

serum sensitivity, 1012<br />

Imipenem-cilastatin<br />

-y-aminobutyric acid binding, 758<br />

C. trachomatis, 773<br />

gonorrhea, 773<br />

N. gonorrhoeae, 773<br />

pentylenetetrazole convulsive threshold,<br />

758<br />

pharmacokinetics, 530<br />

Immunoblotting<br />

P. aeruginosa, 649<br />

Immunoglobulin, intravenous<br />

respiratory syncytial virus, 1269<br />

Impetigo<br />

erythromycin, 1780<br />

mupirocin, 1780<br />

Indoloquinoxaline<br />

derivatives, 1720<br />

herpes simplex virus type 1, 1720<br />

Influenza A virus<br />

alpha-2b interferon, 47<br />

Influenza B virus<br />

alpha-2b interferon, 47<br />

ribavirin small-particle aerosol, 761<br />

Influenza viruses<br />

(RS)-3-adenin-9-yl-2-hydroxypropanoic<br />

acid, 906<br />

(RS)-AHPA, 906<br />

carbocyclin 3-deazaadenosine, 906<br />

carbodine, 906<br />

5-chlorotubercidin, 906<br />

5-cyanoimidazole-4-carboxamide, 906<br />

5-cyano-1-,-D-ribofuranosyl-imidazole-4carboxamide,<br />

906<br />

cyclopentenyl cytosine, 906<br />

SUBJECT INDEX xxi<br />

3-deazaguanine, 906<br />

3-deazauridine, 906<br />

5'-deoxy-5-fluorouridine, 906<br />

(S)-DHIPA, 906<br />

(S)-9-(2,3-dihydroxypropyl)adenine, 906<br />

(S)-HPMPA, 906<br />

(S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine,<br />

906<br />

3-methylhypoxanthine, 906<br />

3'-C-methyluridine, 906<br />

neplanocin A, 900<br />

neplanocin C, 906<br />

P-536, 1257<br />

pyrazofurin, 906<br />

ribavirin, 906<br />

T-25, 906<br />

T-26, 906<br />

tubercidin, 906<br />

xylotubercidin, 906<br />

Inositol hexaphosphate<br />

B. microti, 391<br />

P. falciparum, 391<br />

Interferon<br />

alfa-2b, recombinant<br />

rhinovirus, 224<br />

alpha-2a, recombinant<br />

respiratory syncytial virus, 589<br />

cytomegalovirus, 678<br />

S26308, 678<br />

Intra-abdominal infections<br />

cefoperazone-sulbactam, 730<br />

Intravenous immunoglobulin<br />

respiratory syncytial virus, 1269<br />

Iodine alcohol<br />

Enterobacteriaceae, 873<br />

5-Iodo-2'-deoxyuridine<br />

herpes simplex virus type 1, 1046<br />

Iododeoxyuridine<br />

guinea pig embryonic fibroblasts, 1533<br />

herpes simplex virus type 1, 1533<br />

2-Iodo-L-histidine<br />

P. falciparum, 1655<br />

lontophoresis<br />

tobramycin, 978<br />

Ipratropium bromide<br />

rhinovirus, 1644<br />

Isoelectric focusing<br />

,B-lactamases, 397, 1730<br />

comparative studies, 397<br />

PhastSystem, 1730<br />

Isometamidium<br />

P. carinii, 896<br />

Isoniazid<br />

M. avium, 1131<br />

M. tuberculosis, 1208, 1441<br />

Isoprinosine<br />

combinations<br />

3'-azido-3'-deoxythymidine, 1784<br />

AZT, 1784<br />

human immunodeficiency virus type 1,<br />

1984<br />

human immunodeficiency virus type 1,<br />

1984<br />

Itraconazole<br />

high-performance liquid chromatography,<br />

1310<br />

pharmacokinetics, 1310, 1595<br />

renal dysfunction, 1595<br />

S. schenckii, 1619<br />

sporotrichosis, 1619

xxii SUBJECT INDEX<br />

Jasplakinolide<br />

antifungal agents, 1154<br />

C. albicans, 1154<br />

C<strong>and</strong>ida spp., 1154<br />

comparative activity<br />

clotrimazole <strong>and</strong> miconazole, 1154<br />

Josamycin<br />

Arthrobacter spp., 420<br />

C. trachomatis, 1350<br />

comparative activity, 1710<br />

R. conorii, 255<br />

R. rickettsii, 255<br />

Staphylococcus spp., 420<br />

Kanamycin<br />

B. bronchiseptica, 1891<br />

C. coli resistance, 1170<br />

C. jejuni resistance, 1170<br />

Campylobacter resistance, 945<br />

E. coli<br />

lipopolysaccharide, 1247<br />

fecal flora resistance, 1801<br />

H. ducreyi, 1458<br />

hyperbilirubinemia<br />

centrifugal ultrafiltration, 1571<br />

K. pneumoniae resistance, 1379<br />

M. avium, 1131<br />

N. asteroides, 1776<br />

S. aureus resistance, 932<br />

S. marcescens resistance, 1379<br />

Shigella spp., 20<br />

Keratitis<br />

P. aeruginosa, 978<br />

tobramycin, 978<br />

Ketoconazole<br />

C. albicans, 209<br />

combinations<br />

SF 86-327, 1237<br />

T. (S.) cruzi, 1237<br />

comparative activity<br />

fluconazole, 209<br />

pharmacokinetics, 209<br />

T. (S.) cruzi, 1237<br />

T. vaginalis, 1323<br />

testosterone, 646<br />

Kingella denitrificans<br />

R plasmid, 765<br />

tetracycline resistance, 765<br />

Klebsiella aerogenes<br />

YTR 830, 925<br />

Klebsiella pneumoniae<br />

amikacin resistance, 1379<br />

transposon mediated, 1416<br />

P-lactam resistance, 1660<br />

,-lactamases, 626, 1660<br />

cephaloridine, 364<br />

cephalosporin resistance, 1660<br />

CGP 17520, 364<br />

cystitis, 636<br />

E-3846, 636<br />

etoposide, 1456<br />

gentamicin resistance, 1379<br />

kanamycin resistance, 1379<br />

lomefloxacin, 656<br />

meningitis, 1705<br />

netilmicin resistance, 1379<br />

plasmids, 1660<br />

pyelonephritis, 636<br />

R-3746, 671<br />

R plasmid, 9, 626, 1379, 1416<br />

surface protein antigens, 364<br />

temocillin, 1705<br />

tobramycin resistance, 1379<br />

Klebsiella spp.<br />

CS-807, 1082<br />

PD 117,596, 1450<br />

tigemonam, 84<br />

U-76,252, 1082<br />

Labyrinthitis<br />

cytomegalovirus, 865<br />

ganciclovir, 865<br />

Lactobacillus reuteri<br />

production <strong>and</strong> isolation of reuterin,<br />

1854<br />

Lactobacillus spp.<br />

daptomycin, 788<br />

paldimycin, 788<br />

Legionella pneumophila<br />

A-61827, 27<br />

azithromycin, 752<br />

carumonam, 1593<br />

PD 117,596, 1450<br />

Legionella spp.<br />

NY-198, 1427<br />

Legionnaires disease<br />

NY-198, 1427<br />

Letters to the editor<br />

antacids<br />

ciprofloxacin pharmacokinetics, 949<br />

B. subtilis<br />

streptomycin adenylyltransferase, 949<br />

ciprofloxacin<br />

antacids, 949<br />

pharmacokinetics, 949<br />

common cold therapy, 605, 606, 608<br />

Cryptosporidium sp., 1907<br />

fleroxacin, 791<br />

in vitro simulation of serious infections,<br />

1600<br />

M. tuberculosis, 287<br />

N. gonorrhoeae<br />

P-lactamase, 158<br />

R plasmid, 158<br />

tetracycline resistance, 951<br />

pharmacokinetics<br />

ciprofloxacin, 949<br />

puerperal infections, 407<br />

pyrazinamide, 287<br />

S. aureus, 1464<br />

S. typhimurium, 791<br />

streptomycin<br />

B. subtilis adenylyltransferase, 949<br />

sulfadimethoxine, 1907<br />

susceptibility testing, 1464<br />

tetracycline<br />

N. gonorrhoeae resistance, 951<br />

ticarcillin-clavulanic acid, 407<br />

zinc for common cold, 605, 606, 608<br />

pH <strong>and</strong> free ion concentration, 608<br />

stability constants, 606<br />

Lidocaine<br />

ceftriaxone reconstitution, 1439<br />

Lincomycin<br />

Arthrobacter spp., 420<br />

Staphylococcus spp., 420<br />

Lincosamides<br />

Arthrobacter resistance, 420<br />

Staphylococcus resistance, 420<br />

Lipid X<br />

pharmacokinetics, 37<br />

Lipopolysaccharides<br />

E. coli<br />

amikacin, 1247<br />

ANTIMICROB. AGENTS CHEMOTHER.<br />

gentamicin, 1247<br />

kanamycin, 1247<br />

spectinomycin, 1247<br />

tobramycin, 1247<br />

Liposomes<br />

amikacin<br />

M. avium-M. intracellulare, 1404<br />

ampicillin, 1560<br />

enviroxime, 890<br />

L. monocytogenes, 1560<br />

lipid composition, 1560<br />

phosphonoacetate, 858<br />

phosphonoformate, 858<br />

stearylamine-phosphatidylcholine, 966<br />

T. b. gambiense, 966<br />

Liposome-swelling assay<br />

P. aeruginosa, 1267<br />

Listeria monocytogenes<br />

ampicillin, 1204<br />

nanoparticle polyisohexylcyanoacrylate-bound,<br />

1204<br />

ampicillin, liposome entrapped<br />

lipid composition, 1560<br />

azithromycin, 752<br />

DuP 105, 150, 580<br />

DuP 721, 150, 580<br />

Listeria spp.<br />

tigemonam, 84<br />

Lomefloxacin<br />

B. fragilis, 617<br />

Branhamella spp., 656<br />

comparative activity<br />

amoxicillin, ciprofloxacin, cefuroxime,<br />

fleroxacin, ofloxacin, <strong>and</strong> trimethoprim,<br />

617<br />

ciprofloxacin, enoxacin, norfloxacin,<br />

<strong>and</strong> ofloxacin, 656<br />

E. coli, 656<br />

Enterobacter spp., 656<br />

Enterobacteriaceae, 617<br />

H. influenzae, 617, 656<br />

high-performance liquid chromatography,<br />

1503, 1508<br />

K. pneumoniae, 656<br />

Neisseria spp., 617<br />

P. aeruginosa, 617<br />

pharmacokinetics, 1503, 1508<br />

Pseudomonas spp., 656<br />

Salmonella spp., 656<br />

Shigella spp., 656<br />

Staphylococcus spp., 617, 656<br />

Streptococcus spp., 617<br />

tolerance, 1503<br />

LY163892<br />

B. catarrhalis, 268<br />

chemical stability in storage, 1477<br />

comparative activity<br />

amoxicillin, amoxicillin-clavulanic<br />

acid, <strong>and</strong> cefaclor, 268<br />

cefaclor <strong>and</strong> cefuroxime, 131<br />

cefaclor, cephalexin, cephalothin, <strong>and</strong><br />

cefuroxime, 1477<br />

E. coli, 268<br />

H. influenzae, 131, 268<br />

pediatric infections, 268<br />

pharmacokinetics, 1738<br />

S. aureus, 131<br />

Streptococcus spp., 268<br />

susceptibility test conditions, 1477<br />

M14659<br />

comparative activity

VOL. 32, 1988<br />

ceftazidime <strong>and</strong> ceftriaxone, 1648<br />

E. coli, 1648<br />

low-iron environment, 1648<br />

Macrolides<br />

comparative activity, 1710<br />

T. vaginalis, 144<br />

Malachite green<br />

E. coli<br />

heat treatment, 1680<br />

Malaria<br />

antimalarial agents<br />

mechanisms of action, 793<br />

minireview, 793<br />

chemoprophylaxis, 953<br />

chloroquine resistance, 799<br />

minireviews, 793, 799, 953, 957<br />

treatment, 957<br />

Marrow transplantation<br />

ganciclovir, 271<br />

Massularia accuminata<br />

B. gingivalis, 598<br />

B. melaninogenicus, 598<br />

ME1207<br />

,-lactamases, 1421<br />

comparative activity<br />

cefaclor, cefixime, <strong>and</strong> T-2525, 1421<br />

E. coli, 1421<br />

H. influenzae, 1421<br />

N. gonorrhoeae, 1421<br />

P. cepacia, 1421<br />

P. rettgeri, 1421<br />

S. pneumoniae, 1421<br />

Staphylococcus spp., 1421<br />

Measles virus<br />

P-536, 1257<br />

Mebendazole<br />

T. vaginalis, 144<br />

Mefloquine<br />

polymorphonuclear neutrophils, 1124<br />

Meningitis<br />

coccidioidal<br />

fluconazole, 369<br />

gentamicin<br />

cerebrospinal fluid penetration,<br />

1034<br />

H. influenzae, 1034<br />

K. pneumoniae, 1705<br />

temocillin, 1705<br />

Methicillin<br />

dysgonic fermenter 2, 78<br />

Methylenepenams<br />

antibacterial properties, 1005<br />

Methylglyoxal bis(guanylhydrazone)<br />

P. carinii, 896<br />

3-Methylhypoxanthine<br />

influenza viruses, 906<br />

5-Methylthioribose analogs<br />

G. lamblia, 1904<br />

0. malhamensis, 1904<br />

P. falciparum, 1904<br />

3'-C-Methyluridine<br />

influenza viruses, 906<br />

Metronidazole<br />

combinations<br />

enterococci, 1769<br />

streptomycin, 1769<br />

enterococci, 1769<br />

T. vaginalis, 144, 1323<br />

Mezlocillin<br />

B. catarrhalis, 259<br />

Bacillus spp., 642<br />

combinations<br />

ciprofloxacin, 782<br />

P. maltophilia, 782<br />

hyperbilirubinemia<br />

centrifugal ultrafiltration, 1571<br />

M. morganii, 1385<br />

P. maltophilia, 782<br />

P. vulgaris, 1385<br />

pharmacokinetics, 777<br />

Miconazole<br />

comparative activity<br />

amphotericin B, 1864<br />

polymorphonuclear leukocytes, 1864<br />

T. vaginalis, 1323<br />

Microsporum spp.<br />

G2, 1586<br />

Minireviews<br />

antibiotic biosynthetic genes, 1472<br />

antifungal agents, 1<br />

antimalarial agents<br />

mechanisms of action, 793<br />

azoles, I<br />

B. catarrhalis<br />

susceptibility testing, 1747<br />

bacterial adhesion, 1603, 1609<br />

biosynthetic genes, 1472<br />

C. trachomatis<br />

antibodies, monoclonal, 1295<br />

susceptibility testing, 1295<br />

Campylobacter spp.<br />

resistance mechanisms, 1107<br />

chloroquine<br />

mechanism of resistance, 799<br />

H. influenzae<br />

susceptibility testing, 1747<br />

malaria, 793, 799<br />

chemoprophylaxis, 953<br />

treatment, 957<br />

mixed aerobic-anaerobic infections, 611<br />

N. gonorrhoeae<br />

susceptibility testing, 1747<br />

P. falciparum, 799<br />

pharmacokinetics<br />

outcome of infections, 289<br />

Plasmodium spp., 793<br />

rhinovirus colds chemotherapy, 409<br />

Streptomyces spp.<br />

cloned genes, 1465, 1472<br />

recombinant DNA systems, 1465<br />

susceptibility testing<br />

B. catarrhalis, 1747<br />

H. influenzae, 1747<br />

N. gonorrhoeae, 1747<br />

triazoles, I<br />

Minocycline<br />

C. trachomatis, 1080, 1350<br />

comparative activity<br />

demeclocycline, doxycycline, erythromycin,<br />

nalidixic acid, oxytetracycline,<br />

rifampin, <strong>and</strong> tetracycline,<br />

986<br />

E. risticii, 986<br />

H. ducreyi, 1458<br />

N. asteroides, 1776<br />

P. multocida, 213<br />

Miocamycin<br />

comparative activity, 1710<br />

Mixed infections<br />

aerobic-anaerobic, 611<br />

minireview, 611<br />

Morganella morganii<br />

ampicillin, 1385<br />

P-lactam resistance, 1385<br />

P-lactamase, 1385<br />

carbenicillin, 1385<br />

SUBJECT INDEX xxiii<br />

cefotaxime, 1385<br />

cefoxitin, 1385<br />

ceftriaxone, 1385<br />

cephaloridine, 1385<br />

imipenem, 1385<br />

mezlocillin, 1385<br />

Morganella spp.<br />

E-1040, 1666<br />

R-3746, 671<br />

tigemonam, 84<br />

Moxalactam<br />

B. catarrhalis, 259<br />

comparative activity<br />

clindamycin-gentamicin, 853<br />

cost analysis, 853<br />

endomyometritis, 853<br />

hyperbilirubinemia<br />

centrifugal ultrafiltration, 1571<br />

P. aeruginosa filamentous forms<br />

human granulocytes, 1565<br />

P. vulgaris, 1073<br />

Shigella spp., 20<br />

Mtr phenotype<br />

N. gonorrhoeae, 971<br />

Mucor racemosus<br />

cycloheximide efflux, 341<br />

trichodermin, 341<br />

Mupirocin<br />

comparative activity<br />

erythromycin, 1780<br />

impetigo, 1780<br />

Mycobacterium avium<br />

amikacin, 1131<br />

capreomycin, 1131<br />

ethionamide, 1131<br />

isoniazid, 1131<br />

kanamycin, 1131<br />

rifampin, 1131<br />

streptomycin, 1131<br />

susceptibility testing, 1131<br />

Mycobacterium avium complex<br />

acquired immune deficiency syndrome,<br />

1392<br />

amikacin, 886, 1149, 1400<br />

amikacin-clofazimine, 1400<br />

amikacin-clofazimine-rifabutin, 1400<br />

amikacin-rifabutin, 1400<br />

amikacin-tumor necrosis factor, 1149<br />

azithromycin, 1149<br />

azithromycin-tumor necrosis factor,<br />

1149<br />

clofazime-ethambutol, 1392<br />

clofazimine-ciprofloxacin, 1392<br />

ethambutol-ciprofloxacin, 1392<br />

ethambutol-erythromycin, 1392<br />

ethambutol-rifampin, 1392<br />

ethambutol-rifampin-ciprofloxacin, 1392<br />

ethambutol-rifampin-ciprofloxacin-erythromycin,<br />

1392<br />

ethambutol-rifampin-erythromycin, 1392<br />

fatty acids, 400<br />

model man, 886<br />

rifabutin-ciprofloxacin, 1392<br />

rifabutin-clofazimine, 1392<br />

rifabutin-ethambutol, 1392<br />

rifampin-ciprofloxacin, 1392<br />

rifampin-erythromycin, 1392<br />

roxithromycin, 1149<br />

roxithromycin-tumor necrosis factor,<br />

1149<br />

Mycobacterium avium-M. intracellulare<br />

amikacin, 1404<br />

liposome encapsulated, 1404

xxiv SUBJECT INDEX<br />

Mycobacterium leprae<br />

clarithromycin, 1758<br />

clofazimine, 1583<br />

erythromycin, 1758<br />

phenazines, 1583<br />

roxithromycin, 1758<br />

Mycobacterium smegmatis<br />

cyclohexane triones, 814<br />

Mycobacterium spp.<br />

dihydromycoplanecin A, 110<br />

Mycobacterium tuberculosis<br />

A-56620, 1441<br />

ATP bioluminescence assay, 1208<br />

cefonicid, 1441<br />

ceforanide, 1441<br />

cefotaxime, 1441<br />

cefpirome, 1441<br />

ceftizoxime, 1441<br />

cephapirin, 1441<br />

difloxacin, 1441<br />

ethambutol, 1208, 1441<br />

imipenem, 1441<br />

isoniazid, 1208, 1441<br />

letter to the editor, 287<br />

PD 127,391, 1251<br />

pyrazinamide, 125, 287<br />

pHs, different, 1002<br />

radiometric method, 1002<br />

rifampin, 1208, 1441<br />

SK&F 88070, 1441<br />

streptomycin, 1208, 1441<br />

susceptibility testing, 125<br />

Mycoplasma hominis<br />

A-63075, 1500<br />

clarithromycin, 1500<br />

difloxacin, 1500<br />

erythromycin, 1500<br />

temafloxacin, 1500<br />

Mycoplasma pneumoniae<br />

A-63075, 1500<br />

clarithromycin, 1500<br />

difloxacin, 1500<br />

erythromycin, 1500<br />

temafloxacin, 1500<br />

Naegleria fowleri<br />

acrolein, 962<br />

cyclophosphamide, 962<br />

Nafcillin<br />

hyperbilirubinemia<br />

centrifugal ultrafiltration, 1571<br />

Nalidixic acid<br />

B. bronchiseptica, 1891<br />

cleavable-complex assay, 1086<br />

comparative activity<br />

ciprofloxacin, enoxacin, norfloxacin,<br />

<strong>and</strong> ofloxacin, 1285<br />

demeclocycline, doxycycline, erythromycin,<br />

minocycline, oxytetracycline,<br />

rifampin, <strong>and</strong> tetracycline,<br />

986<br />

E. faecalis resistance, 1285<br />

E. risticii, 986<br />

Enterobacteriaceae resistance, 1285<br />

fecal flora resistance, 1801<br />

GABA receptor, 1624<br />

P. aeruginosa resistance, 1285<br />

P. falciparum, 1182<br />

S. aureus, 1192<br />

resistance, 1285<br />

Shigella spp., 20<br />

Nauclea latifolia<br />

B. gingivalis, 598<br />

B. melaninogenicus, 598<br />

Neisseria gonorrhoeae<br />

A-61827, 27<br />

azithromycin, 752<br />

,B-lactamases, 158, 1430<br />

cefodizime, 426<br />

cefotaxime, 426<br />

DNA gyrase inhibitors, 1788<br />

genetic transformation, 1788<br />

imipenem-cilastatin, 773<br />

letters to the editor, 158, 951<br />

ME1207, 1421<br />

minireview, 1747<br />

Mtr phenotype, 971<br />

PD 117,596, 1450<br />

R-3746, 671<br />

R plasmids, 158, 488<br />

transfer to Neisseria spp., 1430<br />

susceptibility testing, 1747<br />

T-3262, 663<br />

tetracycline resistance, 488, 951<br />

trospectomycin, 216<br />

Neisseria meningitidis<br />

azithromycin, 752<br />

cefixime, 1896<br />

cefpodoxime, 1896<br />

ceftriaxone, 18%<br />

ciprofloxacin, 1740<br />

penicillin resistance, 706<br />

R plasmid<br />

transfer from N. gonorrhoeae, 1430<br />

Neisseria perflava-N. sicca<br />

tetracycline<br />

resistance, 1271<br />

Neisseria spp.<br />

ceftibuten, 1576<br />

E-1040, 1666<br />

lomefloxacin, 617<br />

PD 127,391, 1251<br />

R plasmid, 488, 765<br />

transfer from N. gonorrhoeae, 1430<br />

tetracycline resistance, 488, 765<br />

tigemonam, 84<br />

U-76,253A, 443<br />

Neomycin<br />

B. bronchiseptica, 1891<br />

Nephrotoxicity<br />

apalcillin, 942<br />

cefazolin, 314<br />

cefoperazone, 314<br />

ceftazidime, 314<br />

cephaloglycin, 314<br />

cephaloridine, 314, 912<br />

cephalothin, 314<br />

gentamicin, 912<br />

hydrocortisone, influence of, 992<br />

Neplanocin A<br />

influenza viruses, 906<br />

Neplanocin C<br />

influenza viruses, 906<br />

Netilmicin<br />

A. denitrificans subsp. xylosoxidans,<br />

276<br />

B. catarrhalis, 259<br />

cardiopulmonary bypass, 631<br />

K. pneumoniae resistance, 1379<br />

pharmacokinetics, 631<br />

S. marcescens resistance, 1379<br />

Neutrophils<br />

clindamycin<br />

periodontal bacteria, 1521<br />

ANTIMICROB. AGENTS CHEMOTHER.<br />

Nifurtimox<br />

immune response, effect on, 241<br />

T. cruzi, 241<br />

Nigerian chewing sticks<br />

B. gingivalis, 598<br />

B. melaninogenicus, 598<br />

Nitrosoureas<br />

amphQtericin B<br />

C. albicans, 327<br />

Nocardia asteroides<br />

amikacin, 1776<br />

ampicillin, 1776<br />

1-lactamase, 1776<br />

carbenicillin, 1776<br />

cefotaxime, 1776<br />

ceftriaxone, 1776<br />

ciprofloxacin, 1776<br />

erythromycin, 1776<br />

gentamicin, 1776<br />

imipenem, 1776<br />

kanamycin, 1776<br />

minocycline, 1776<br />

sulfamethoxazole, 1776<br />

susceptibility patterns, 1776<br />

Nocardia spp.<br />

A-56620, 1078<br />

A-62254, 1078<br />

amifloxacin, 1078<br />

cefepime, 1078<br />

cefpirome, 1078<br />

ciprofloxacin, 1078<br />

difloxacin, 1078<br />

enoxacin, 1078<br />

imipenem, 1078<br />

PD-1 17558, 1078<br />

RO 23-6240, 1078<br />

S-25930, 1078<br />

S-25932, 1078<br />

Nonoxynol-9<br />

T. vaginalis, 1323<br />

Norfloxacin<br />

A. denitrificans subsp. xylosoxidans, 276<br />

B.fragilis, 1437, 1869<br />

binding to feces, 1869<br />

Bordetella spp., 137<br />

C. trachomatis, 1080, 1350, 1735<br />

C. freundii resistance, 922<br />

cleavable-complex assay, 1086<br />

comparative activity<br />

amifloxacin, ciprofloxacin, enoxacin,<br />

<strong>and</strong> ofloxacin, 928<br />

doxycycline <strong>and</strong> minocycline, 1735<br />

tobramycin, 1820<br />

conjunctivitis, 1820<br />

E. coli, 1292<br />

endogenous active efflux, 1187<br />

E. faecium, 1869<br />

fecal binding, 1869<br />

gram-negative bacteria, 1292<br />

gram-positive bacteria, 1292<br />

H. influenzae, 1820<br />

Haemophilus spp., 147<br />

ocular infections, 1820<br />

P. aeruginosa, 1292<br />

P. falciparum, 1182<br />

P. maltophilia, 782<br />

P. pseudomallei, 928, 1435<br />

S. aureus, 1192, 1820<br />

S. pneumoniae, 1820<br />

Shigella spp., 20<br />

Staphylococcus spp., 1820<br />

streptococci, alpha-hemolytic, 1820<br />

theophylline pharmacokinetics, 510

VOL. 32, 1988<br />

urinary tract infections, 1292<br />

L-Norvalyl-L-chlorovinylglycine<br />

comparative activity, 319<br />

gram-positive bacteria, 319<br />

Staphylococcus spp., 319<br />

Nosocomial infections<br />

Staphylococcus spp., 202<br />

Novobiocin<br />

A. lignieresii, 1354<br />

B. bronchiseptica, 1891<br />

P. falciparum, 1182<br />

P. multocida, 1354<br />

Nucleic acid synthesis<br />

bacterial adhesion, 1609<br />

minireview, 1609<br />

NY-198<br />

B. fragilis, 1437<br />

C. trachomatis, 1080, 1735<br />

comparative activity<br />

ciprofloxacin, 1427<br />

doxycycline <strong>and</strong> minocycline, 1735<br />

Legionella spp., 1427<br />

Legionnaires disease, 1427<br />

pharmacokinetics, 156, 1427<br />

Ochromonas malhamensis<br />

5-methylthioribose analogs, 1904<br />

Ocular infections<br />

H. influenzae, 1820<br />

norfloxacin, 1820<br />

S. aureus, 1820<br />

S. pneumoniae, 1820<br />

Staphylococcus spp., 1820<br />

streptococci, alpha-hemolytic, 1820<br />

tobramycin, 1820<br />

Ofloxacin<br />

A. denitrificans subsp. xylosoxidans,<br />

276<br />

B. fragilis, 1437<br />

bite wound bacteria, 1143<br />

Bordetella spp., 137<br />

C. trachomatis, 1080, 1350, 1735<br />

C. freundii resistance, 922<br />

cleavable-complex assay, 1086<br />

comparative activity<br />

amifloxacin, ciprofloxacin, enoxacin,<br />

<strong>and</strong> norfloxacin, 928<br />

doxycycline <strong>and</strong> minocycline, 1735<br />

cystitis, 1640<br />

cytogenetic effects, 936<br />

DR-3355 isomer, 1336<br />

E. coli, 1640<br />

GABA receptor, 1624<br />

Haemophilus spp., 147<br />

P. falciparum, 1182<br />

P. pseudomallei, 928<br />

pharmacokinetics, 1590, 1640<br />

S. aureus, 1192<br />

Shigella spp., 20<br />

Ole<strong>and</strong>omycin<br />

Arthrobacter spp., 420<br />

Staphylococcus spp., 420<br />

Oligonucleotide probes<br />

,3-lactamases, 397<br />

comparative studies, 397<br />

Open-heart surgery<br />

flucloxacillin, 930<br />

Oral bacteria<br />

tetracycline resistance, 1271<br />

Ornithine decarboxylase inhibitors<br />

T. gondii, 303<br />

Osteomyelitis<br />

enoxacin, 834<br />

vancomycin bone concentrations, 1320<br />

Outer membrane<br />

permeability<br />

P. aeruginosa, 1267<br />

P. cepacia, 1636<br />

proteins<br />

E. coli, 1879<br />

iron regulated, 1879<br />

Oxacillin<br />

Bacillus spp., 642<br />

bactericidal testing, 1614<br />

coagulase-negative staphylococcal susceptibility,<br />

1754<br />

P. multocida, 213<br />

S. aureus, 1614<br />

MBCs, 374<br />

susceptibility, 1754<br />

Oxetanocin G<br />

cytomegalovirus, 1053<br />

Oxolinic acid<br />

B. bronchiseptica, 1891<br />

cleavable-complex assay, 1086<br />

P. falciparum, 1182<br />

Oxyimino-cephalosporins<br />

,B-lactamase, 1243<br />

E. coli, 1243<br />

Oxytetracycline<br />

B. bronchiseptica, 1891<br />

comparative activity<br />

demeclocycline, doxycycline, erythromycin,<br />

minocycline, nalidixic<br />

acid, rifampin, <strong>and</strong> tetracycline,<br />

986<br />

E. risticii, 986<br />

P-536<br />

encephalomyocarditis virus, 1257<br />

influenza virus, 1257<br />

measles virus, 1257<br />

poliovirus type 1, 1257<br />

T. cruzi, 1412<br />

type 5, 1257<br />

herpes simplex virus type 1, 1257<br />

UDP-glucose analog, 1257<br />

vaccinia virus, 1257<br />

vesicular stomatitis virus, 1257<br />

PADAC<br />

P-lactamase assay, 1040<br />

Paldimycin<br />

Actinomyces spp., 788<br />

Bifidobacterium spp., 788<br />

Clostridium spp., 788<br />

comparative activity<br />

daptomycin, penicillin, <strong>and</strong> vancomycin,<br />

788<br />

Eubacterium spp., 788<br />

Lactobacillus spp., 788<br />

Peptostreptococcus spp., 788<br />

Propionibacterium spp., 788<br />

Pap fimbrial adhesion<br />

berberine sulfate, 1274<br />

Paradoxical effect<br />

P-lactams, 1073<br />

P. vulgaris, 1073<br />

Parainfluenza virus<br />

sulfated polysaccharides, 1742<br />

Pasteurella multocida<br />

actinomycin D, 1354<br />

amoxicillin-clavulanic acid, 213<br />

ampicillin, 213<br />

SUBJECT INDEX xxv<br />

cefaclor, 213<br />

cefadroxil, 213<br />

cefuroxime, 213<br />

cephalexin, 213<br />

chloramphenicol, 213<br />

clindamycin, 213<br />

daptomycin, 1354<br />

erythromycin, 213<br />

minocycline, 213<br />

novobiocin, 1354<br />

oxacillin, 213<br />

penicillin, 213<br />

phospholipid composition, 1354<br />

polymyxin, 1354<br />

rifamycin, 1354<br />

tetracycline, 213<br />

trimethoprim-sulfamethoxazole, 213<br />

Pasteurella spp.<br />

P-lactamase, 1282<br />

R plasmid, 1282<br />

PD-1 17558<br />

Nocardia spp., 1078<br />

PD 117,596<br />

Acinetobacter spp., 1450<br />

B. catarrhalis, 1450<br />

C. jejuni, 1450<br />

comparative activity<br />

amikacin, aztreonam, cephalothin, CI<br />

934, ciprofloxacin, imipenem, <strong>and</strong><br />

piperacillin, 1450<br />

Corynebacterium spp., 1450<br />

E. coli, 1450<br />

Enterobacter spp., 1450<br />

Enterococcus spp., 1450<br />

Haemophilus spp., 1450<br />

Klebsiella spp., 1450<br />

L. pneumophila, 1450<br />

N. gonorrhoeae, 1450<br />

P. mirabilis, 1450<br />

Pseudomonas spp., 1450<br />

S. aureus, 1450<br />

S. marcescens, 1450<br />

Streptococcus spp., 1450<br />

PD 127,391<br />

B. fragilis, 1251<br />

C. trachomatis, 1251<br />

comparative activity<br />

ceftazidime, ciprofloxacin, gentamicin,<br />

<strong>and</strong> imipenem, 1278<br />

cefuroxime, ciprofloxacin, gentamicin,<br />

nalidixic acid, <strong>and</strong> ofloxacin, 1251<br />

Enterobacteriaceae, 1251<br />

gram-negative aerobes, 1278<br />

gram-positive aerobes, 1278<br />

H. influenzae, 1251<br />

M. tuberculosis, 1251<br />

Neisseria spp., 1251<br />

P. aeruginosa, 1251, 1278<br />

Pseudomonas spp., 1278<br />

S. pneumoniae, 1251<br />

Staphylococcus spp., 1251<br />

Pediatric infections<br />

LY163892, 268<br />

Pefloxacin<br />

A. denitrificans subsp. xylosoxidans,<br />

276<br />

B. catarrhalis, 259<br />

C. trachomatis, 1350<br />

combinations<br />

endocarditis, 919<br />

fosfomycin, 919<br />

S. aureus, 919<br />

comparative activity

xxvi SUBJECT INDEX<br />

amikacin-ceftazidime, 231<br />

ceftazidime-amikacin, 231<br />

endocarditis, 231, 919<br />

GABA receptor, 1624<br />

Haemophilus spp., 147<br />

P. aeruginosa, 231<br />

resistance, development of, 231<br />

P. falciparum, 1182<br />

S. aureus, 919<br />

Shigella spp., 20<br />

Penems<br />

protein binding, 159<br />

spectrophotometric assay, 159<br />

Penicillin<br />

B. catarrhalis, 259<br />

Bacillus spp., 642<br />

biosynthesis<br />

P. chrysogenum glucokinase-deficient<br />

mutant, 1061<br />

Chlamydia sp. strain TWAR, 257<br />

dysgonic fermenter 2, 78<br />

H. ducreyi, 1458<br />

H. influenzae, 498<br />

N. meningitidis resistance, 706<br />

P. multocida, 213<br />

S. aureus resistance, 1164<br />

T. vaginalis, 1323<br />

Penicillin G<br />

bite wound bacteria, 1143<br />

methylene analogs<br />

antibacterial properties, 1005<br />

Penicillinase<br />

P. cepacia, 838<br />

Penicillin-binding proteins<br />

B. fragilis, 1848<br />

H. influenzae, 498<br />

Penicillium chrysogenum<br />

P-galactosidase activity, 1061<br />

glucokinase-deficient mutant, 1061<br />

penicillin biosynthesis, 1061<br />

Pentamidine<br />

comparative activity<br />

dapsone, trimethoprim-dapsone, <strong>and</strong><br />

trimethoprim-sulfamethoxazole,<br />

623<br />

P. carinii, 623, 896, 1490<br />

pharmacokinetics, 1490<br />

pneumonia, 623, 1490<br />

Pentosan polysulfate<br />

cytomegalovirus, 1742<br />

herpes simplex virus, 1742<br />

human immunodeficiency virus, 1742<br />

vesicular stomatitis virus, 1742<br />

Pentostam<br />

P. carinii, 896<br />

Pentylenetetrazole<br />

BMY-26225, 758<br />

cefazolin, 758<br />

convulsive threshold, 758<br />

imipenem-cilastatin, 758<br />

rat model, 758<br />

Peptidoglycan synthesis<br />

bacterial adhesion, 1609<br />

minireview, 1609<br />

Peptococcus spp.<br />

DR-3355, 1336<br />

Peptostreptococcus anaerobius<br />

tetracycline<br />

resistance, 1271<br />

Peptostreptococcus spp.<br />

daptomycin, 788<br />

paldimycin, 788<br />

Percutaneous transhepatic biliary drainage<br />

cefotiam, 726<br />

sulbenicillin, 726<br />

ursodeoxycholate, 726<br />

Periodontal disease<br />

A. actinomycetemcomitans, 1521<br />

C. ochracea, 1521<br />

clindamycin, 1521<br />

E. corrodens, 1521<br />

tetracycline resistance, 1271<br />

Pharmacokinetics<br />

A40926, 246<br />

amdinocillin pivoxil<br />

influence of food, 592<br />

amikacin, 236<br />

amopyroquin, 568<br />

apalcillin, 942<br />

calcium fosfomycin, 938<br />

carumonam, 354<br />

cefazolin, 33<br />

cefetamet, 573<br />

cefetamet pivoxil, 573<br />

cefonicid, 485<br />

protein binding, 128<br />

cefoperazone, 42<br />

cefoperazone-sulbactam, 42, 503, 730<br />

continuous ambulatory peritoneal dialysis,<br />

51<br />

cefotaxime<br />

protein binding, 128<br />

cefpiramide, 33, 1360<br />

cefpirome, 13%<br />

ceftazidime, 1845<br />

ceftazidime-vancomycin, 92<br />

ceftizoxime<br />

protein binding, 128<br />

ciprofloxacin, 949, 982, 1537<br />

clindamycin, 1825<br />

dihydromycoplanecin A, 110<br />

erythromycin estolate, 561<br />

erythromycin ethylsuccinate, 561<br />

fleroxacin, 1515<br />

fluconazole, 209, 369<br />

flurithromycin, 1875<br />

ganciclovir, 1899<br />

gentamicin, 467, 736<br />

±2HM-HBG, 1807<br />

(R,S)-9-[4-hydroxy-2(hydroxymethyl)<br />

butyl]guanine, 1807<br />

imipenem-cilastatin, 530<br />

itraconazole, 1310<br />

renal dysfunction, 1595<br />

ketoconazole, 209<br />

letter to the editor, 949<br />

lipid X, 37<br />

lomefloxacin, 1503, 1508<br />

LY163892, 1738<br />

mezlocillin, 777<br />

minireview, 289<br />

monoclonal anti-lipid A antibody, 710<br />

netilmicin, 631<br />

NY-198, 156, 1427<br />

ofloxacin, 1590, 1640<br />

outcome of infections, 289<br />

pentamidine, 1490<br />

ribavirin aerosol, 117<br />

rimantadine, 1699, 1813<br />

roxithromycin, 1461<br />

sulbactam, 42<br />

teicoplanin, 1223<br />

temocillin, 1705<br />

theophylline<br />

ciprofloxacin, effect of, 75<br />

ANTIMICROB. AGENTS CHEMOTHER.<br />

norfloxacin, 510<br />

tobramycin<br />

charcoal, effect of, 274<br />

trimethoprim-sulfamethoxazole, 1640<br />

trimetrexate, 324<br />

tromethamine fosfomycin, 938<br />

vancomycin, 92, 631, 848<br />

vancomycin-ceftazidime, 92<br />

PhastSystem<br />

13-lactamases, 1730<br />

Phenazines<br />

M. leprae, 1583<br />

structure-activity relationships, 1583<br />

Pheromones<br />

S. faecalis, 547<br />

Phlebovirus<br />

ribavirin, 331<br />

Phosphatidylcholine<br />

liposomes, 966<br />

T. b. gambiense, 966<br />

Phospholipids<br />

A. lignieresii, 1354<br />

P. multocida, 1354<br />

Phosphonoacetate<br />

herpes simplex virus type 2, 858<br />

liposomes, 858<br />

Phosphonoformate<br />

herpes simplex virus type 2, 858<br />

liposomes, 858<br />

Phosphonylmethoxyethyl purines<br />

human immunodeficiency virus, 1025<br />

Pipemidic acid<br />

C. trachomatis, 1080<br />

Piperacillin<br />

A. denitrificans subsp. xylosoxidans, 276<br />

B. catarrhalis, 259<br />

cephaloridine nephrotoxicity, 912<br />

combinations<br />

ciprofloxacin, 782<br />

P. maltophilia, 782<br />

dysgonic fermenter 2, 78<br />

gentamicin nephrotoxicity, 912<br />

P. maltophilia, 782<br />

P. pseudomallei, 1435<br />

P. vulgaris, 1073<br />

Piritrexim<br />

P. carinii, 430<br />

T. gondii, 430<br />

Plasma bactericidal activity<br />

erythromycin estolate, 1227<br />

erythromycin ethylsuccinate, 1227<br />

Plasmids<br />

1-lactamases, 175, 1730<br />

DNA probes, 175<br />

resistance<br />

Acinetobacter spp., 15<br />

C. coli, 1170<br />

C. difficile, 1213<br />

C. freundii, 9<br />

C. jejuni, 1170<br />

E. aerogenes, 9<br />

E. coli, 9, 1243, 1552<br />

E. corrodens, 765<br />

Enterobacteriaceae, 1289<br />

Enterococcus spp., 1793<br />

K. denitrificans, 765<br />

K. pneumoniae, 9, 626, 1379, 1416,<br />

1660<br />

letter to the editor, 158<br />

N. gonorrhoeae, 158, 488, 1430<br />

Neisseria spp., 488, 765<br />

P. morganii, 9<br />

Pasteurella spp., 1282

VOL. 32, 1988<br />

S. aureus, 932, 1164, 1174<br />

S. faecalis, 547, 1528<br />

S. marcescens, 9, 1289, 1379, 1834<br />

S. sonnei, 1598<br />

S. wien, 1262<br />

Staphylococcus spp., 1494<br />

Streptococcus spp., 1793<br />

sulfonamides, 1684<br />

Plasmodium berghei<br />

cyclosporine, 462<br />

stage-selective inhibition, 462<br />

Plasmodium falciparum<br />

amifloxacin, 1182<br />

amopyroquin, 568<br />

B. javanica, 1725<br />

2-bromo-L-histidine, 1655<br />

2-chloro-L-histidine, 1655<br />

chloroquine resistance, 799<br />

cinchonidine, 250<br />

cinchonine, 250<br />

ciprofloxacin, 1182<br />

coumermycin A, 1182<br />

enoxacin, 1182<br />

2-fluoro-L-histidine, 1655<br />

histidine analogs, 1655<br />

inositol hexaphosphate, 391<br />

2-iodo-L-histidine, 1655<br />

5-methylthioribose analogs, 1904<br />

minireview, 799<br />

nalidixic acid, 1182<br />

norfloxacin, 1182<br />

novobiocin, 1182<br />

ofloxacin, 1182<br />

oxolinic acid, 1182<br />

pefloxacin, 1182<br />

quassinoids, 1725<br />

quinidine, 250<br />

quinine, 250<br />

S. amara, 1725<br />

WR 194,965 phosphate, 540<br />

Plasmodium spp.<br />

antimalarial agents<br />

mechanisms of action, 793<br />

minireview, 793<br />

minireview, 793<br />

Pneumococci<br />

U-76,253A, 443<br />

Pneumocystis carinii<br />

acquired immunodeficiency syndrome,<br />

1057<br />

amicarbalide, 896<br />

ampicillin, 896<br />

Astiban, 896<br />

chloramphenicol, 896<br />

chlorpromazine, 896<br />

clind4mycin, 807<br />

clindamycin-primaquine, 807<br />

dapsone, 96, 623, 1057, 1158<br />

dapsone-trimethoprim, 623<br />

dehydroemetine, 896<br />

diaveridine, 96<br />

difluoromethylornithine, 896<br />

DL-a-difluoromethylornithine, 1158<br />

diminazene, 896<br />

aceturate, 1158<br />

ethidium, 896<br />

gentamicin, 896<br />

imidocarb, 896<br />

isom.etamidium, 896<br />

methylglyoxal bis(guanylhydrazone), 896<br />

pentamidine, 623, 896, 1490<br />

Pentostam, 896<br />

piritrexim, 430<br />

pneumonia, 623, 896, 1057, 1490<br />

primaquine, 807<br />

primaquine-clindamycin, 807<br />

pyrimethamine, 96<br />

quinacrine, 896<br />

quinapyramine, 896<br />

quinidine, 896<br />

quinine, 896<br />

spectinomycin, 896<br />

spiramycin, 896<br />

sulfadiazine, 96<br />

sulfadoxine, 96<br />

sulfamethoxazole, 96<br />

suramin, 1158<br />

trimethoprim, 96<br />

trimethoprim-dapsone, 623<br />

trimethoprimn-sulfamethoxazole, 623,<br />

1158<br />

trimetrexate, 324<br />

Pneumonia<br />

dapsone, 1057<br />

P. carinii, 1057, 1490<br />

dosages <strong>and</strong> intervals, 623<br />

pentamidine, 1490<br />

Poliovirus<br />

sulfated polysaccharides, 1742<br />

type I<br />

P-536, 1257<br />

Polycystic kidney disease<br />

ciprofloxacin, 844<br />

Polyisohexylcyanoacrylate<br />

ampicillin binding<br />

L. monocytogenes, 1204<br />

Polymorphonuclear leukocytes<br />

amphotericin B, 1864<br />

miconazole, 1864<br />

P. aeruginosa<br />

moxalactam-induced filamentous<br />

forms, 1565<br />

Polymorphonuclear neutrophils<br />

amodiaquine, 1124<br />

chloroquine, 1124<br />

mefloquine, 1124<br />

Polymyxin<br />

A. lignieresii, 1354<br />

E. coli, 308<br />

P. multocida, 1354<br />

Polymyxin B<br />

B. bronchiseptica, 1891<br />

Polyvinylpyrrolidone<br />

Enterobacteriaceae, 873<br />

Porins<br />

P. cepacia, 1636<br />

Postantibiotic effect<br />

ampicillin, 450<br />

ciprofloxarin, 450<br />

E. coli, 450<br />

tobramycin, 450<br />

Primaquine<br />

combinations<br />

clindamycin, 807<br />

P. carinii, 807<br />

P. carinii, 807<br />

Pristinamycin<br />

aerobic bacteria, 1094<br />

comparative activity<br />

cefoxitin, chloramphenicol, clindamycin,<br />

metronidazole, penicillin,<br />

pristinamnycin group IA, <strong>and</strong><br />

pristinamycin group IIA, 1094<br />

Procaine<br />

E. coli permeability, 153<br />

SUBJECT INDEX xxvii<br />

Propionibacterium spp.<br />

daptomycin, 788<br />

paldimycin, 788<br />

Prostatic tissue<br />

enoxacin concentrations, 1433<br />

Protein synthesis<br />

bacterial adhesion, 1603<br />

minireyiew, 1603<br />

Proteus mirabilis<br />

CS-807, 1082<br />

cystitis, 636<br />

E-3846, 636<br />

PD 117,596, 1450<br />

pyelonephritis, 636<br />

R-3746, 671<br />

U-76,252, 1082<br />

YTR 830, 925<br />

Proteus morganii<br />

R plasmids, 9<br />

Proteus spp.<br />

tigenionam, 84<br />

trospectomycin, 216<br />

Proteus vulgaris<br />

ampicillin, 1385<br />

f-lactamases, 1073, 1385<br />

1-lactams<br />

paradoxical effect, 1073<br />

resistance, 1385<br />

carbenicillin, 1385<br />

cefbuperazone, 1073<br />

cefmenoxime, 1073<br />

cefmetazole, 1073<br />

cefoperazone, 1073<br />

cefotaxime, 1073, 1385<br />

cefotiam, 1073<br />

cefoxitin, 1385<br />

ceftazidime, 1073<br />

ceftizoxime, 1073<br />

ceftriaxone, 1073, 1385<br />

cefuroxime, 1073<br />

cefuzonam, 1073<br />

cephaloridine, 1073, 1385<br />

cephalothin, 1073<br />

imipenem, 1385<br />

mezlocillin, 1385<br />

moxalactam, 1073<br />

piperacillin, 1073<br />

R-3746, 671<br />

Prothrombin<br />

cefotetan effect, 1446<br />

cefoxitin effect, 1446<br />

Providencia rettgeri<br />

ME1207, 1421<br />

Providencia spp.<br />

R-3746, 671<br />

tigemonam, 84<br />

PSE-2<br />

sequence, 134<br />

Pseudomonas aeruginosa<br />

A-61827, 27<br />

amikacin-ceftazidime, 231<br />

resistance, development of, 231<br />

aminoglycoside resistance, 689<br />

ampicillin, 552<br />

antibodies<br />

monoclonal, 649<br />

aztreonam, 552<br />

P-lactamases, 1443<br />

heterogeneity, 1893<br />

carumonam, 1593<br />

cefepime resistance, 1443<br />

cefixime, 1896<br />

cefoperazone-ceftazidime, 298

xxviii SUBJECT INDEX<br />

cefotaxime resistance, 1443<br />

cefpirome, 1396<br />

cefpodoxime, 1896<br />

ceftazidime resistance, 1443<br />

ceftazidime-amikacin, 231<br />

resistance, development of, 231<br />

ceftazidime-cefoperazone, 298<br />

ceftriaxone, 552, 1896<br />

ciprofloxacin resistance, 535<br />

CS-807, 1082<br />

cystitis, 636<br />

DuP 105, 580<br />

DuP 721, 580<br />

E1040, 693, 1666<br />

E-3846, 636<br />

endocarditis, 231<br />

enhanced antibiotic binding, 649<br />

etoposide, 1456<br />

fluoroquinolone resistance, 1285<br />

gentamicin, 552<br />

imipenem resistance, 1267<br />

immunoblotting, 649<br />

in vitro simulation of serious infections,<br />

552<br />

keratitis, 978<br />

liposome-swelling assay, 1267<br />

lomefloxacin, 617<br />

moxalactam-induced filamentous forms<br />

human granulocytes, 1565<br />

norfloxacin, 1292<br />

outer membrane<br />

permeability, 1267<br />

proteins, 785<br />

PD 127,391, 1251, 1278<br />

pefloxacin, 231<br />

pyelonephritis, 636<br />

quinolone resistance, 785<br />

T-3262, 663, 827<br />

tobramycin, 978<br />

binding to alginate, 518<br />

tolA mutant, 649<br />

U-76,252, 1082<br />

Pseudomonas cepacia<br />

,B-lactam resistance, 1636<br />

P-lactamase, 838<br />

cystic fibrosis, 1636<br />

E-1040, 1666<br />

ME1207, 1421<br />

outer membrane permeability, 1636<br />

penicillinase, 838<br />

porins, 1636<br />

T-3262, 663<br />

Pseudomonas maltophilia<br />

A-56620, 782<br />

amikacin, 782<br />

aztreonam, 782<br />

P-lactamase<br />

cloning of operon on E. coli, 819<br />

carbenicillin, 782<br />

cefoperazone, 782<br />

cefsulodin, 782<br />

ceftazidime, 782<br />

ciprofloxacin, 782<br />

ciprofloxacin-amikacin, 782<br />

ciprofloxacin-aztreonam, 782<br />

ciprofloxacin-cefoperazone, 782<br />

ciprofloxacin-cefsulodin, 782<br />

ciprofloxacin-ceftazidime, 782<br />

ciprofloxacin-gentamicin, 782<br />

ciprofloxacin-imipenem, 782<br />

ciprofloxacin-mezlocillin, 782<br />

ciprofloxacin-piperacillin, 782<br />

ciprofloxacin-tobramycin, 782<br />

difloxacin, 782<br />

gentamicin, 782<br />

imipenem, 782<br />

mezlocillin, 782<br />

norfloxacin, 782<br />

piperacillin, 782<br />

Sch 34343, 782<br />

T-3262, 663<br />

ticarcillin, 782<br />

tobramycin, 782<br />

Pseudomonas pseudomallei<br />

amifloxacin, 928<br />

amoxicillin, 1435<br />

amoxicillin-clavulanic acid, 1435<br />

carumonam, 1435<br />

cefotaxime, 1435<br />

ceftazidime, 1435<br />

ceftriaxone, 1435<br />

ciprofloxacin, 928, 1435<br />

enoxacin, 928<br />

imipenem, 1435<br />

norfloxacin, 928, 1435<br />

ofloxacin, 928<br />

piperacillin, 1435<br />

ticarcillin, 1435<br />

ticarcillin-clavulanic acid, 1435<br />

Pseudomonas spp.<br />

amiloride, 395<br />

cystic fibrosis, 395<br />

E-1040, 1666<br />

lomefloxacin, 656<br />

PD 117,5%, 1450<br />

PD 127,391, 1278<br />

R-3746, 671<br />

tigemonam, 84, 346<br />

tobramycin, 395<br />

U-76,253A, 443<br />

Puerperal infections<br />

letter to the editor, 407<br />

ticarcillin-clavulanic acid, 407<br />

Pulmonary aspergillosis<br />

amphotericin B, 1676<br />

Punta Toro virus<br />

ribavirin, 331<br />

Pyelonephritis<br />

daptomycin, 81<br />

daptomycin-gentamicin, 81<br />

E-3846, 636<br />

gentamicin, 81, 736<br />

gentamicin-daptomycin, 81<br />

S. faecalis, 81<br />

Pyrazinamide<br />

letter to the editor, 285<br />

M. tuberculosis, 125, 285<br />

pHs, different, 1002<br />

radiometric method, 1002<br />

susceptibility testing, 125<br />

Pyrazofurin<br />

influenza viruses, 906<br />

Pyridinium-2-azo-p-dimethylaniline chromophore<br />

P-lactamase assay, 1040<br />

Pyrimethamine<br />

P. carinii, 96<br />

T. gondii, 303<br />

Pyrimidine deoxynucleotide metabolism<br />

herpes simplex virus type 1, 1100<br />

Quassinoids<br />

E. histolytica, 1725<br />

P. falciparum, 1725<br />

ANTIMICROB. AGENTS CHEMOTHER.<br />

Quinacrine<br />

P. carinii, 896<br />

Quinapyramine<br />

P. carinii, 896<br />

Quinidine<br />

P. carinii, 8%<br />

P. falciparum, 250<br />

Quinine<br />

E. coli permeability, 153<br />

P. carinii, 896<br />

P. falciparum, 250<br />

Quinolones<br />

C. freundii resistance, 922<br />

cleavable-complex assay, 1086<br />

DNA gyrase resistance, 104<br />

DNA synthesis, 1113<br />

E. coli, 1113<br />

permeation, 438<br />

fecal binding, 1869<br />

GABA receptor, 1624<br />

y-aminobutyric acid receptor, 1624<br />

inhibition of y-aminobutyric acid binding<br />

to receptor sites, 190<br />

P. aeruginosa resistance, 785<br />

R-3746<br />

Bacteroides spp., 671<br />

Branhamella spp., 671<br />

C. diversus, 671<br />

C. freundii, 671<br />

Clostridium spp., 671<br />

comparative activity<br />

amoxicillin-clavulanic acid, cefaclor,<br />

cefixime, cephalexin, <strong>and</strong> trimethoprim-sulfamethoxazole,<br />

671<br />

E. aerogenes, 671<br />

E. cloacae, 671<br />

E. coli, 671<br />

Enterococcus spp., 671<br />

H. influenzae, 671<br />

K. pneumoniae, 671<br />

Morganella spp., 671<br />

N. gonorrhoeae, 671<br />

P. mirabilis, 671<br />

P. vulgaris, 671<br />

Providencia spp., 671<br />

Pseudomonas spp., 671<br />

S. marcescens, 671<br />

S. pneumoniae, 671<br />

Salmonella spp., 671<br />

Shigella spp., 671<br />

streptococci, 671<br />

Yersinia spp., 671<br />

Radiochemical method<br />

E. coli biofilms, 770<br />

Radiometric method<br />

M. tuberculosis, 125<br />

pyrazinamide, 125<br />

Rat granuloma pouch<br />

cefpirome, 1396<br />

Recombinant DNA<br />

minireview, 1465<br />

Streptomyces spp., 1465<br />

Renal cyst infection<br />

ciprofloxacin, 844<br />

Reovirus<br />

sulfated polysaccharides, 1742<br />

Respiratory syncytial virus<br />

immunoglobulin, intravenous, 1269<br />

interferon alpha-2a, recombinant, 589<br />

intravenous immunoglobulin, 1269

VOL. 32, 1988<br />

Reuterin<br />

high-performance liquid chromatography,<br />

1854<br />

isolation, 1854<br />

production, 1854<br />

Reverse transcriptases<br />

human immunodeficiency virus, 1887<br />

human immunodeficiency virus type 1,<br />

684, 1733<br />

human immunodeficiency virus type 2,<br />

1733<br />

simian immunodeficiency virus, 1733,<br />

1887<br />

Rhinovirus<br />

alpha-2b interferon, 47<br />

colds chemotherapy, 409<br />

enviroxime, 890<br />

interferon, recombinant alfa-2b, 224<br />

ipratropium bromide, 1644<br />

minireview, 409<br />

Ribavirin<br />

aerosol<br />

pharmacokinetics, 117<br />

Argentine hemorrhagic fever, 1304<br />

influenza B virus, 761<br />

influenza viruses, 906<br />

Phlebovirus, 331<br />

Punta Toro virus, 331<br />

small-particle aerosol, 761<br />

vesicular stomatitis virus transcription,<br />

492<br />

Ribonucleotide reductase<br />

herpes simplex virus type 1, 1100<br />

Rickettsia conorii<br />

erythromycin, 255<br />

josamycin, 255<br />

spiramycin, 255<br />

Rickettsia rickettsii<br />

erythromycin, 255<br />

josamycin, 255<br />

spiramycin, 255<br />

Rifabutin<br />

combinations<br />

amikacin, 1400<br />

ciprofloxacin, 1392<br />

clofazimine, 1392<br />

ethambutol, 1392<br />

M. avium complex, 1392, 1400<br />

human immunodeficiency virus type 1,<br />

684<br />

Rifampin<br />

B. bronchiseptica, 1891<br />

B. catarrhalis, 259<br />

Bordetella spp., 137<br />

C. trachomatis, 1350<br />

combinations<br />

ciprofloxacin, 1392<br />

erythromycin, 1392<br />

ethambutol, 1392<br />

M. avium complex, 1392<br />

trimethoprim, 802<br />

urinary tract infections, 802<br />

comparative activity<br />

demeclocycline, doxycycline, erythromycin,<br />

minocycline, nalidixic<br />

acid, oxytetracycline, <strong>and</strong> tetracycline,<br />

986<br />

dysgonic fermenter 2, 78<br />

E. coli<br />

heat treatment, 1680<br />

E. risticii, 986<br />

H. ducreyi, 1458<br />

H. influenzae, 180<br />

M. avium, 1131<br />

M. tuberculosis, 1208, 1441<br />

Rifampin-trimethoprim<br />

comparative activity<br />

sulfamethoxazole-trimethoprim, 802<br />

urinary tract infections, 802<br />

Rifamycin<br />

A. lignieresii, 1354<br />

P. multocida, 1354<br />

Rikamycin<br />

C. trachomatis, 1350<br />

Rimantadine<br />

metabolism, 1699<br />

pharmacokinetics, 1699, 1813<br />

RO 23-6240<br />

C. trachomatis, 1080<br />

Nocardia spp., 1078<br />

Rokitamycin<br />

comparative activity, 1710<br />

Rosaramicin<br />

Arthrobacter spp., 420<br />

Staphylococcus spp., 420<br />

Rosoxacin<br />

C. trachomatis, 1350<br />

H. ducreyi, 1458<br />

Roxithromycin<br />

Bordetella spp., 137<br />

C. trachomatis, 1350<br />

combinations<br />

M. avium complex, 1149<br />

tumor necrosis factor, 1149<br />

comparative activity, 1710<br />

clarithromycin <strong>and</strong> erythromycin, 1758<br />

M. avium complex, 1149<br />

M. leprae, 1758<br />

pharmacokinetics, 1461<br />

T. gondii, 524<br />

T. pallidum, resistant, 164<br />

tonsillectomy, 1461<br />

toxicity, 1541<br />

uptake <strong>and</strong> distribution, 1541<br />

S-6123<br />

comparative activity<br />

ampicillin, ciprofloxacin, clindamycin,<br />

tetracycline, <strong>and</strong> trimethoprimsulfamethoxazole,<br />

1341<br />

E. coli, 1341<br />

Enterococcus spp., 1341<br />

gram-negative bacteria, 1341<br />

H. influenzae, 1341<br />

mechanism of action, 1341<br />

Staphylococcus spp., 1341<br />

Streptococcus spp., 1341<br />

S-25930<br />

Nocardia spp., 1078<br />

S-25932<br />

Nocardia spp., 1078<br />

S26308<br />

cytomegalovirus, 678<br />

interferon, 678<br />

Saccharomyces cerevisiae<br />

cilofungin, 1331<br />

Salmonella paratyphi A<br />

ampicillin resistance, 195<br />

cross-resistant mutant, 195<br />

mutation, pleiotropic, 195<br />

Salmonella spp.<br />

lomefloxacin, 656<br />

R-3746, 671<br />

tigemonam, 84<br />

SUBJECT INDEX xxix<br />

Salmonella typhimurium<br />

A-61827, 27<br />

allicin, 1763<br />

ampicillin, 57<br />

chloramphenicol, 57<br />

ciprofloxacin, 57<br />

diallyl thiosulfinate, 1763<br />

fleroxacin, 791<br />

letter to the editor, 791<br />

Salmonella wien<br />

FIme plasmid, 1262<br />

R plasmid, 1262<br />

tetracycline resistance, class B, 1262<br />

TnJO-like transposon, 1262<br />

Sarcina lutea<br />

etoposide, 1456<br />

Scrub typhus<br />

chloramphenicol, 285<br />

ciprofloxacin, 285<br />

gentamicin, 285<br />

SDZ 89-485<br />

S. schenckii, 1619<br />

sporotrichosis, 1619<br />

Sedecamycin<br />

comparative activity<br />

carbadox, lincomycin, <strong>and</strong> tiamulin,<br />

458<br />

T. hyodysenteriae, 458<br />

Serindeia werneckei<br />

B. gingivalis, 598<br />

B. melaninogenicus, 598<br />

Serratia marcescens<br />

6'-N-acetyltransferase type 4, 1289<br />

amikacin resistance, 1289, 1379<br />

gentamicin resistance, 1379<br />

kanamycin resistance, 1379<br />

netilmicin resistance, 1379<br />

PD 117,596, 1450<br />

R-3746, 671<br />

R plasmid, 9, 1289, 1379, 1834<br />

tigemonam, 84<br />

tobramycin resistance, 1379<br />

Serratia spp.<br />

E-1040, 1666<br />

Serum bactericidal activity<br />

cefoxitin, 1511<br />

ceftizoxime, 1511<br />

SF 86-327<br />

combinations<br />

ketoconazole, 1237<br />

T. (S.) cruzi, 1237<br />

T. (S.) cruzi, 1237<br />

Shigella sonnei<br />

R plasmids, 1598<br />

trimethoprim resistance, 1598<br />

Shigella spp.<br />

amikacin, 20<br />

ampicillin, 20<br />

ampicillin-sulbactam, 20<br />

cefam<strong>and</strong>ole, 20<br />

cefoperazone, 20<br />

cefotaxime, 20<br />

ceftazidime, 20<br />

ceftriaxone, 20<br />

cefuroxime, 20<br />

cephalothin, 20<br />

chloramphenicol, 20<br />

ciprofloxacin, 20<br />

enoxacin, 20<br />

gentamicin, 20<br />

kanamycin, 20<br />

lomefloxacin, 656<br />

moxalactam, 20

xxx SUBJECT INDEX<br />

nalidixic acid, 20<br />

norfloxacin, 20<br />

ofloxacin, 20<br />

pefloxacin, 20<br />

R-3746, 671<br />

streptomycin, 20<br />

sulfanmethoxazole, 20<br />

tetracycline, 20<br />

tigemonam, 84<br />

trimethoprimn, 20<br />

trimethoprim-sulfamethoxazole,<br />

20<br />

Simarouba amara<br />

E. histolytica, 1725<br />

P. falciparum, 1725<br />

quassinoids, 1725<br />

Simian immunodeficiency virus<br />

3'-azido-3'-deoxythyiidine triphosphate,<br />

1733<br />

AZT triphosphate, 1733<br />

foscarnet, 1733<br />

reverse transcriptase, 1733, 1887<br />

Simian varicella-zoster virus<br />

+2HM-HBG, 1807<br />

(R,S)-9-[4-hydroxy-2(hydroxymethyl)<br />

butyl]guanite, 1807<br />

Sindbis virus<br />

carrageenans, 1742<br />

dextran sulfate, 1742<br />

fucoidan, 1742<br />

pentosan polysulfate, 1742<br />

sulfated polysaccharides, 1742<br />

SK&F 88070<br />

M. tuberculosis, 1441<br />

Skin infections<br />

cefonicid, 485<br />

cephalexin hydrochloride, 882<br />

cephalexin monohydrate, 882<br />

Skin structure infections<br />

cefonicid, 485<br />

Sodium hydroxide digestion method<br />

gentamicin, 595<br />

SodiUim hypochlorite<br />

Enterobacteriaceae, 873<br />

Soft tissue infections<br />

cephalexin hydrochloride, 882<br />

cephalexin monohydrate, 882<br />

Spectinomycin<br />

E. coli<br />

lipopolysaccharide, 1247<br />

gonorrhea<br />

disk zone diameter as predictor of outcome,<br />

775<br />

f. ducreyi, 1458<br />

P. carinii, 896<br />

Spectrophotometric assay<br />

protein binding of penems, 159<br />

Spermine<br />

E. coli, 308<br />

Spiramycin<br />

Arthrobacter spp., 420<br />

comparative activity, 1710<br />

P. carinii, 896<br />

R. conorii, 255<br />

R. rickettsii, 255<br />

Staphylococcus spp., 420<br />

T. gondii, 303, 524<br />

Sporothrix schenckii<br />

amphotericin B, 1619<br />

itraconazole, 1619<br />

SDZ 89-485, 1619<br />

terbinafine, 1619<br />

Sporotrichosis<br />

amphotericin B, 1619<br />

itraconazole, 1619<br />

SDZ 89-485, 1619<br />

terbinafine, 1619<br />

Staphylococcus aureus<br />

A-61827, 27<br />

acriflavin resistance, 932<br />

acrinol resistance, 932<br />

amikacin resistance, 932<br />

bactericidal testing, 1614<br />

benzalkonium chloride resistance, 932<br />

,-lactamase, 1614, 1754<br />

transposon, 1164<br />

cefazolin, 262<br />

cefotaxime-chloramphenicol, 1375<br />

cefpirome, 13%<br />

ceftriaxone-chloramphenicol, 1375<br />

cephalexin hydrochloride, 882<br />

cephalexin monohydrate, 882<br />

cephalosporins, 170<br />

cephalothin, 374<br />

chlorhexidine resistance, 932<br />

cinoxacin, 1192<br />

ciprofloxacin, 747, 1192<br />

conjunctivitis, 1820<br />

daptomycin, 279, 454<br />

difloxacin, 262<br />

DNA gyrase, 1192<br />

DuP 105, 580<br />

DuP 721, 580<br />

endocarditis, 262, 747, 919<br />

enoxacin, 262<br />

ethidium bromide resistance, 932<br />

etoposide, 1456<br />

fluoroquinolone resistance, 1285<br />

fosfomycin, 919<br />

fosfomycin-pefloxacin, 919<br />

gentamicin resistance, 932, 1174<br />

imipenem sub-MICs<br />

killing, 1012<br />

phagocytosis, 1012<br />

serum sensitivity, 1012<br />

kanamycin resistance, 932<br />

letter to the editor, 1464<br />

LY163892, 131<br />

MBC reproducibility, 374<br />

nalidixic acid, 1192<br />

norfloxacin, 1192, 1820<br />

ocular infections, 1820<br />

ofloxacin, 1192<br />

oxacillin, 374, 1614<br />

susceptibility, 1754<br />

PD 117,596, 1450<br />

pefloxacin, 919<br />

pefloxacin-fosfomycin, 919<br />

penicillin resistance, 1164<br />

R plasmids, 932, 1164, 1174<br />

resistance phenotype, 170<br />

susceptibility testing, 1464<br />

T-3262, 663<br />

tobramycin, 1820<br />

resistance, 932<br />

U-76,253A, 443<br />

vancomycin, 374, 454<br />

Staphylococcus carnosus<br />

methicillin resistance.<br />

cloning from S. epidermidis,<br />

1494<br />

Staphylococcus epidermidis<br />

catheters, 1627<br />

cefam<strong>and</strong>ole, 63<br />

cefazolin, 63<br />

ANTIMICROB. AGENTS CHEMOTHER.<br />

daptomycin, 63, 279<br />

disodium EDTA, 1627<br />

DuP 105, 580<br />

DuP 721, 580<br />

endocarditis, 63<br />

methicillin resistance<br />

cloning in S. carnosus, 1494<br />

R plasmid, 1494<br />

T-3262, 661<br />

vancomycin, 63, 1627<br />

Staphylococcus spp.<br />

A-61827, 27<br />

carbomycin, 420<br />

cefixime, 18%<br />

cefpodoxime, 18%<br />

ceftriaxone, 1896<br />

celesticetin, 420<br />

cephalexin hydrochloride, 882<br />

cephalexin monohydrate, 882<br />

clindamycin, 420<br />

coagulase negative<br />

P-lactamase, 1754<br />

oxacillin susceptibility, 1754<br />

conjunctivitis, 1820<br />

CS-807, 1082<br />

daptomycin, 24, 279<br />

DR-3355, 1336<br />

DuP 105, 150<br />

DuP 721, 150<br />

E-1040, 1666<br />

E-3846, 636<br />

erythromycin, 420<br />

halovinylglycine compounds, 319<br />

L-norvalyl peptide derivatives,<br />

319<br />

josamycin, 420<br />

lincomycin, 420<br />

resistance, 420<br />

lomefloxacin, 617, 656<br />

ME1207, 1421<br />

norfloxacin, 1820<br />

nosocomial infections<br />

cardiac surgery, 202<br />

coronary angioplasty, 202<br />

ocular infections, 1820<br />

ole<strong>and</strong>omycin, 420<br />

PD 127,391, 1251<br />

rosaramicin, 420<br />

S-6123, 1341<br />

spiramycin, 420<br />

T-3262, 827<br />

tobramycin, 1820<br />

trospectomycin, 216<br />

tylosin, 420<br />

U-76,252, 1082<br />

U-76,253A, 443<br />

vernamycin B, 420<br />

Stearylamine<br />

liposomes, %6<br />

T. b. gambiense, 966<br />

Stomatitis, denture<br />

C. albicans, 1859<br />

fluconazole, 1859<br />

Streptococci<br />

alpha-hemolytic<br />

conjunctivitis, 1820<br />

norfloxacin, 1820<br />

ocular infections, 1820<br />

tobramycin, 1820<br />

group B<br />

cefotaxime-chloramphenicol, 1375<br />

ceftriaxone-chloramphenicol, 1375

VOL . 32, 1988<br />

Streptococcus faecalis<br />

P-lactamase, 122, 547, 768<br />

cystitis, 636<br />

daptomycin, 81, 877<br />

effect on translocation, 337<br />

daptomycin-gentamicin, 81, 877<br />

E-3846, 636<br />

endocarditis, 877<br />

erythromycin resistance, 547<br />

gentamicin, 81, 736<br />

resistance, 547<br />

gentamicin-daptomycin, 81, 877<br />

gentamicin-penicillin G procaine, 877<br />

gentamicin-vancomycin, 877<br />

penicillin G procaine, 877<br />

penicillin G procaine-gentamicin, 877<br />

pheromones, 547<br />

pyelonephritis, 81, 636<br />

R plasmid, 547<br />

vancomycin, 877<br />

vancomycin-gentamicin, 877<br />

Streptococcus faecium<br />

aminoglycoside resistance, 1528<br />

gentamicin resistance, 1528<br />

R plasmids, 1528<br />

Streptococcus pneumoniae<br />

ampicillin, 552<br />

aztreonam, 552<br />

ceftriaxone, 552<br />

conjunctivitis, 1820<br />

daptomycin, 24<br />

gentamicin, 552<br />

in vitro simulation of serious infections,<br />

552<br />

ME1207, 1421<br />

norfloxacin, 1820<br />

ocular infections, 1820<br />

PD 127,391, 1251<br />

R-3746, 671<br />

tigemonam, 84<br />

tobramycin, 1820<br />

Streptococcus pyogenes<br />

A-61827, 27<br />

berberine sulfate<br />

fibronectin, 1370<br />

hexadecane, 1370<br />

host cell adherence, 1370<br />

cephalexin hydrochloride, 882<br />

cephalexin monohydrate, 882<br />

Streptococcus sanguis<br />

etoposide, 1456<br />

Streptococcus sobrinus<br />

C31G, 350<br />

Streptococcus spp.<br />

A-61827, 27<br />

C31G, 350<br />

Campylobacter resistance gene, 1793<br />

ceftibuten, 1576<br />

CS-807, 1082<br />

daptomycin, 141<br />

DuP 105, 150, 580<br />

DuP 721, 150, 580<br />

E-1040, 1666<br />

endocarditis, 141<br />

erythromycin estolate, 1227<br />

erythromycin ethylsuccinate, 1227<br />

lomefloxacin, 617<br />

LY163892, 268<br />

PD 117,596, 1450<br />

penicillin G, 141<br />

R-3746, 671<br />

R plasmids, 1793<br />

S-6123, 1341<br />

T-3262, 827<br />

tetracycline<br />

resistance, 1271<br />

tigemonam, 84, 346<br />

trospectomycin, 216<br />

U-76,252, 1082<br />

U-76,253A, 443<br />

Streptomyces avermitilis<br />

avermectin production<br />

glucose metabolism, 282<br />

Streptomyces spp.<br />

antibiotic biosynthetic genes, 1472<br />

biosynthetic genes, 1472<br />

cloned genes, 1465, 1472<br />

minireviews, 1465, 1472<br />

recombinant DNA, 1465<br />

Streptomycin<br />

adenylyltransferase<br />

B. subtilis, 949<br />

letter to the editor, 949<br />

combinations<br />

enterococci, 1769<br />

streptomycin, 1769<br />

enterococci, 1769<br />

fecal flora resistance, 1801<br />

M. avium, 1131<br />

M. tuberculosis, 1208, 1441<br />

Shigella spp., 20<br />

Sulbactam<br />

bioassay, 1347<br />

combinations<br />

ampicillin, 1830<br />

B. fragilis, 403<br />

B. fragilis-E. coli, 1830<br />

cefoperazone, 403<br />

pharmacokinetics, 42<br />

Sulbenicillin<br />

biliary excretion<br />

ursodeoxycholate, 726<br />

percutaneous transhepatic biliary drainage,<br />

726<br />

Sulfadiazine<br />

P. carinii, 96<br />

Sulfadimethoxine<br />

B. bronchiseptica, 1891<br />

Cryptosporidium sp., 1907<br />

letter to the editor, 1907<br />

Sulfadoxine<br />

P. carinii, 96<br />

T. gondii, 303<br />

Sulfamethoxazole<br />

C. trachomatis, 1350<br />

combinations<br />

trimethoprim, 802<br />

urinary tract infections, 802<br />

H. ducreyi, 1458<br />

hyperbilirubinemia<br />

centrifugal ultrafiltration, 1571<br />

N. asteroides, 1776<br />

P. carinii, 96<br />

Shigella spp., 20<br />

Sulfamethoxazole-trimethoprim<br />

Bordetella spp., 137<br />

comparative activity<br />

rifampin-trimethoprim, 802<br />

urinary tract infections, 802<br />

Sulfamonomethoxine<br />

B. bronchiseptica, 1891<br />

Sulfated polysaccharides<br />

adenovirus, 1742<br />

coxsackievirus, 1742<br />

cytomegalovirus, 1742<br />

herpes simplex virus, 1742<br />

SUBJECT INDEX xxxi<br />

human immunodeficiency virus, 1742<br />

parainfluenza virus, 1742<br />

poliovirus, 1742<br />

reovirus, 1742<br />

Sindbis virus, 1742<br />

vaccinia virus, 1742<br />

vesicular stomatitis virus, 1742<br />

Sulfisoxazole<br />

B. catarrhalis, 259<br />

Chlamydia sp. strain TWAR, 257<br />

H. influenzae, 180<br />

hyperbilirubinemia<br />

centrifugal ultrafiltration, 1571<br />

Sulfonamides<br />

dihydropteroate synthase (sullI) gene,<br />

1684<br />

resistance plasmids, 1684<br />

sulII gene<br />

nucleotide sequence, 1684<br />

Suramin<br />

P. carinii, 1158<br />

Susceptibility testing<br />

B. catarrhalis, 1747<br />

C. trachomatis, 1350<br />

minireview, 1295<br />

monoclonal antibodies, 1295<br />

ceftibuten, 1576<br />

Enterobacteriaceae, 1365<br />

gram-negative bacteria, 385<br />

H. influenzae, 1747<br />

chloramphenicol, 1484<br />

letter to the editor, 1464<br />

LY163892, 1477<br />

M. avium, 1131<br />

M. tuberculosis, 125<br />

minireview, 1747<br />

N. gonorrhoeae, 1747<br />

pyrazinamide, 125<br />

S. aureus, 1464<br />

T. pallidum subsp. pallidum, 68<br />

T-25<br />

influenza viruses, 906<br />

T-26<br />

influenza viruses, 906<br />

T-3262<br />

B. catarrhalis, 663<br />

B. fragilis, 663, 1437<br />

C. trachomatis, 1080<br />

comparative activity<br />

ceftazidime, ciprofloxacin, gentamicin,<br />

imipenem, <strong>and</strong> ofloxacin, 663<br />

ciprofloxacin, ofloxacin, norfloxacin,<br />

<strong>and</strong> pipemidic acid, 827<br />

E. coli, 663, 827<br />

E. faecalis, 663<br />

Enterobacteriaceae, 663, 827<br />

Enterococcus spp., 827<br />

H. influenzae, 663<br />

N. gonorrhoeae, 663<br />

P. aeruginosa, 663, 827<br />

P. cepacia, 663<br />

P. maltophilia, 663<br />

S. aureus, 663<br />

S. epidermidis, 663<br />

Staphylococcus spp., 827<br />

Streptococcus spp., 827<br />

Talampicillin<br />

dental granuloma, 566<br />

Teicoplanin<br />

combinations<br />

Corynebacterium group JK, 434

xxxii SUBJECT INDEX<br />

gentamicin <strong>and</strong> tobramycin, 434<br />

Corynebacterium group JK, 434<br />

pharmacokinetics, 1223<br />

Temafloxacin<br />

comparative activity<br />

erythromycin, 1500<br />

M. hominis, 1500<br />

M. pneumoniae, 1500<br />

U. urealyticum, 1500<br />

Temocillin<br />

A. denitrificans subsp. xylosoxidans,<br />

276<br />

infusion system, 1705<br />

K. pneumoniae, 1705<br />

meningitis, 1705<br />

pharmacokinetics, 1705<br />

Terbinafine<br />

Aspergillus spp., 780<br />

comparative activity<br />

amphotericin B <strong>and</strong> ketoconazole, 780<br />

S. schenckii, 1619<br />

sporotrichosis, 1619<br />

Terminalia glaucescens<br />

B. gingivalis, 598<br />

B. melaninogenicus, 598<br />

Testosterone<br />

fluconazole, 646<br />

ketoconazole, 646<br />

Tetracaine<br />

E. coli permeability, 153<br />

Tetracycline<br />

B. bronchiseptica, 1891<br />

B. catarrhalis, 259<br />

B. fragilis resistance, 1271<br />

Bacillus spp., 642<br />

bite wound bacteria, 1143<br />

Bordetella spp., 137<br />

C. trachomatis, 1350<br />

Campylobacter resistance, 1793<br />

Chlamydia sp. strain TWAR, 257<br />

comparative activity<br />

demeclocycline, doxycycline, erythromycin,<br />

minocycline, nalidixic<br />

acid, oxytetracycline, <strong>and</strong> rifampin,<br />

986<br />

cryptic resistance determinant on<br />

Tn4400, 1797<br />

detoxification, 1797<br />

E. risticii, 986<br />

efflux, 1797<br />

Eubacterium spp. resistance, 1271<br />

F. nucleatum resistance, 1271<br />

fecal flora resistance, 1801<br />

H. ducreyi, 1458<br />

H. influenzae, 180<br />

letter to the editor, 951<br />

N. gonorrhoeae resistance, 488, 951<br />

N. perflava-N. sicca resistance, 1271<br />

Neisseria resistance, 488<br />

oral bacteria, 1271<br />

P. anaerobius resistance, 1271<br />

P. multocida, 213<br />

periodontal disease, 1271<br />

resistance<br />

degradation, 1797<br />

E. corrodens, 765<br />

efflux, 1797<br />

K. denitrificans, 765<br />

Neisseria spp., 765<br />

S. wien resistance, 1262<br />

Shigella spp., 20<br />

Streptococcus spp. resistance, 1271<br />

V. parvula resistance, 1271<br />

Theophylline<br />

GABA receptor, 1624<br />

y-aminobutyric acid receptor, 1624<br />

pharmacokinetics<br />

ciprofloxacin, effect of, 75<br />

norfloxacin, 510<br />

Thiamphenicol<br />

H. ducreyi, 1458<br />

Ticarcillin<br />

B. catarrhalis, 259<br />

dysgonic fermenter 2, 78<br />

Enterobacteriaceae, 873<br />

P. maltophilia, 782<br />

P. pseudomallei, 1435<br />

Ticarcillin-clavulanic acid<br />

A. denitrificans subsp. xylosoxidans, 276<br />

B. catarrhalis, 259<br />

Bacillus spp., 642<br />

comparative activity<br />

clindamycin-amikacin, 1557<br />

head <strong>and</strong> neck surgery in cancer<br />

patients, 1557<br />

letter to the editor, 407<br />

P. pseudomallei, 1435<br />

puerperal infections, 407<br />

wound infections, 1557<br />

Ticarcillin-potassium clavulanate<br />

Enterobacteriaceae resistance, 1365<br />

Tigemonam<br />

A. hydrophila, 84<br />

Acinetobacter spp., 84<br />

B. catarrhalis, 84<br />

Bacteroides spp., 84<br />

C. diversus, 84<br />

comparative activity<br />

aztreonam, cefaclor, <strong>and</strong> trimethoprim-sulfamethoxazole,<br />

346<br />

E. aerogenes, 84<br />

E. cloacae, 84<br />

E. coli, 84, 346<br />

Enterobacter spp., 84<br />

Enterobacteriaceae, 84<br />

Enterococcus spp., 84<br />

Haemophilus spp., 84<br />

Klebsiella spp., 84<br />

Listeria spp., 84<br />

Morganella spp., 84<br />

Neisseria spp., 84<br />

Proteus spp., 84<br />

Providencia spp., 84<br />

Pseudomonas spp., 84, 346<br />

S. marcescens, 84<br />

S. pneumoniae, 84<br />

Salmonella spp., 84<br />

Shigella spp., 84<br />

Streptococcus spp., 84, 346<br />

Y. enterocolitica, 84<br />

Tinidazole<br />

T. vaginalis, 144<br />

Tobramycin<br />

A. denitrificans subsp. xylosoxidans,<br />

276<br />

B. catarrhalis, 259<br />

combinations<br />

amiloride, 395<br />

ampicillin, 1231<br />

biliary tract infections, 1231<br />

ciprofloxacin, 782<br />

P. maltophilia, 782<br />

Pseudomonas spp., 395<br />

comparative activity<br />

norfloxacin, 1820<br />

conjunctivitis, 1820<br />

ANTIMICROB. AGENTS CHEMOTHER.<br />

E. coli, 450<br />

lipopolysaccharide, 1247<br />

Enterobacteriaceae, 873<br />

H. influenzae, 1820<br />

iontophoretic application, 978<br />

K. pneumoniae resistance, 1379<br />

keratitis, 978<br />

ocular infections, 1820<br />

P. aeruginosa, 978<br />

alginate binding, 518<br />

P. maltophilia, 782<br />

pharmacokinetics<br />

charcoal, effect of, 274<br />

postantibiotic effect, 450<br />

Pseudomonas spp., 395<br />

S. aureus, 1820<br />

resistance, 932<br />

S. marcescens resistance, 1379<br />

S. pneumoniae, 1820<br />

Staphylococcus spp., 1820<br />

streptococci, alpha-hemolytic, 1820<br />

Tobramycin-ampicillin<br />

biliary tract infections, 1231<br />

comparative activity<br />

cefoperazone, 1231<br />

Tonsillectomy<br />

erythromycin<br />

acistrate, 1019<br />

stearate, 1019<br />

tissue <strong>and</strong> plasma concentrations,<br />

1019<br />

roxithromycin, 1461<br />

Torulopsis glabrata<br />

cilofungin, 1331<br />

Total hip arthroplasty<br />

vancomycin bone concentrations, 1320<br />

Toxoplasma gondii<br />

A-56268, 524<br />

azithromycin, 524, 755<br />

enzyme-linked immunosorbent assay,<br />

303<br />

ornithine decarboxylase inhibitors, 303<br />

piritrexim, 430<br />

pyrimethamine, 303<br />

roxithromycin, 524<br />

spiramycin, 303, 524<br />

sulfadoxine, 303<br />

Translocation<br />

enterococci, 1769<br />

Treponema hyodysenteriae<br />

sedecamycin, 458<br />

Treponema pallidum<br />

erythromycin resistance, 164<br />

roxithromycin resistance, 164<br />

Treponema pallidum subsp. pallidum<br />

susceptibility testing, 68<br />

Triazoles<br />

minireview, 1<br />

Trichodermin<br />

M. racemosus, 341<br />

Trichomonas vaginalis<br />

aminoglycosides, 144<br />

amphotericin B, 1323<br />

anisomycin, 144<br />

antifungal agents, 144<br />

P-lactams, 144<br />

chemotaxis, 1323<br />

folic acid antagonists, 144<br />

furazolidone, 144<br />

gentamicin, 1323<br />

imidazoles, 1323<br />

ketoconazole, 1323<br />

macrolides, 144

VOL. 32, 1988<br />

mebendazole, i44<br />

metronidazole, 144, 1323<br />

miconazole, 1323<br />

Nonoxynol-9, 1323<br />

penicillin, 1323<br />

tinidazole, 144<br />

Trichophyton spp.<br />

G2, 1586<br />

Trimethoprim<br />

combinations<br />

dapsone, 623<br />

P. carinii, 623<br />

pneumonia, 623<br />

rifampin <strong>and</strong> sulfamethoxazole, 802<br />

urinary tract infections, 802<br />

Enterobacteriaceae, 873<br />

H. ducreyi, 1458<br />

H. influenzae resistance, 477<br />

P. carinii, 96<br />

S. sonnei resistance, 1598<br />

Shigella spp., 20<br />

Trimethoprim-sulfamnethoxazole<br />

A. denitrificans subsp. xylosoxidans,<br />

276<br />

B. catarrhalis, 259<br />

Bacillus spp., 642<br />

comparative activity<br />

ciprofloxacin, 1327<br />

dapsone, pentamidine, <strong>and</strong> trimethoprim-dapsone,<br />

623<br />

cystitis, 1640<br />

dysgonic fermenter 2, 78<br />

E. coli, 1640<br />

Enterobacteriaceae, 1327<br />

H. ducreyi, 1458<br />

H. influenzae, 180<br />

P. carinii, 623, 1158<br />

P. multocida, 213<br />

pharmacokinetics, 1640<br />

pneumonia, 623<br />

Shigella spp., 20<br />

urinary tract infections, 1327<br />

Trimetrexate<br />

high-pressure liquid chromatography,<br />

324<br />

P. carinii, 324<br />

pharmacokinetics, 324<br />

Tromethamine fosfomycin<br />

pharmacokinetics, 938<br />

young <strong>and</strong> elderly adults, 938<br />

Trospectomycin<br />

B. catarrhalis, 216<br />

B. fragilis, 584<br />

Bacteroides spp., 216, 584<br />

C. trachomatis, 216<br />

C. difficile, 216<br />

Chlamydia sp. strain TWAR, 257<br />

Clostridium spp., 216<br />

comparatiVe activity<br />

ampicillin, cefaclor, cefoxitin, clindamycin,<br />

<strong>and</strong> doxycycline, 584<br />

ampicillin, gentamicin, <strong>and</strong><br />

spectinomycin, 216<br />

Enterobacteriaceae, 216<br />

H. influenzae, 216<br />

N. gonorrhoeae, 216<br />

Proteus spp., 216<br />

Staphylococcus spp., 216<br />

Streptococcus spp., 216<br />

Trypanosoma brucei gambiense<br />

stearylamine- <strong>and</strong> phosphatidylcholineliposomes,<br />

966<br />

Trypanosoma cruzi<br />

nifurtimox, 241<br />

immune response, effect on, 241<br />

P536, 1412<br />

UDP-glucose analog, 1412<br />

Trypanosoma (Schizotrypanum) cruzi<br />

ketoconazole, 1237<br />

ketoconazole-SF 86-327, 1237<br />

SF 86-327, 1237<br />

Tubercidin<br />

influenza viruses, 906<br />

Tumor necrosis factor<br />

combinations<br />

amikacin, azithronycin, <strong>and</strong><br />

roxithromycin, 1149<br />

M. avium complex, 1149<br />

Tylosin<br />

Arthrobacter spp., 420<br />

E. coli<br />

heat treatment, 1680<br />

Staphylococcus spp., 420<br />

U-76,252<br />

A. hydrophila, 1082<br />

B. catarrhalis, 1082<br />

C. diversus, 1082<br />

comparative activity<br />

amoxicillin, amoxicillin-clavulanic<br />

acid, cefaclor, cefuroxime, cephalexin,<br />

<strong>and</strong> erythromycin, 1082<br />

E. coli, 1082<br />

E. faecalis, 1082<br />

Enterobacteriaceae; 1082<br />

H. influenzae, 1082<br />

Klebsiella spp., 1082<br />

P. aeruginosa, 1082<br />

P. mirabilis, 1082<br />

Staphylococcus spp., 1082<br />

Streptococcus spp., 1082<br />

U-76,253A<br />

Acinetobacter spp., 443<br />

B. catarrhalis, 443<br />

comparative activity<br />

amoxicillin, amoxicillin-clavulanic<br />

acid, cefaclor, cefixime, <strong>and</strong> cefuroxime,<br />

443<br />

Enterobacteriaceae, 443<br />

enterococci, 443<br />

H. influenzae, 443<br />

Neisseria spp., 443<br />

pneumococci, 443<br />

Pseudomonas spp., 443<br />

S. aareus, 443<br />

Staphylococcus spp., 443<br />

Streptococcus spp., 443<br />

UDP-glucose analogs<br />

herpes simplex virus type 1, 1257<br />

P-536, 1257, 1412<br />

T. cruzi, 1412<br />

Ureaplasma urealyticum<br />

A-63075, 1500<br />

clarithromycin, 1500<br />

difloxacin; 1500<br />

erythromycin, 1500<br />

temafloxacin, 1500<br />

Uridine<br />

3'-azido-3'-deoxythymidine toxicity,<br />

997<br />

AZT toxicity, 997<br />

Urinary tract infections<br />

berberine sulfate, 1274<br />

carumonam, 473, 1031<br />

SUBJECT INDEX xxxiii<br />

ceftazidime, 1031<br />

ciprofloxacin, 1327<br />

Enterobacteriaceae, 1327<br />

gentamicin, 473<br />

norfloxacin, 1292<br />

rifampin-trimethoprim, 802<br />

sulfamethoxazole-trimethoprim, 802<br />

trimethoprim-sulfamethoxazole, 1327<br />

Ursodeoxycholate<br />

biliary excretion<br />

cefotiam, 726<br />

sulbenicillin, 726<br />

Vaccinia virus<br />

P-536, 1257<br />

sulfated polysaccharides, 1742<br />

Vancomycin<br />

Bacillus spp., 642<br />

bone concentrations<br />

osteomyelitis, 1320<br />

total hip arthroplasty, 1320<br />

cardiopulmonary bypass, 631<br />

catheters, 1627<br />

combinations<br />

Corynebacterium group JK, 434<br />

gentamicin <strong>and</strong> tobramycin, 434<br />

comparative activity<br />

cefam<strong>and</strong>ole, cefazolin, <strong>and</strong> daptomycin,<br />

63<br />

daptomycin, 454<br />

Corynebacterium group JK, 434<br />

dysgonic fermenter 2, 78<br />

E. coli<br />

heat treatment, 1680<br />

endocarditis, 63<br />

pharmacokinetics, 92, 631, 848<br />

S. aureus, 454<br />

MBCs, 374<br />

S. epidermidis, 63, 1627<br />

Vancomycin-ceftazidime<br />

pharmacokinetics, 92<br />

Varicella-zoster virus<br />

acyclovir triphosphate, 1137<br />

3'-azido-3'-deoxythymidine, 265<br />

AZT, 265<br />

B-220, 1720<br />

buciclovir triphosphate, 1137<br />

9-(3,4-dihydroxybutyl)guanine triphosphate,<br />

1137<br />

DNA polymerases, 1137<br />

9-[4-hydroxy-2(hydroxymethyl)butyl]<br />

guanine triphosphate, 1137<br />

9-(2-hydroxyethoxymethyl)guanine triphosphate,<br />

1137<br />

Veillonella parvula<br />

tetracycline<br />

resistance, 1271<br />

Vernamycin B<br />

Arthrobacter spp., 420<br />

Staphylococcus spp., 420<br />

Vernonia amygdalina<br />

B. gingivalis, 598<br />

B. melaninogenicus, 598<br />

Vesicular stomatitis virus<br />

carrageenans, 1742<br />

dextran sulfate, 1742<br />

fucoidan, 1742<br />

P-536, 1257<br />

pentosan polysulfate, 1742<br />

ribavirin, phosphorylated, 492<br />

sulfated polysaccharides, 1742<br />

transcription, 492

xxxiv SUBJECT INDEX ANTIMICROB. AGENTS CHEMOTHER.<br />

Virus-antigen assays<br />

human immunodeficiency virus type 1,<br />

684<br />

Vitamin K<br />

cefotetan effect on metabolism, 1446<br />

cefoxitin effect on metabolism, 1446<br />

Wound infections<br />

clindamycin-amikacin, 1557<br />

ticarcillin-clavulanic acid, 1557<br />

WR 194,965 phosphate<br />

crystal <strong>and</strong> molecular structure, 540<br />

Xanthomonas maltophilia<br />

E-1040, 1666<br />

Xylotubercidin<br />

influenza viruses, 906<br />

Yersinia enterocolitica<br />

tigemonam, 84<br />

Yersinia spp.<br />

R-3746, 671<br />

YTR 830<br />

1-lactamases, 925<br />

C. freundii, 925<br />

comparative activity<br />

clavulanic acid <strong>and</strong> sulbactam,<br />

925<br />

E. cloacae, 925<br />

E. coli, 925<br />

K. aerogenes, 925<br />

mechanisms of action, 925<br />

P. mirabilis, 925<br />

Zinc<br />

common cold, 605, 606, 608<br />

letters to the editor, 605, 606, 608

logo

Prodotti

Risorse

Aziende

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!